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ABSTRACT
OBJECTIVES : Extant experimental research implicates sleep disturbance as causal to
dysregulation of emotional processes and neurocognitive functioning. Clinical research
with psychiatric samples suggests that sleep disturbance may be an etiological or
sustaining factor in certain conditions, rather than solely a symptom. Recently proposed
models have hypothesized cognitive-affective processing (CAP) as a potential mediator
for the relationship between sleep disturbance and depressed mood. This study
investigated relevant neuropsychological and sleep-physiological variables to explore the
applicability of this type of model within a sleep apnea referral sample.

METHODS: 61 participants referred for polysomnogram also completed self-report
measures of mood and sleep, as well as a neuropsychological battery consisting of
standard neurocognitive measures and novel cognitive-affective processing counterpart
measures.

RESULTS: Correlational and ANCOVA analyses suggested cognitive-affective
processing measures were potentialy more sensitive toward dysfunction secondary to
sleep-disordered breathing than standard neurocognitive measures. Regression analyses
were mixed, while most of the a priori model was confirmed, unexpected null findings
between sleep physiology and depression suggested poor fit for this sample. Exploratory
analyses suggest there may be a more complex model relating the three constructs of
interest, incorporating related sleep physiology and affective state constructs.
iv

CONCLUSIONS: Within our sample, findings suggest dysfunctional sleep-breathing
physiology impacts the affective valence of previously identified subcortical-frontal
retrieval dysfunction. The relative absence of findings within standard measures suggests
that cognitive-affective processing measures may be more sensitive to finer gradients of
sleep disturbance severity. Additionally, this finding is independent of the incidental
findings that the cognitive-affective processing is sensitive to negative mood and
psychological distress about lack of sleep, suggesting the neurocognitive measure is
sensitive to both physiological and psychological sequelae. This study provides initial
support for a neuropsychological measure of how humans process emotionally-laden
information, which has significant potential for use in research and clinical fields. Future
research will generate normative data for the novel cognitive-affective processing
measures, as well as explore the original and expanded model of negative mood within
other psychiatric and neurological samples.
Keywords: Sleep, Cognitive Processing, Emotional Processing, Depression, Obstructive
Sleep Apnea
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CHAPTER 1
INTRODUCTION
Relevance & Importance
Deficits in sleep quality and associated sleep loss are experienced by nearly all people at
some point during life, whether from lifestyle or disorder, and whether chronic or acute.
These periods of disturbed sleep are usually limited in their length and incidence, but for
many individuals they can last for extended lengths of time, and often re-emerge at
various points of a lifetime. Even relatively mild and limited periods of disturbed sleep
are associated with a myriad of daytime behavioral impairments. Research has estimated
that the overall prevalence rate of adults obtaining insufficient sleep is 20% (Hublin,
Kaprio, Partinen, & Koskenvuo, 2001). Additionally, a study of over 1,000 young adults
over 5.5 years found that the degree of this partial sleep deprivation was proportional to
the amount of daytime sleepiness experienced (Breslau, Roth, Rosenthal, & Andreski,
1997). Neurocognitive functioning is thought to mediate the relationship between
sleepiness and behavioral performance decrements, which in turn are directly related to
the occurrence of functional accidents in everyday life.
Overall, accidents related to some degree of sleep deprivation have been
estimated to have an economic impact ranging between $43 and $56 billion (U.S.; Leger,
1994). Motor vehicle collisions are the most commonly associated cost of sleep
deprivation, yet are thought to be highly underestimated (Horne & Reyner, 1999;
McCartt, Ribner, Pack, & Hammer, 1996; Mitler, Carskadon, Czeisler, Dement, Dinges,
& Graebner, 1988). In addition to motor vehicle collisions, sleep deprivation research has
repeatedly found that airline pilots (Bourgeois-Bougrine, Casrbon, Counelle, Mollard, &
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Coblentz, 2003; Price & Holley, 1990), truck drivers (Lyznicki, Doege, Davis, &
Williams, 1998; McCartt, Rohrbaugh, Hammer, & Fuller, 2000), medical residents
(Landrigan, Rothschild, Cronin, Kaushal, Burdick, Katz, et al., 2004; Lockley, Barger,
Ayas, Rothschild, & Czeisler, 2007), shift workers (Richardson, Miner, & Czeisler, 19891990), and other professions are at high risk for making high-damage accidents due to
sleepiness and its related sequelae. Blood alcohol content (BAC) is a useful comparison
metric for sleep deprived populations. Driving performance for those deprived of one
night of sleep was found to be equivalent to those non-sleep deprived individuals driving
with a BAC of 0.07% (Fairclough & Graham, 1999); for comparison, driving in the state
of Michigan or Ontario with a BAC of 0.08% or higher is illegal. Multiple other studies
have found that as uninterrupted waking periods exceed 16 hours, psychomotor
performance impairments progressively increase to levels comparable to BACs ranging
between 0.05% and 0.1% (Dawson & Reid, 1997; Williamson & Feyer, 2000).
In addition to functional accidents, disturbed sleep is demonstrated to cause
significant quality of life decrements, which strongly drive patients to seek assistance.
Reimer and Flemons (2003) conducted a literature review investigating how sleep quality
and quantity correlated with a wide range of domains that contribute to quality of life.
They found that across all measures and etiologies of disturbed sleep, quality and
quantity of sleep were related to some or all measures. For instance, the large Sleep Heart
Health Study (n = 5816), in which 90% of participants received an in-home
polysomnograph, found that those suffering from excessive daytime sleepiness had
significantly poorer quality of health in all subscales measured (Baldwin, Griffith, Nieto,
O’Connor, Walsleben, & Redline, 2001). In clinical sleep-disordered breathing
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populations (of which obstructive sleep apnea is the predominant diagnosis),
symptomatic fragmented sleep (meaning many sub-conscious arousals from deep sleep
throughout a night) has been associated with increased mortality, abnormal waking
electroencephalograms (EEG), metabolic and endocrine dysregulation, decreased
immune and inflammatory responsivity, and cardiovascular sequelae (Dinges, Rogers, &
Baynard, 2005). In sum, sleepiness secondary to poor sleep is associated with
neurocognitive dysfunction, behavioral accidents, and quality of life decrements (both
mood and functional).
Relatively recent improvements in the methodology available for sleep research
(e.g. polysomnogram, functional imaging) have allowed for more detailed investigation
of the relationship between quality and quantity of sleep and daytime behavioral
outcomes. The following sections will briefly review the current understanding of sleep
physiology, explain how it relates to neurocognitive processing, cognitive-affective
processing, and mood, and finally introduce a published cognitive model of sleepdependent emotional processing in order to guide proposed investigation of
neuropsychological functioning in obstructive sleep apnea.

Sleep
The following section is a significantly condensed overview of sleep physiology,
emphasizing the introduction and definition of terminology that is relevant to the present
study. An expanded version of this section is available in Appendix A.
Sleep Stages and Characteristics
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Sleep in mammalian species has been generally categorized into two separate types rapid eye movement (REM) sleep, and non-rapid eye movement (NREM) sleep, which
has predominantly been further subdivided in primates into four, progressively deeper,
stages (Rechtschaffen & Kales, 1968). Research in human sleep patterns has identified a
90 minute alternating, ultraradian cycle between NREM and REM sleep. The American
Academy of Sleep Medicine (AASM; Iber, 2007) recently updated the terminology used
to break sleep down based on electroencephalograph (EEG) readings into REM sleep,
and NREM stages labeled N1, N2, N3.
Table 1 summarizes the EEG (AASM, 2007; Steriade & Amzica, 1998),
neurochemical (Rosenthal, 1998; Saper, Chou, & Scammell, 2001), and functional
anatomic characteristics (Nofzinger, 2005) associated with each stage.
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Table 1
Summary of EEG, Neurochemical, and Neurofunctional Characteristics of Sleep Stages
State

EEG

Awake

Desynchronized
beta waves (12-30
Hz)

N1

Transition from
alpha waves (8-12
Hz) to theta waves
(4-7 Hz)

N2

N3

REM

11-16 Hz, but
predominately 1214 Hz

0-4 Hz, at least
20% delta waves
(0.5-2 Hz)

Theta wave
reemergence (4-7
Hz)
High frequency
gamma waves (3080 Hz)

EEG
markers

Sleep Characteristics

Neurochemical

Functional

RAS efferents to
HT, THAL, BFB
Use CA, HTM,
ACh, Asp, Glu
Drowsiness
If woken, will report
not having been asleep
Sleep
spindles

Tranquil state
maintained

K-complexes

50% of total sleep time

Slow-wave
sleep (SWS)

Mass cortical
synchronization
(organization
processing related to
daytime cognition)
Rapid eye movement
bursts in rhythm with
PGO waveforms

PGO waves
(originating
from pons,
LGNT, &
OC)

20-25% of total sleep
over 4-5 periods
Descending muscle
atonia & increased
variability of
heart/breathing rate &
temperature

GABAergic
neurons in cortex,
THAL, and HT
highly active
Decreased
subcortical
cholinergic
systems of
forebrain and
brainstem

ACh neurons of
PT = "REM-on
cells," highly
active
5HT & NE
neurons of Raphe
& LC = "REM-off
cells," are
deactivated

Reduced activity
of the PFC, TL,
BG, THAL,
brainstem
Reduction level
intensifies with
progression
through N1-N3

Increased
activity of the
mbPFC, OC,
Thalamic nuclei,
PT, ACC,
AMYG, HPC
Decreased
activity of the
PCC, PL, dlPFC

Note, top-bottom & left-right: PGO - Ponto-geniculo-occipital, LGNT - lateral geniculate
nucleus of the thalamus, OC - occipital cortex, RAS - reticular activating system, HT
- hypothalamus, THAL - thalamus, BFB - basal forebrain, CA - catelcholomines,
HTM - histamine, ACh - acetylcholine, Asp - asparate, Glu - glutamate, GABA gamma-aminobutryic acid, PT - pontine tegmentum, 5HT - serotonin, NE norepinepherine, LC - locus coeruleus, (mb/dl) PFC - (mediobasal/dorsolateral)
prefrontal cortex, TL - temporal lobe, BG - basal ganglia, OC - occipital cortex,
ACC - anterior cingulate cortex, AMYG - amygdala, HPC - hippocampus, PCC posterior cingulate cortex, PL - parietal lobe
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Sleep-Wake Cycle
Three separate yet networked neuroanatomical systems regulate the sleep-wake cycle in
humans (Borbely & Achermann, 1999; Pace-Schott & Hobson, 2002).
A homeostatic regulation system is responsible for intensity, length, and quantity
of sleep. Adenosine has been identified as a molecular-level somnogen integral to this
system at the cellular level. During wakeful periods, it is hypothesized to naturally
accumulate to levels that impact sleep/wake related areas of the brain. This nucleoside
has an activating effect on ventrolateral preoptic area neurons bordering the basal
forebrain and an inhibitory effect on wake-promoting areas of the basal forebrain
(Porkka-Heiskanen, Strecker, Thakkar, Bjorkum, Greene, & McCarley, 1997). Thus,
during wakeful accumulation of adenosine, a drive towards sleep accrues. Preoptic neural
circuitry has been associated with the homeostatic functions.
A circadian system manages the timing of sleep and wake periods within the
overall day-night cycle, promoting both wakefulness and sleep - at opposite phases. The
anterio-hypothalamic elements are associated with circadian functions. The circadian
timing system (CTS) is comprised of three components, the central of which is the
suprachiasmatic nucleus (SCN) of the anterior hypothalamus, which acts as a circadian
pacemaker - coordinating circadian oscillator subcomponents via control over melatonin
secretion by the pineal gland (Rossenwasser & Turek, 2005). The SCN is responsible for
establishing the sleep-wake circadian rhythm. The SCN is entrained (i.e., synchronized)
via physiological and environmental signals. The subcomponent circadian-oscillators in
peripheral tissues are in turn entrained by physiological signals from the pacemaker
component. Peripheral circadian oscillators are understood also to contain endogenous,

6

cellular-level pacemaker "clock cells," independent of the circadian system as a whole
(Herzog, 2007). The SCN is thus thought to entrain the various peripheral cellular
oscillators rather than sustain their rhythmic activity (Okamura, 2004). The third
component of the CTS are the efferent projections that serve to regulate otherwise nonrhythmic physiological and behavioral systems (e.g., body temperature,
autonomic/endocrine systems, feeding, sleep/wake state, locomotor activity).
The cyclical vacillation between REM and NREM sleep within each sleep period
is controlled by an ultradian system. Mesencephalic and pontine rostral brainstem areas
are associated with REM/NREM regulation; Table 1 offers more details.
Saper, Chou, and Scammell (2001) reviewed recent literature on sleep regulation
and identified a substantial amount of evidence that a reciprocal inhibition model of sleep
and arousal systems exists; they termed it a sleep-wake switch. GABAergic and
galaninergic neurons of the ventrolateral preoptic nucleus (VLPO) are active and
necessary for normal sleep. In contrast, hypocretin/orexin (exchangeable names) neurons
within the posterior lateral hypothalamus (PLHT) are necessary for maintaining normal
wakefulness. These two systems are thought to exist in a sustained state of balanced
reciprocal inhibition (a bi-stable feedback loop) when not influenced from external
pressures. Once either of the systems is excited, it inhibits the other, thereby resulting in
further excitation due to decreased inhibitory afferents from its partner. In sum, human
sleep physiology can be conceptualized as three gears nested within each other, with the
transition between sleep and wakefulness occurring in rapid fashion when the
homeostatic and circadian gears align.
Sleep Deprivation
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Basal sleep need is defined as habitual sleep duration in the absence of any sleep debt.
Sleep debt is conceptualized as "the fundamental duration of sleep below which waking
deficits begin to accumulate" (Dinges, Rogers, & Baynard, 2005, p. 68). Both
experimental and epidemiologic research has found high interindividual variance in
amount of sleep habitually obtained. A large study found that after long-duration sleep
designed to eliminate sleep debt, average sleep length stabilized at 8.17 hours (Wehr,
Moul, Barbato, Giesen, Seidel, Barker, & Bender, 1993); another large, dose-dependent
sleep deprivation study statistically estimated a daily requirement of 8.16 hours of sleep
to avoid negative impacts on functioning during the subsequent wake period (Van
Dongen, Maislin, Mullington, & Dinges, 2003). The following section will discuss a
number of past and present theoretical frameworks for understanding sleep deprivation.
Models
In the 1980's, a two component hypothesis of sleep gained popularity - core and optional
sleep (Horne, 1988). The analogy of appetite was cited by its proponents, in which
hunger cues consumption of food until satiation, but additional food can be consumed
beyond the body's immediate need. Core sleep is composed of primarily slow wave sleep,
and it is the quality and length of this period of sleep that determines the degree of
daytime cognitive functioning and alertness. Optional sleep is conceptualized as
superfluous, or a luxury without confirmed function; one proposed possibility is that
optional sleep serves as an evolutionary behavioral carry-over meant to keep the
individual withdrawn and safe during the remaining hours of darkness. Proponents
redefined the average amount of core sleep required each night from 4-5 hours to 6 hours.
However, if this were true, chronic sleep restriction of 6 hours would not be expected to
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result in detrimental functional impacts in humans, which is not the case (Van Dongen,
Maislin, Mullington, & Dinges, 2003). That study will be addressed in more detail below.
Another hypothesis proposes that at the onset of a chronic restriction of sleep
time, acute neurobehavioral functioning decrements occur, but that over time individuals
are able to adapt to the new, reduced sleep period. Research has shown that self-reports
of sleepiness drop after an initial spike when sleep time is chronically restricted to 4-6
hours per night, up to 8 months (Belenky, Wesensten, Thorne, Thomas, Sing, Redmond,
et al., 2003; Lubin, 1967). Abruptness of sleep restriction is an important moderating
factor within this hypothesis, with research demonstrating that gradual (versus
precipitous) accumulation of a set amount of sleep debt resulted in neurobehavioral
performance decrements smaller in magnitude (Van Dongen, Maislin, Mullington, &
Dinges, 2003). Other research suggests that adaptation to sleep deprivation may differ
depending on which neurobehavioral outcomes are measured. It appears that waking
EEG and non-REM slow-wave sleep (SWS) show the most and quickest adaptation,
subjective sleepiness shows slower and less adaptation, and that neurocognitive
functioning shows the slowest and least adaptation to sleep deprivation (Van Dongen,
Rogers, Dinges, 2003; Van Dongen, et al., 2003).
A bio-mathematical two-process model taps the well-researched regulation
components of sleep: (1) the homeostatic process that exponentially builds during waking
periods and exponentially declines during SWS periods, and (2) a near-24 hour circadian
regulation process. The hypothesis proposes that wakeful cognition is primarily based on
alertness (A), and that this construct could be mathematically modeled as the quantitative
difference between the homeostatic process (S) and the circadian process (C): A=S-C. In
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a blind study, this model was found to accurately predict neurobehavioral responses
based on total sleep deprivation, but failed to accurately predict cognitive performance
and sleepiness across a chronic sleep deprivation paradigm (Borbely & Achermann,
1999).
All of the prior hypotheses and models share a common feature in their
conceptualization of chronic sleep deprivation, which is an emphasis on cumulative sleep
time lost. The "wake extension" hypothesis approaches alterations of the sleep-wake
cycle from a different angle, instead emphasizing cumulative wake-time cost. Proponents
attempted to reconcile the neurocognitive results found in complete sleep deprivation and
those from chronic sleep deprivation by positing that during periods of wakefulness,
neurobiological costs/consequences accumulate (Van Dongen, Maislin, Mullington, &
Dinges, 2003).
Researchers used a sleep dose-response experiment (8, 6, or 4 hours in bed across
two weeks, and a 0 hours in bed condition across 3 days) to investigate their hypothesized
model. Results showed a near-linear accumulation of cognitive performance deficits
across all conditions. The rate (slope) of deterioration was inversely related to amount of
sleep time; the 0 hour condition demonstrated the highest rate of deterioration. At the two
week period, the 4 hours time in bed (TIB) condition was performing with similar
cognitive decrements to the 0 hours TIB at the three day mark. Calculating the
cumulative sleep loss for each condition reveals that the 4 hour TIB group had lost
approximately 55 hours of sleep, whereas the 0 hours TIB group had lost approximately
25 hours. To reconcile this inconsistent observation, the wake-extension time (defined as
"continuous wake duration" - "habitual wake duration") was calculated for each group.
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This approach resulted in the same values across the restricted sleep conditions as the
previous approach. However, for the full sleep deprivation condition, each day after the
end of the first "habitual wake duration" added a full 24 hours to the wake extension
time, thereby bringing the observed deficits into alignment with quantification of
sleep/wake disruption (for visual representation of this phenomenon, see Figure 4 within
the Van Dongen et al., 2003 paper). This study clearly demonstrates that cumulative
wake extension and cumulative sleep loss are different constructs with different
quantitative values dependent on how sleep loss occurs. Further, it suggests that the field
should conceptualize sleep debt as an accrual of wakefulness beyond roughly 16 hours
with an associated neurobiologic cost.

Disturbed Sleep & Neurobehavioral Functioning
Sleep deprivation results in increased sleep propensity, as measured by reduced sleep
onset latency and reduced latency between the transition from lighter NREM sleep to
SWS on polysomnograms (PSG; Carskadon & Dement, 1987). After one night of
complete sleep deprivation, average sleep onset latency drops to less than 1-2 minutes,
and the time to progress from sleep onset to deep SWS is halved (Dinges, 1986).
Progressive reductions in daytime sleep onset latency has also been demonstrated in a
week long, 5 hour sleep restriction paradigm (Carskadon & Dement, 1981). Increased
sleep propensity, even when being resisted, results in the occurrence of microsleeps
intruding into wakefulness (Akerstedt, 1987). The state instability hypothesis posits that
neurocognitive performance becomes progressively more variable as homeostatic
pressure accumulates and increasingly disrupts normal neurocognitive processing, which
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begins to become more dependent on compensatory mechanisms (Doran, Van Dongen, &
Dinges, 2001). Behavioral examples of these compensatory mechanisms include sleepdeprived individuals falling asleep while walking and "semidreaming" while performing
verbal cognitive tasks (Kleitman, 1963; Dinges, 1990). Errors of commission are
explained as ineffective compensatory efforts initiated during the resistance of sleep
(Durmer & Dinges, 2005). Thus, at any given moment, sleep deprived individuals
produce widely varied neurocognitive and neurobehavioral performance.
Effects of Disturbed Sleep on Cognitive & Behavioral Functioning
There are several broad findings in the research addressing cognitive performance in
sleep deprived and partial sleep deprived healthy individuals that must be considered
before reviewing domain-specific findings. Research suggests that sleep deprivation often
has unexpectedly measure-specific performance impacts; for example, a study found that
after a 5 night, 40% reduction of habitual sleep time, performance decrements on a
measure of vigilance and simple reaction time were observed but no deficits were noted
on a measure of choice reaction time (Herscovitch & Broughton, 1981). This may be due
to psychometric properties of different measures, or perhaps that the impact of sleep
deprivation is nuanced and focal rather than broad, even within traditionally internally
consistent cognitive domains (Dinges, Rogers, & Baynard, 2005). Cognitive decrements
have generally been found to be dose-dependent to the amount and length of sleep
restriction (Belenky, Wesensten, Thorne, Thomas, Sing, Redmond, et al., 2003). As
previously discussed, extended periods of restricted sleep have an accumulating
impairing effect that can eventually become equivalent to acute sleep deprivation (Van
Dongen, Maislin, Mullington, & Dinges, 2003). Finally, neurobehavioral performance
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deficits associated with sleep deprivation vary significantly between individuals, above
and beyond differences in sleep histories. In fact, it appears that vulnerability or
resiliency to sleep deprivation is a trait, though no neurobiological correlates have been
identified thus far (Van Dongen, Baynard, Maislin, & Dinges, 2004). Though average
deficits scores are stable within-subjects, a hallmark of sleep deprivation is a significant
increase in variability of test performance, between and within measures; this is thought
to reflect the transitory nature of attentional lapses (Waters & Buck, 2011).
To offer a launching point for the following discussion, consider the following. A
large meta-analysis has concluded that upon collapsing measures of three areas of
functional level (cognition, mood and fatigue, and motor functioning), "any sleepdeprived individual is estimated to be comparable to the 9th percentile of non-sleepdeprived subjects" (p. 120, Durmer & Dinges, 2005). Effect sizes for the impact of sleep
loss have generally been classified in the moderate range (Lim & Dinges, 2010). Metaanalysis also found that cognition and mood were affected worse by partial sleep
deprivation than total, though the reverse is true for behavior (Pilcher & Huffcutt, 1996).
In general, performance on cognitive tasks becomes progressively worse as task
engagement time is extended, in an exacerbated "fatigue" effect phenomenon (Kribbs &
Dinges, 1994). Conversely, brief measures with an emphasis on speed or time also are
sensitive (Dinges, 1992). Finally, early theories on cognitive decrements following
disrupted sleep hypothesized that decreased motivation mediated the performance
deficits. However, sleep deprived populations have been demonstrated to pass
neuropsychological measures of adequate effort, as well as perform poorly on high
novelty tasks designed to be intrinsically engaging, suggesting that interest and effort are
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not significant etiological factors in explaining cognitive performance declines (Harrison
& Horne, 2000; Wilkinson, 1961).
Durmer and Dinges (2005) reviewed the literature on the neuropsychological
performance impact of sleep deprivation and identified a number of reliably affected
cognitive processes. This section summarizes the majority of their findings, and includes
more recent research findings to expand upon their review. First, there will be a
discussion of the cognitive findings associated with large amounts of sleep deprivation
(i.e. 4 or less hours per night), then these will be related to partial sleep deprivation and
fragmented sleep.
Individuals who have been deprived of sleep demonstrate slowing on subjectpaced tasks, and make increased errors when a time pressure component is present. Not
unexpectedly, this processing speed deficit is also reliably demonstrated in reaction time
measures. Speed of information processing has been demonstrated to be reliably
impacted by any disruption of normal sleep, with a 27 study meta-analysis finding that
speed was the most impacted cognitive construct, followed by accuracy (Koslowsky &
Babkoff, 1992; Waters & Bucks, 2011). Eye-hand coordination and psychomotor
performance consistently show decrements of roughly 30% in speed and accuracy after
sleep deprivation (Williamson & Feyer, 2000).
Tasks that require continued attention and vigilance are negatively impacted by
sleep deprivation, with increases in omission and commission errors. The functional
impact of increased attentional fatigue negatively affects performance on sustained
attention measures, as well as on other neuropsychological measures that require
extended periods of attention. In fact, a meta-analysis of 70 studies concluded that
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extended simple attention is more significantly impacted than performance on tasks
requiring divided attention (Lim & Dinges, 2010). For example, on cognitive tasks with a
learning component, sleep deprived individuals are less efficient at reaching equivalent
levels of acquisition, though often can reach normative expected performance levels
when given additional time and exposure to the stimuli. Short-term recall for successfully
encoded information has also been shown to suffer post-sleep deprivation. After 1 night
of sleep deprivation, individuals scored worse on measures of visual and verbal shortterm memory, and performance was related to the magnitude of abnormally decreased
intraparietal sulcus and hippocampal activity (Chee & Chuah, 2007; Chen, Hardy, Zhang,
LaHoste, & Bazan, 2006; Van der Werf, Altena, Schoonheim, Sanz-Arigita, Vis, De
Rijke, et al., 2009). Working memory tasks that require maintenance and manipulation of
information from multiple modalities are compromised as well, resulting in difficulty
with temporal organization of information, decreased ability to maintain flexible
thinking, and decreased ability to filter distractions and maintain focus on relevant
information and cues. One study estimated working memory performance drops
averaging 37% after large amounts of sleep deprivation (Turner, Drummond, Salamat, &
Brown, 2007).
Neuropsychological measures thought to rely on more complex cognitive
processes have often been considered insensitive to partial sleep deprivation. It is thought
that problem-solving and critical thinking based tasks allow for convergent skills being
tapped in parallel, permitting intact performance via compensatory support from less
affected systems (Waters & Bucks, 2011). However, consistent with the weaknesses
previously noted in more simple working memory tasks, sleep deprived individuals have
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impaired performance on certain complex cognitive tasks that require executive functions
such as mental flexibility and multitasking, perhaps reflecting the increased variability in
general cognitive performance following sleep deprivation. More specifically, divergent
thinking tasks that require lateral thinking, assimilation and utilization of feedback, and
risk assessment all show decrements after sleep deprivation. Executive processing errors
such as decreased insight into performance decrements, suppression of inappropriate
responses, and increased ineffective response perseveration are also well-documented.
Associated with the decrements in executive functioning, sleep deprived individuals rely
more heavily on compensatory effort to maintain adequate performance; this comes at the
cost of situational awareness, as neglect for activities and stimuli judged to be
nonessential increases (Durmer & Dinges, 2005).
The deficits discussed have led researchers to conclude that deprivation of sleep
negatively impacts performance on tasks believed to originate from or mediated through
the prefrontal cortex (PFC) - for those tasks that are attention-rich, more specifically, the
dorsolateral PFC (Kane & Engle, 2002). When sleep restriction is increased to complete
deprivation for 36 hours, research found that young participants produced
neuropsychological deficit profiles comparable to an elderly habitual sleep group
(Harrison & Horne, 2000). This is consistent with current attribution of documented
neurocognitive deficits in aging to declines in PFC functioning (Corey-Bloom,
Wiederholt, Edelstein, Salmon, Cahn, & Barrett-Connor, 1996). Functional neuroimaging
research suggests that two elements of the functional network connected to the PFC are
disrupted after sleep deprivation (Harth, 1995; Posner, 1994). The first is an anterior
network consisting of the PFC, basal ganglia, and anterior cingulate, which are involved
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in selective attention and the mental maintenance of a memory for immediate
manipulation (i.e. working memory). The second is a posterior network consisting of the
superior parietal lobes, pulvinar, and superior colliculus, which is thought to control
attentional switching and divided attention. The anterior cingulate has afferent
projections to the superior parietal lobes, and is innervated by the PFC, connecting the
three network components.
Significant-to-complete sleep deprivation is a useful paradigm to research the
neurocognitive correlates of decreased sleep; however, the ecological application is
limited. Sleep decrements in vivo generally take the form of partial sleep deprivation or
fragmented sleep. Recent research that has improved methodological controls for sleep
history and external influencing factors has found that 4 or more days of 7 or less hours
of sleep restriction per night results in measureable decrements in neurobehavioral
functioning and performance (Belenky, Wesensten, Thorne, Thomas, Sing, Redmond, et
al., 2003; Dinges, Pack, Williams, Gillen, Powell, Ott, et al., 1997). Restriction between 6
and 3 hours per night results in increased sleep propensity, working memory deficits, and
impaired sustained attention and vigilance (Carskadon & Dement, 1981; Drake, Roehrs,
Burduvali, Bonahoom, Rosekind, & Roth, 2001). The most extensive study on sleep
deprivation and restriction to date, conducted by Van Dongen and colleagues (2003), was
previously discussed, confirming that sleep restriction induced neurocognitive
performance decrements accumulate to levels equivalent to acute complete sleep
deprivation. While occupational research on partial sleep deprivation is relatively
common (e.g., for air traffic control, heavy machinery operators, etc.), a relatively underresearched area is the impact of sleep deprivation on everyday complex tasks with high
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potential risk, such as driving. An epidemiological study found an elevated occurrence of
sleep-related vehicle crashes in those individuals who reported an average of less than 7
hours of sleep per night (Strutts, Wilkins, Osberg, Vaughn, 2003). Driving simulator
research has found that 1 night of restricted sleep (5 hours) results in decrements of
performance in simulated normal driving conditions and situations requiring emergency
maneuvers (Horne & Baulk, 2003). Another two studies found that chronic restriction of
sleep (time in bed between 4 and 6 hours) is associated with a significant increase in
number of accidents, and rates increase further after 2 nights of this degree of sleep
restriction (Dorrian, Dinges, Rider, Price, & Rogers, 2003; Rupp, Arnedt, & Carskadon,
2003).
Fragmented sleep refers to repeated arousals (3+ seconds of disrupted EEG
frequency in NREM or increased electromyographic frequency during REM) occurring
throughout a sleep period. Arousals do not result in awakenings. However, multiple
studies have demonstrated that persistent fragmentation of sleep results in the same
effects on daytime somnolence, mood alteration, and cognitive performance decrements
as partial sleep deprivation (Bonnet, 1985; Bonnet, 1986; Bonnet, 1989; Martin,
Engleman, Deary, & Douglas, 1996). In fact, arousals occurring at an average rate of
once per minute throughout a sleep period of normal duration result in neurocognitive
performance decrements equivalent in pattern and magnitude to that of 1 night of
complete sleep deprivation (Bonnet, 1986; Downey & Bonnet, 1987). This is not an
unusual fragmentation pattern for those suffering from intrinsic sleep disorders such as
obstructive sleep apnea (Durmer & Dinges, 2005). These findings hold true in quasiexperimental studies measuring cognitive performance of those with endogenous
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fragmentation of sleep, as well as experimentally fragmented sleep using aural
stimulation (Martin, Wraith, Deary, & Douglas, 1997). A detailed discussion of
cognitive, behavioral, and mood decrements in the obstructive sleep apnea (OSA)
population is provided later in this review. Finally, of considerable importance is the
finding that across all domains, cognitive deficits are reversible following a period of
normal sleep, which means that cognitive dysfunction attributed to disrupted sleep should
be framed in remediable terms and highlights the clinical importance of sleep
intervention (Waters & Buck, 2011).

Sleep & Affect
Affective Processing
The ability to effectively and efficiently process affective-based stimuli is crucial for
human functioning from a socio-evolutionary perspective, as suggested first by Charles
Darwin in 1872 (Norris & Cacioppo, 2007). The generation and regulation of emotions
and the guidance provided by emotional content and cues is fundamental to individual
mental health, interpersonal functioning, and societal structure. In the past decade,
cognitive neuroscience and clinical neuropsychology have rapidly embraced and
investigated the domain of emotional or affective processing as a critical element of
normal and abnormal cognition, and recognized the relationship between affective
processing and clinical mental health (Labar & Cabeza, 2006). The following will
provide a brief outline of a systems-level framework of affective informational
processing.
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To discuss affective processing, a few terms and constructs should be clarified.
For the purposes of this review, the term emotion is meant to represent a complex
physiological, behavioral, and cognitive experience associated with the onset and
maintenance of mood/s. Affective is a descriptor meant to refer to characteristics that
conveys emotionally-relevant information, and affect is meant to refer to the process or
state of consciously labeling and experiencing internal emotional states (generally
resulting in phenotypic expression of the emotion, as often commentated on clinically).
Thus, affective processing is a form of information processing whereby emotionallyrelevant information is gleaned from a stimulus, analyzed, and then utilized in order to
facilitate correct/adaptive/appropriate reaction. Suchy (2011) posits that there are three
theoretical properties that are necessary for an affective processing system (APS). First,
the brain's APS needs the ability to detect emotionally-germane stimuli and judge the
affective qualities and characteristics (e.g., valence and intensity) quickly (likely
incorporating aspects of preconscious detection) in order to facilitate an immediate,
adaptive reaction. Second, an APS must also be able to initiate and maintain
physiological, behavioral, and cognitive events that comprise the response. Third, an
association and memory component is required to learn emotionally relevant
characteristics of a stimulus that was initially emotionally-neutral. Two related neural
circuits are involved in triggering emotional responses to stimuli - the amygdala
processes and responds to external stimuli, and the hypothalamus processes and responds
to disruption to internal homeostasis. The following will focus on the amygdala, as this
process involves the reviewed and proposed research methodologies.
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Two information processing routes exist, with both sharing an input pathway and
the amygdala acting as a mediator for behavioral and physiological responses (Suchy,
2011). The "fast route" (≈10-12 msec.) of affective information processing begins with
the sensory organ input projecting to the thalamus and primary visual cortex, where
crude, basic information (i.e., valence and intensity) regarding the stimuli is perceived.
The fast route next consists of this affective information being received by the basolateral
amygdala which projects to the orbitofrontal cortex and striatum involved with emotional
learning circuitry, and also to the central nucleus of the amygdala which in turn projects
to the hypothalamus and brainstem nuclei to generate physiological and behavioral
responses. The "slow route" (≈30-40 msec.) involves primary association cortices that
supply information about the perceived stimuli and supramodal association cortices that
supply more abstract and contextual meanings about the stimuli. These include the
secondary sensory cortex, tertiary sensory cortex, and hippocampus.
The integration of affective processing and cognitive research has resulted in
some domain-specific findings. Attentional blink paradigms have shown that responding
to a target during rapid stimuli presentation causes momentary depletion of attentional
resources, resulting in missed targets that immediately follow a first target. Strong
affective valence of the second target ameliorates this depletion. However, individuals
with amygdala damage cannot benefit from this phenomenon (Anderson & Phelps,
2001). Significantly faster psychomotor response speed has also been found for
negative/threatening valenced stimuli, above and beyond that which can be explained by
increased provision of attentional resources to the stimuli (Flykt & Caldara, 2006; LoBue
& DeLoache, 2008). The amygdala has also been found to facilitate episodic memory for
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affectively salient stimuli (Frank & Tomaz, 2000). This occurs due to improved encoding
via amygdala modulation of the perceptual cortical areas and improved consolidation of
affective stimuli in proportion to the relative survival importance of the associated
outcome (Phelps, 2004). Individuals with damaged or dysfunctional amygdala do not
benefit from the memory facilitation by affective characteristics of emotional stimuli as
found in healthy controls (Dolan & Fullam, 2010).
The Role of Sleep in Affective-cognitive Processing
The domain of learning and memory is a useful cognitive domain to research as it relates
to the affective processing system (APS), as it is understood to tap elements of attention,
working memory, and executive functions such as organization. Impact of sleep quality
on memory recall has focused on two stages, the initial formation of new memories
(encoding), and then the subsequent solidification of the memories (consolidation). Both
will be addressed with an emphasis on encoding as it is more germane to this dissertation
(Marshall & Born, 2009; Walker, 2009).
Affective Memory Encoding and Sleep
The elicitation of emotional states can strongly modulate the initial stages of learning
(i.e., encoding). Stimuli with emotionally arousing affective traits are recalled better than
those considered neutral (Buchanan & Lovallo, 2001; Heuer & Reisberg, 1990; Phelps,
2004). The modulation effect of emotionally arousing stimuli on encoding occurs in
different ways depending on the affective stimuli's valence (positive, neutral, negative)
and arousal level (calm to excitement). High arousal affective characteristics enhance
memory encoding through the adrenergic system. Introduction of propanolol (a betaadrenoceptor antagonist) to individuals prior to exposure to a gradient of different

22

emotionally arousing stimuli (narratives, individual words) results in a disappearance of
the enhancing effects of affect on learning found in control groups (Cahill, Prins, Weber,
& McGaugh, 1994; Strange, Hurlemann, & Dolan, 2003). Lesion and functional
neuroimaging has identified the amygdala, anterior hippocampus, ipsilateral
parahippocampus, and ventrolateral prefrontal cortex as being involved with the
formation of memory for affectively-valenced information (Cahill, Haier, Fallon, Alkire,
Tang, & Keator, 1996; Dolcos, Labar, Cabeza, 2004; Kilpatrick & Cahill, 2003). In the
absence of high arousal, valence of stimuli (versus neutrality) still positively modulates
encoding, though this is primarily governed by frontally-mediated strategic and semantic
processes outside of the amygdala and paralimbic system (Labar & Cabez, 2006). High
arousing stimuli with a negative valence have been found to have the strongest enhancing
effect on encoding compared to positive and neutral stimuli (Kensinger & Corkin, 2003).
The above findings relate to individuals under normal sleeping conditions.
Beginning at a cellular level, in rodent studies REM sleep deprivation (24-72 hours) has
been found to reduce hippocampal neuron excitability and significantly impair long-term
potentiation (LTP), a process demonstrated to be a critical mechanism for memory
formation (Davis, Harding, & Wright, 2003). The LTP observed after REM sleep
deprivation decays within 1.5 hours, suggesting significant impairment in hippocampal
plasticity. Behaviorally, avoidance learning, passive avoidance learning, and taste
aversion processes are all significantly impaired in rodents following both general sleep
deprivation and specific REM deprivation (McGrath & Cohen, 1978; Smith, 1985).
Deficits in performance are present even when the deprivation is limited to 5 hours, and
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continued practice trials do not result in performance improvements (Gruart-Masso,
Nadal-Alemany, Coll-Andreu, Portell-Cortes, & Marti-Nicolovius, 1995).
In one thorough human study, participants were either deprived of sleep for 36
hours or allowed a habitual sleep period, then exposed to emotionally arousing and
neutral stimuli (Walker, unpublished results, most recently cited in Saletin & Walker,
2012). All participants then were allowed two habitual sleep periods before recall was
tested, thereby controlling for impaired recall due to sleep deprivation confounds;
retention of material was thus deemed to represent encoding processes. Control group
individuals demonstrated significantly superior retention for positive and neutral stimuli
relative to the experimental group. Sleep deprived individuals had significantly impaired
retention for neutral stimuli, but even worse retention of positively valenced stimuli (59%
reduction relative to control group for positive stimuli) compared to controls. Retention
of negative stimuli was not significantly different from that of the control group. In
effect, sleep deprivation led to skewed encoding sessions, with the experimental group
ending the session with a prevailing dominance of memory for negative material, and far
fewer neutral and positive memories. Explanations for this sleep deprivation and affective
valence interaction range from suggestions that the arousal levels differ significantly at
the neural level of the stimuli (rather than the reported level) which interact with the postsleep deprivation hypo-activation of the prefrontal cortex and hyper-activation of the
amygdala to bias toward successful encoding of negative stimuli versus neutral/positive
stimuli (Chee & Chuah, 2008; Kensinger & Corkin, 2004; Yoo, Gujar, Hu, Jolesz, &
Walker, 2007). Additionally, as discussed later, the negative affective state in sleep-
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deprived individuals could lead to a mood-congruent encoding bias (Lewis, Critchley,
Smith, & Dolan, 2005).
Affective Memory Consolidation & Sleep
Currently, research suggests that emotion and affective characteristics of stimuli have a
modulating impact on subsequent memory consolidation. Behavioral human studies have
found decreased forgetting of affectively valenced material versus neutral material. This
retrieval benefit emerges more strongly as the delay between encoding and retrieval
attempt increases, as demonstrated in a variety of different delay contrast methodologies:
immediate versus 1 hour or 24 hours (LaBar & Phelps, 1998; Sharot & Phelps, 2004,
respectively), 20 minutes versus 1 week (Kleinsmith & Kaplan, 1963), and 15 minutes
versus 2 weeks (Anderson, Yamaguchi, Grabski, & Lacka, 2006). Research has
demonstrated that using pain manipulation and stress hormone introduction (adrenaline
and corticosterone) post-learning trials increases amygdala activity and selectively
improves long-term memory for affectively valenced stimuli (Cahill & Alkire, 2003;
Cahill, Gorski, & Le, 2003). Neurotransmitter research in this area has identified
adrenergic transmitters and acetylcholine as co-regulators of the consolidation of memory
for affective stimuli. Acetylcholine augments amygdala-reliant memory consolidation;
antagonist and agonist introduction into the amygdala of rodents impairs and enhances
(respectively) memory for previously learned, valenced material (e.g., fear-conditioning
and alteration of reward magnitude paradigms; Power & McGaugh, 2002; Schroeder &
Packard, 2002).
In humans, REM sleep characteristics have been noted to be altered after shockavoidance tasks and contextual fear learning tasks, suggesting that consolidation
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mechanisms impact sleep-stage characteristics (Sanford, Silvestri, Ross, & Morrison,
2001; Sanford, Tang, Ross, & Morrison, 2003). Next-day memory retention has been
demonstrated to be impaired after sleep deprivation between learning and testing, which
is thought to reflect a disruption of memory consolidation (Walker & Stickgold, 2004).
Sensitivity to fear-conditioning consolidation deficits appears to be limited to paradigms
that disrupt/deprive sleep 0-6 hours after the learning task, suggesting that negatively
valenced memory consolidation occurs shortly following learning (Graves, Heller, Pack,
& Abel, 2003; Ji, Wang, & Li, 2003). Emerging research suggests a REM-sleepdependent hypothesis of affective human memory consolidation, elements of which were
proposed by both Cahill (2000) and McGaugh (2004). Consolidation of affectively
arousing stimuli across a 12 hour day, or a 12 hour period including a habitual sleep
period, results in a benefit in consolidation of the affective information only when sleep
occurs between learning and testing (Hu, Stylos-Allan, & Walker, 2006). Total sleep
deprivation for only the first night after exposure to neutral and valenced visual stimuli
resulted in significant decrements in retention for all stimuli at testing 1 week later,
however, the greatest decrement was for neutral stimuli (Atienza & Cantero, 2008). The
authors hypothesized that the consolidation process for emotionally-relevant memories
may be intrinsically more resilient to sleep disruption. Speed of recognition for
affectively valenced facial stimuli is increased after a period of sleep, in proportion to the
amount of REM sleep experienced. In a separate study the power of right-dominant
prefrontal theta activity during REM sleep in a nap following a learning task for
neutral/negatively valenced stimuli was also proportionally related to emotional memory
increase (Nishida, Pearsall, Buckner, & Walker, 2009; Wagner, Kashyab, Diekelmann, &
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Born, 2007). This supports the conclusion of neurophysiological reviews that posit REM
sleep representing a brain environment especially amenable to consolidation of memory
for affective material, based on its pro-cholinergic (forebrain ACh levels up to four times
higher when compared to NREM) characteristics (Marrosu, Portas, Mascia, Casu, Fa,
Giagheddu, et al., 1995; Pare, Collins, & Pelletier, 2002; Walker, 2009). One limitation
of this area of research is the absence of human investigation using positively valenced
stimuli (van der Helm & Walker, 2009).
Emotional Experience, Regulation, & Sleep
Research on the impact of sleep deprivation, or loss, on emotion is limited, despite the
fact that nearly all psychiatric and neurological condition involving disturbed mood also
have documented, co-occurring sleep disruption. Affective volatility, lability, and
irritability are subjectively increased following sleep deprivation (Horne, 1985).
Emotional disturbance due to chronic restricted sleep (5 hours per night across 1 week)
has been demonstrated to have an accruing impact (Dinges, Pack, Williams, Gillen,
Powell, Ott, et al., 1997). Furthermore, restricted sleep has been found to blunt intrinsic
positive reactions to rewarding/goal-oriented activities and increase negative emotional
reactions toward experiences that disrupt the achievement of goals or rewards (Zohar,
Tzischinsky, Epstein, & Lavie, 2005).
Only recently have researchers investigated the interaction between sleep and
psychophysiological/emotional reactivity. One functional MRI study exposed controls
and sleep deprived (1 night) individuals to images spanning a gradient between negative,
neutral, and positive valences (Yoo, Gujar, Hu, Jolesz, & Walker, 2007). Both groups
demonstrated increased amygdala activation in proportion to the gradient of the negative
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images, but the sleep deprived group showed a 60% increase in extent of activation and
three times the volume of amygdala recruitment compared to the control group.
Researchers noted decreased functional connectivity between the medial prefrontal cortex
and the amygdala, a pathway normally thought to represent frontal inhibition of
amygdala reactivity. This finding suggests that sleep is crucial to appropriate top-down
inhibitory functioning within the mPFC-amygdala circuit, and that this circuit
significantly governs appropriate emotional responses to affectively loaded stimuli.
Functional imaging research on populations with mood disorders that commonly have cooccurring disturbed sleep patterns have also identified abnormalities in this circuit
(Davidson, Pizzagalli, Nitschke, & Putna, 2002). Little conclusive research findings exist
for positively valenced material (van der Helm & Walker, 2009).
Current conceptualization of mood disorders almost universally includes sleep
disturbance as a common feature or formal symptom (American Psychiatric Association,
2013), with reviews of the research into the relationship generally concluding mood and
sleep disturbances are bi-directional (Bliwise, 2004; Harvey, 2001). However, a massive
(N = 18,631) longitudinal twin-study offered strong evidence that poor sleep predates
onset of depression, though the methodology could not confirm a mechanistic causal
relationship (Paunio et al., 2009). Depression is a clinical condition that is highly relevant
to the intersect between abnormal affective processing and disturbed sleep. Depression
has comorbidity rates of disturbed sleep as high as 90%, with polysomnogram (PSG)
profiles indicating increased sleep latency and arousals, along with decreased REM sleep
latency and increased REM time and density (American Psychiatric Association, 2013;
Waller, Hardy, Pole, Giles, Gullion, Rush, 1989; Armitage, 2007; Gottesmann &
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Gottesmann, 2007). Depressed individuals exhibit heightened activity in the anterior
paralimbic cortex and midbrain reticular formation while awake, which researchers have
suggested may reflect a predisposition to encode negatively valenced experiences and
consolidate them more easily (Nofzinger, Price, Meltzer, Buysse, Villemagne, Miewald,
et al., 2000).
Walker and Van der Helm (2009) proposed a clinical model of sleep-dependent
emotional processing, based upon their literature review, concluding that under
conditions of sleep loss, the brain has a tendency toward encoding negatively valenced
stimuli and emotional memories, hyper-active limbic reactivity toward negatively
valenced events, and that negative memory consolidation is increased during REM sleep
(which tends to be higher density post-sleep deprivation). Their model proposes a "sleep
to forget and sleep to remember (SFSR)" hypothesis to explain the consistent finding that
emotional memory initially is comprised of both affective (generally amygdalaassociated activity) and informational (hippocampal-associated activity) components, but
that over time (many months) the affective component is stripped from the informational
component of the memory (Dolcos, LaBar, Cabeza, 2004, 2005). The SFSR hypothesis
posits that this decoupling predominately takes place during sleep, with the end result
being sleeping to forget the affective/emotional component but sleeping to remember the
informational component. Failure to strip the affective component due to disturbed sleep
results in potential mood impacts during wakeful hours. Further, their model argues that
REM sleep offers a distinctly advantageous neurobiological environment for the
information-association facilitation of core memories and the depotentiation and
elimination of an affective charge associated with memories. The authors also point out
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that the findings that affective valence impacts cognitive processing and memory across
waking periods absent of sleep suggest that sleep may be a preferential period for
consolidation but that a mechanism similar to REM sleep or completely independent
occurs during waking periods. How this segment of affective-processing relates to sleep
in both healthy controls and mood disorder populations requires further elucidation.
However, in effect, these authors suggest that there may be an alternate or
complementary conceptualization of how depression relates to sleep and neurocognitive
processes (see Figure 1).

Figure 1. Two Conceptualizations of the Interaction between Depression, Sleep, and
Cognitive Impairments.
Note, NP: Neuropsychological. A) Common neuropsychological conceptualization of
cognitive difficulties for a chronic depressive patient. B) Modified neuropsychological
conceptualization, *cognitive processing dysfunction includes a negative bias in
processing emotionally-valenced information (i.e., cognitive-affective processing).

Obstructive Sleep Apnea
Obstructive sleep apnea (OSA) is a common sleep disorder, estimated to affect roughly 2
to 4% of the adult population (Bresnitz, Goldberg, & Kosinski, 1994; Kripke, AncoliIsrael, Klauber, Wingard, Mason, & Mullaney, 1997; Olson, King, Hensley, & Saunders,
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1995). Base rates vary slightly based on demographics; 4% of middle-aged men versus
2% of middle-aged women are thought to suffer, with a large spike after the age of 65
resulting in estimates of up to 42% of this age group suffering (Ancoli-Israel, Kripke,
Klauber, Mason, Fell, & Kaplan, 1991; Young, Dempsey, Skatrud, Weber, & Badr,
1993). The pathophysiology of OSA is characterized by repeated episodes of momentary
(10+ seconds) incomplete (hyponea event, 50+%) or complete (apnea event, 100%
reduction) cessation of airflow. In OSA, the decreases in airflow are attributable to
obstruction or restriction of the breathing airway by the tongue and/or soft palate. The
near complete attenuation of skeletal muscle tone that occurs in N2 (intermittently) and
REM sleep is true for neck musculature as well, making these stages a common period
for the breathing events to occur. During apnea/hyponea events, blood oxygen saturation
(SaO2) can fall to dangerous levels and physical exertion to breathe by the diaphragm and
chest muscles increases. These trigger neurological mechanisms that cause a neurological
arousal to resume muscle tone and breathing almost never completely awakens an
individual, but does result in fragmented sleep and disturbed sleep architecture (Bassiri &
Guilleminault, 2000). Diagnosis of OSA is usually done with a polysomnography (PSG),
which also allows for an apnea-hyponea index (AHI; based on average number of apnea
or hyponea events occurring each hour) to be assigned as an indicator of severity; a score
of <5 is considered normal, a score of 30+ is severe.
OSA is associated with a cluster of cardiovascular health complications such as
hypertension, heart disease and stroke (Guilleminault & Robinson, 1997). Individuals
diagnosed with OSA are estimated to have annual health care costs twice as high as
age/sex-matched controls (Kapur, Blough, Sandblom, Hert, de Maine, Sullivan, et al.,
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1999). Finally, this population also has a higher accident morbidity rate, thought to in
part be related to attentional performance comparable to mildly to moderately intoxicated
controls (George & Smiley, 1999; Powell, Riley, Schechtman, Blumen, Dinges, &
Guilleminault, 1999). Unfortunately, the compliance rates for the primary treatment
option for OSA (Continuous Positive Airway Pressure; CPAP) is low; non-compliance
(less than 4 hours per night) rates range from 46-83% (Weaver & Grunstein, 2008). The
same study found that patient perception of symptoms is a significant factor in noncompliance. The sub-awakening arousals and fragmented sleep found in OSA patients are
inherently difficult for the patients to perceive. Alternative routes of educating identified
OSA patients about the health and functioning impacts of their condition is a prime area
for the clinical neuropsychologist to contribute to treatment.
Neurocognitive Deficit Correlates
One meta-analysis of peer reviewed OSA articles with neuropsychological findings
between the years of 1985 and 2002 identified 37 peer-reviewed articles related to
neuropsychological performance in OSA populations (excluding non-clinically
diagnosed, cognition-related comborbid, non-adult, and central apnea populations or
studies using non-validated measures), which were subsequently divided into nonmutually exclusive pre-treatment, treatment efficacy, and correlational study groups
(Aloia, Arnedt, Davis, Riggs, & Byrd, 2004). Pre-treatment results suggest spared global
cognition and language functioning, consistent with sleep deprivation findings that
crystallized knowledge remains intact and compensatory recruitment allows for wellpreserved general cognitive functioning. Attention (especially vigilance), memory, and
executive functioning performance was found to be significantly lower in over two-thirds
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of the studies reviewed. While motor speed was found to be intact, fine motor control
suffered in 80% of measures. Residual impairment after continuous positive air pressure
(CPAP) treatment revealed that only fine motor control did not improve with treatment.
Severity rating based on hypoxemia (i.e. amount of sleep time where SaO2 <80%) was
related to global cognition, whereas a rating based on sleep fragmentation (AHI) was
associated with attention/vigilance performance. One area that the present study hopes to
address were methodological concerns that Aloia and colleagues (2004) developed during
the process of article collection, which included clarifying the exact diagnostic criteria
used, quantifying and specifying degree of treatment compliance (and treatment
compliance history), and finally ideally including a contrast group when possible (i.e., a
group examined by polysomnogram and not diagnosed with OSA).
Another thorough meta-analysis by Fulda and Schulz (2001) identified 24 articles,
with 28 patient groups (total N = 893) related to cognitive functioning in sleep-related
breathing disorders (unfortunately without inclusion criteria). The authors found
moderate to large effect sizes for decrements in sustained attention performance, delayed
visual memory, working memory, and driving simulation tasks. Small to moderate effect
sizes were noted in tests of verbal fluency, vigilance, and delayed recall for verbal
stimuli. Reasoning and concept formation showed no significant difference. Executive
functioning measures were too diverse and limited to make a quantifiable estimate.
Beebe and colleagues (Beebe, Groesz, Wells, Nichols, & McGee, 2002) found 25
studies that met their meta-analysis review criteria, and set out to investigate
neuropsychological performance in OSA populations compared to normative data as well
as OSA population performance compared to control groups (two sets of effect sizes).
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The authors' analysis accumulated reviews that represented 1,092 OSA patients and 899
healthy controls. Both the norm-referenced and the case-controlled data indicated that
untreated OSA had a non-significant impact on verbal and intellectual functioning, but a
substantial impact on vigilance and executive functions. Motor and visual functions
produced mixed results, with post-hoc analysis indicating that fine-motor control and
drawing measures were significantly sensitive to OSA, whereas motor speed and visual
perception were not. Memory functions were the most variable, which the authors
attributed to the wide variability in methodologies and measures used. It should be noted
that the previous meta-analyses had nine overlapping studies.
Mood Correlates
Obstructive sleep apnea patients have been demonstrated to have increased rates of
diagnosed depression. The degree of increase and the relationship between the two
diagnostic constructs is less clear, but a few large scale and meta-analytic findings will be
reviewed here to offer the generally accepted comorbidity parameters. A recent
epidemiologic study investigating comorbidity between sleep-related breathing disorders
and major depressive disorder estimated that of the 18,980 individuals reviewed, 17.6%
of those presenting with one diagnosis also presented with the other; the odds of having a
sleep-related breathing disorder was 5.26 for those diagnosed with a major depressive
disorder. Furthermore, this relationship was not significantly changed when obesity and
hypertension were controlled (Ohayon, 2003). A longitudinal study of men and women (n
= 1, 408) that repeatedly collected polysomnogram diagnostic data and self-reported
depressive symptoms found that an increase in 1 degree of sleep-related breathing
disorder severity (e.g., mild to moderate) was associated with a 1.8-fold increase in

34

adjusted odds for presenting with depression (Peppard, Szklo-Coxe, Hla, & Young,
2006). Combining the longitudinal data with cross-sectional data resulted in 1.6, 2.0, and
2.6 fold increased odds of developing depression compared to controls for minimal, mild,
and moderate or worse sleep-related breathing disorder severity ratings respectively.
Research has proposed and investigated multiple potential mechanisms
underlying the relationship between OSA and depression. As discussed, two hallmark
symptoms of OSA are sleep fragmentation and hypoxemia. Research has found that
within OSA populations, amount of sleep fragmentation correlates proportionally with
excessive daytime sleepiness and self-report of depressive symptoms, with some
researchers proposing that the impact to quality of life and functioning that EDS has is
responsible for the depression (Sforza, de Saint Hilaire, Pelissolo, Rochat, Ibanez, 2002).
Severity of hypoxic event occurrence has been found to correlate with cognitive
performance impairments with effect sizes ranging from .3 standard deviations in mild
AHI to 2-3 for moderate to severe AHI ratings, (Engleman, Kingshott, Martin, &
Douglas, 2000). Additionally, imaging studies have observed cerebral metabolic
disruption during periods of nocturnal hypoxemia in OSA patients, both findings
suggesting a disrupting effect to normal neural functioning (Kamba, Inoue, Higami, Suto,
Ogawa,& Chen, 2001). Depressive symptoms have been independently associated with
white matter hyperintensities in those with affect disorders (Taylor, MacFall, Steffens,
Payne, Provenzale, & Krishnan, 2003; Thomas, O'Brien, Barber, McMeekin, & Perry,
2003). Unfortunately, only one study with a small sample size could be reviewed that
combined these intersecting findings, and concluded that amongst older OSA patients,
more subcortical white matter hyperintensities were found in those with severe OSA
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versus mild, and that there existed a positive correlation between white matter
hyperintensities and reported depressive symptoms (Aloia, Arnedt, Davis, Riggs, & Byrd,
2004).
It is possible that the relationship between OSA and depression exists but that
methodologically lax investigations have resulted in literature reviews overstating the
strength of this relationship. For instance, one review of 16 studies that examined this
relationship strength found that 9 found a strong relationship, five suggested that
depression is secondary to OSA (or that depression resolved after OSA treatment), and
two indicated the comorbidity rate of OSA and depression does not significantly exceed
that of other diagnoses with similar base rates (Andrews & Oei, 2004). Additionally,
though it logically makes sense that rises in depression would follow OSA
symptomatology, clinical researchers have pointed out that some sedating medication
prescribed to depressed individuals (e.g., benzodiazepines for sleep or comorbid anxiety)
may adversely affect oral skeletal muscle tone, increasing risk for the onset of OSA
(Guilleminault, 1990).
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CHAPTER 2
THE PRESENT STUDY
Rationale, Objectives, & Hypotheses
Walker and Van der Helm posit that their model of sleep-dependent emotional processing
may be clinically useful when applied to understanding the etiology of psychiatric
disorders and comorbid sleep complaints through a cognitive conceptualization.
Obstructive sleep apnea is a medical condition with (1) a better understood mechanism
than psychiatric disorders, (2) well documented cognitive deficits as demonstrated on
standard neuropsychological measures of attention, memory, and executive function
domains, and (3) fairly well established research supporting increased risk and rate of
depressed mood. Walker and Van der Helm's model thus provides a framework to
investigate this medical condition as it relates to cognitive-affective processing which
could possibly add insight into the relationship the disorder has with depressed mood.
To that goal, this study hopes to accomplish a number of objectives of varying
inter-relation. They can be summarized under four major themes, listed below, with
specific hypotheses and justification following each theme.
1. To determine whether results from past investigations into the
interrelationships between sleep physiological indicators, subjective sleep measures,
cognitive performance, and mood could be replicated; (a) objective indicators of sleep
quality (i.e., polysomnogram), self-reported sleep quality, mood, and standard measures
of neuropsychological performance that have been shown to be related to sleep and mood
will be correlated with one another; (b) using clinical cutoffs, more severe OSA severity
groups will perform significantly worse than less severe OSA groups on a learning and
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memory task as well as on executive measures of verbal divergent production; (c) using
objective clinical cutoffs, more severe OSA severity groups will report significantly more
negative mood than less severe OSA groups on both depression and positive/negativeaffect self-report inventories.
2. To document the psychometric properties of two novel measures of cognitiveaffective processing; (a) created measures of cognitive-affective processing will
demonstrate acceptable psychometric properties.
3. To investigate how the sleep and mood measures relate to the novel cognitiveaffective measures; (a) cognitive-affective processing measures designed to parallel
standard neuropsychological measures will be significantly related to objective indicators
of sleep quality (i.e., polysomnogram), self-reported sleep quality, and mood; (b) more
severe OSA severity groups will perform significantly worse than less severe OSA
groups on cognitive-affective processing measures; (c) more severe OSA severity groups
will demonstrate significantly more negative (or less positive) processing independent of
quantitative production within the cognitive-affective processing memory measure.
4. To investigate whether the novel cognitive-affective measures help explain the
relationship between sleep disturbance and mood; (a) the relationships between objective
sleep disruption and negative mood will be partially explained by this cognitive-affective
processing valence bias.
The selected traditional neuropsychological measures were selected largely based
upon published performance decrements in OSA populations. Additionally, these
measures, sleep indicators, and mood indicators have been demonstrated to relate
individually and in subgroups to each other multiple times within samples similar to the
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present study's, as well as with other clinical and non-clinical samples. There is strong
evidence for physiological sleep disruption impacting neurocognitive functioning, and
subjective report of sleep quality being related to mood.
One cognitive-affective measure has already been piloted and demonstrated
appropriate psychometric properties; it is expected to do the same in this population.
Another cognitive-affective measure is new, but has been created with statistically
analogous properties to a well researched and validated memory measure for neutral
words. Thus, it is expected to demonstrate appropriate properties as well.
The described cognitive, sleep, and mood constructs have all been found to relate
to each other to varying degrees in the literature, though no research has looked at all of
this project's variables within one sample. It is expected that these individual and smaller
subsets of relationships will all be found within the present sample. There are mixed
findings on how strong of a relationship polysomnogram indicators (e.g., fragmented
sleep, hypoxemia) have with a variety of cognitive performance measures and mood.
Similar findings exist for self-reported sleep. The neuropsychological domains and
aspects of mood this study measures were selected with the goal of maximizing statistical
power for demonstrating predictive utility of the sleep indicators.
Portions of this study are exploratory in nature. As such, the relationships between
the newly constructed measures, cognition, self-report/physiological sleep quality, and
mood will be investigated. These analyses will guide future research focusing on OSA
populations, affective-cognitive processing, and sleep quality.
The exploratory analyses will be used to explore whether the aforementioned
clinical model appears to explain observations in the obtained sample. Affective
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characteristics of stimuli should interact with OSA severity, and have an enhancing effect
on tasks tapping memory for negatively valenced stimuli independent of memory
production, and an interfering impact with tasks of fluency. Additionally, qualitatively
negative valence of affective-processing should predict depressive symptoms and
possibly mediate the relationship between OSA and/or sleep disturbance severity and
depressive symptoms.
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CHAPTER 3
DESIGN AND METHODOLOGY
Participants
Participants were recruited from a database of outpatients referred for evaluation of
possible obstructive sleep apnea at the Windsor Regional Hospital. A power analysis was
conducted, and set a sample-size goal of N = 59, see below for statistical details.
Inclusion criteria included: a referral for polysomnograph (PSG) sleep study (with or
without CPAP titration), and 18 years of age or older. Exclusionary criteria included:
history of traumatic brain injury or stroke, history of/current neurological conditions
affecting functioning (aside from other sleep disorders), presence of moderate-severe
chronic pain, a psychiatric condition aside from depression, current recreatinoal
substance use, or alcohol use reaching “hazardous levels” (21+ drinks per week for men,
14+ drinks per week for women, per gender-specific cutoffs accepted by the National
Institute of Alcohol Abuse and Alcoholism and reported in Reid, Fiellin, O’Connor,
1999). Recruitment of pre-diagnosis/pre-treatment referrals, along with patients with
confirmed OSA who used their CPAP during the polysomnogram, allowed for the
maximal range of sleep fragmentation dysfunction. This strategy also allowed for treated
versus untreated comparisons.
Approval from the Research Ethics Board of the Windsor Regional Hospital was
obtained in addition to the Research Ethics Board of the University of Windsor prior to
data collection. Participants were incentivized to participate by the offer of a gift
certificate for a small Tim Horton's item and validated hospital parking. Recruiters also
explained that by participating in the research, the individual will be assisting in
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contributing to the body of clinical research related to their disorder, which will hopefully
assist in future treatments and symptom management for the clinical group as a whole.
Additionally, participants were informed of an opt-in offer for the neurocognitive
test results to be compared to a priori conservative cut-offs, with the understanding that if
the profile contained a significant number of significantly low enough test scores, the
participant would be contacted and provided instructions regarding the general referral
process required (i.e., discussing cognitive health options with their primary care
physician or their sleep/respiratory physician), as well as referral source groups
associated within the Windsor Regional Hospital, and local independent groups. The cutoff for an abnormal profile was set at two scores of the ten battery items falling at or
below two standard deviations below zero. Research on the frequency of abnormal test
scores in healthy adults, as a function of battery size and normative adjustments, has
demonstrated that only 3.4 to 4.6% of healthy adults are observed scoring at the described
conservative cut-off (Schretlen, Testa, Winicki, Pearlson, & Gordon, 2008). The
advantage of this approach included removing clinical judgment from the decision
making process, and instead relied solely on a statistically validated and a conservative
decision tree.
The opt-in procedure meant that by default, the participant was not contacted with
the feedback. Opt-in participants who produced profiles within normal limits were
contacted and informed of that fact. All opt-in participants were also reminded that their
participation in this study was not the same as a clinical neuropsychological assessment,
and that their opting-in to the screen did not equate entering into a patient-clinician
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relationship. Participants who remained in the opt-out category were still offered referral
information if they wished.
The risks of participating were minimal, but explained in full to potential
participants. Depressed mood and some general psychiatric screening questions were
used during data collection. Discussing symptoms associated with depressed mood can
sometimes draw attention to them, resulting in psychological distress. If a participant
endorsed clinically significant levels of depression, suicidal ideation, or other psychiatric
symptoms, similar referral process information and options were provided (along with
encouragement for contacting emergency services if suicidal ideation arose).
As with all clinical research, there was the ethical question of the researcher
incidentally gaining healthcare provider responsibilities. The extensive explanation
provided to potential participants regarding the purpose and limitations of the
neurocognitive profile review, along with encouragement to contact two of their already
established healthcare providers in addition to a referral to clinical psychological service
providers, prevented the research team entering a healthcare provider role with the
participant. As such, information gained from the data collection phase of this project
was not and will not be provided to any of the aforementioned healthcare providers, as it
was not gathered for that purpose.

Measures
Sample Characteristics and Self-report Measures
Demographic and self-report data was collected through administration of a series of
questionnaires and measures. The assembled measures were chosen with the goal of
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assessing three constructs: 1) the sample's medical history and demographic
characteristics, 2) subjective reports of sleep quality, and 3) mood and emotional state.
Demographics and General Medical Background
A self-report form was created and included questions related to: gender, date of birth,
country of birth, first language, education, average household income, military service,
list of medications, CPAP use and compliance, sleep habit information, and
medical/psychiatric history questions. It also inquired as to presence and degree of any
pain, along with questions about the participants' previous night of sleep. Medical
conditions and age were translated into a Charlson Comorbidity Index score per
published formulas (Charlson, Pompei, Ales, & Mackenzie, 1987; Charlson, Szatrowski,
Peterson, & Gold, 1994). See Appendix B for this form.
Pittsburgh Sleep Quality Index (PSQI; Buysse, Reynolds, Monk, Berman, &
Kupfer, 1989)
The PSQI is a self-report questionnaire designed to assess sleep quality and disturbances,
and currently is the most widely used general measure of sleep quality. It measures a
broad array of domains associated with sleep quality. It consists of 19 questions regarding
sleep characteristics over the past month. These scores form seven equally-weighted
components, 1) Subjective Sleep Quality, 2) Sleep Latency, 3) Sleep Duration, 4)
Habitual Sleep Efficiency, 5) Sleep Disturbances, 6) Use of Sleeping Medication, and 7)
Daytime Dysfunction. These in turn provide a global score ranging from 0-21 (0 = no
reported sleep disturbance, 21 = maximum amount of sleep disturbance).
The creators validated the measure over an 18 month period with a group of
healthy controls ("good sleepers"), a group of patients with depression and a group of
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patients with sleep disorders ("poor sleepers"). A global score over five (6+/21) had high
sensitivity (89.6%) and specificity (86.5%) for distinguishing good versus poor sleepers
(kappa = 0.75, p < .001). Traditional norms are not available, but research has been
published on a variety of groups. These include, healthy controls (n = 52, 2.67 ± 1.70),
OSA (n = 127, 7.5 ± 3.9), major depression (n = 34, 11.09 ± 4.31), disorders of initiating
and maintaining sleep (n = 45, 10.38 ± 4.57), and disorders of excessive daytime
somnolence (n = 17, 6.53 ± 2.98). Scores increase with age, even in healthy controls over
the age of 80 (n = 44, age = 4.75 ± 3) (Buysse, Reynolds, & Monk, 1991; Park et al.,
2007). It is suggested that the PSQI be supplemented with a measure of daytime fatigue
and sleepiness.
Test-retest reliability demonstrated no significant changes in global score and
internal homogeneity was acceptable (Cronbach's alpha = .83). The PSQI significantly
correlates with some polysomnogram (PSG) data (e.g., sleep onset latency, total sleep
time, sleep efficiency, and % of stage 2 sleep), but was found to overestimate PSG
estimates of usual sleep duration and sleep efficiency (Buysse, Hall, Strollo, Kamarck,
Owens, Lee, et al., 2008). See Appendix C for this form.
Epworth Sleepiness Scale (ESS; Johns, 1991)
The ESS is a self-report questionnaire designed to measure the likelihood an individual
has of falling asleep in various situations, and has been widely validated in the sleep
disorder literature. It consists of 8 questions requiring the individual estimate how likely
they might doze or fall asleep in different daily living situations (e.g., sitting and reading,
while stopped at a traffic light, etc.). Each question is rated on a scale of 0-3 (0 = would
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never doze, 3 = high chance of dozing), and a total score above 10 suggests significant
sleepiness.
Test-retest reliability was found to be high (r = .82), and internal consistency was
also found to be appropriate (Cronbach's alpha = .88), when given to a group of medical
students. Validation research has found that ESS scores are correlated with number of
obstructive sleep apnea (OSA) events but not to degree of hypoxemia in OSA patients.
After 3-9 months treatment with CPAP, the OSA group's ESS scores significantly
decreased. Factor analysis of both groups found one factor. More recent research suggests
that the ESS and PSQI measure orthogonal dimensions of sleep/wake symptoms. Both
have also been found to differ from some polysomnogram measured constructs, and thus
an emphasis should be placed on these tools as a measure of subjective elements of the
various sleep constructs (Buysse et al., 2008). See Appendix D for this form.
Center for Epidemiologic Studies Depression Scale (CESD; Radloff, 1977)
The CESD is a self-report questionnaire designed to measure symptoms associated with
depression. Previously validated depression scales were used as the source for 300 items,
which was narrowed to 20 items, each inquiring about the frequency an individual has
experienced a symptom over the past week. All items use a 4-point scale (0 = rarely or
none of the time [<1 day] to 3 = most or all of the time [5-7 days]; four items are reversescored), with total scores ranging from 0-60. These items comprise six scales, each
associated with a major dimension of depression: Depressed Mood, Feelings of Guilt and
Worthlessness, Feelings of Helplessness and Hopelessness, Psychomotor Retardation,
Loss of Appetite, and Sleep Disturbance. Scores ranging from 15-21 suggest mild to
moderate amounts of depressive symptoms and scores over 21 suggest the possibility of
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major depression. A score of 16 or higher is commonly used as a cut-off for clinical
depression, with 85% of those diagnosed with a depressive disorder by a clinician scoring
between 16 and 60. However, 21% who scored within this range had rapid resolution of
their symptoms and/or did not fit criteria for a depression diagnosis. Other researchers
have suggested using a higher cut-off if the goal is the identification of a clinically
depressed population or individual (Zich, Attkisson, & Greenfield, 1990). The CESD is
useful with chronically ill groups who complain of fatigue (e.g. cancer, HIV), including
OSA populations (Bardwell, Moore, Ancoli-Israel, & Dimsdale, 2003; Cockram, Judd,
Mijch, & Norman, 1999; Hann, Winter, & Jacobsen, 1999).
High internal consistency scores were reported, with Cronbach's alpha
coefficients ranging from .85 to .90 across studies. Good reliability scores have been
reported across multiple groups of varied ethnicity and geographic location, age, and
gender (Knight, Williams, McGee & Olaman, 1997; Radloff, 1977; Roberts, Vernon, &
Rhoades, 1989). Test-retest correlations are generally moderate, ranging from .45 to .70;
this is attributed to scores reflecting the past week and therefore being more liable to shift
depending on intervening events. The CESD is not intended as a diagnostic tool, but was
constructed based upon symptoms reported in clinical cases. Furthermore, the CESD
correlates with severity ratings made by clinicians (correlation coefficient = .56), and
with Hamilton Clinician Rating scale scores (.44 to .75), which are based on self-report
of symptoms (Radloff, 1977). Past research using the CESD has found high rates of
depressed symptoms in those diagnosed with OSA, both for community and clinical
samples (17% and 21-41%, respectively). Scores on the CESD scores have been found to
account for a large amount of the fatigue OSA patients experience (24.5% above and
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beyond the 13.4% that OSA severity does; Thomas, Bardwell, Ancoli-Israel, &
Dimsdale, 2006). High CESD scores are also associated with higher percentage of time
spent in REM sleep in OSA patients compared to OSA patients who scored low on the
CESD (Bardwell, Moore, Ancoli-Israel, & Dimsdale, 2000). In women, but not men,
high CESD scores were associated with increased observed apneas (Harris, Glozier,
Ratnavadivel, & Grunstein, 2009). In a different study, controlling for gender, age, and
ethnicity, CESD scores were positively correlated with the number of instances blood
saturation levels dropped by greater than 4% (r = .14, p = .011; Kripke, Ancoli-Israel,
Klauber, Wingard, Mason, & Mullaney, 1997). Across multiple studies on OSA
populations, mood disorder incidence was 33%, with a mean CESD score of 12.6 (SD =
11.3; Bardwell, Ancoli-Israel, Dimsdale, 2001; Bardwell, Moore, Ancoli-Israel,
Dimsdale, 2000 & 2003). Longitudinal research is limited. With regard to the use of this
measure and the OSA construct, one prospective study found that OSA onset/increased
severity was associated with higher CESD scores, but more research needs to be done in
order to investigate the reverse possibility (Harris, Glozier, Ratnavadivel, & Grunstein,
2009). See Appendix E for this form.
Positive and Negative Affective Schedule - Expanded (PANAS - X; Watson &
Clark, 1994)
The PANAS-X is a self-report questionnaire designed to measure affect at the present
moment, or over the past days to weeks to months, depending upon the instructions. It
consists of 60 items, each asking the individual to rate the extent to which they have felt
that emotion over the decided upon time-frame using a 5-point scale (1 = very slightly or
not at all, 5 = extremely). The measure is an expanded version of the original PANAS,
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which was limited to positive emotionality and negative emotionality scales (Watson,
Clark, Tellegen, 1988). These items comprise two broad scales, one positive, the other
negative (PA and NA), each is comprised of multiple, correlated, yet distinguishable
affective states. The PA and NA scales represent valence of emotion, whereas the
specifier states represent the content of affect. These dimensions are thought to be
orthogonal. High NA is representative of unpleasant engagement and subjective distress,
whereas low NA is the absence of these experiences. High PA is epitomized by alertness
and enthusiasm, with low PA representing sadness and lethargy. The specific emotional
states measured include Fear, Sadness, Guilt, Hostility, Shyness, Fatigue, Surprise,
Joviality, Self-Assurance, Attentiveness, and Serenity. The measure was selected to
supplement the CES-D mood information, as the PANAS-X captures a larger variety of
moods (including positive affect), which might be of interest for aspects of the
exploratory analyses.
The expanded measure was developed on a variety of undergraduate and adult
samples ranging in size from 114 to 3,622 (Watson & Clark, 1994). Internal reliabilities
(Cronbach's alpha values) were high for both higher order scales (PA = .83-.90; NA = .85
- .90). The correlations between the PA and NA scale appear to be quasi-independent,
ranging from -.05 to -.35, an advantage for analysis purposes. Looking at the largest
community sample, mean daily scores for the higher order scales are 28.3 (SD = 2.9) for
the PA and 16.4 (SD = 4.1) for the NA. Factor analysis revealed a two factor solution,
with both scales correlating strongly with each respective factor (from .89 to .95), and
correlating weakly with the other (-.02 to -.18). Self-rating is strongly associated with
peer-rating on the measure, with correlations ranging from .35 to .48 for the PA and .21
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to .36 for the NA. Multifactorial design analysis revealed clear and clean contributors to
each of the specific emotional states measured, with almost all items loading exclusively
on their respective emotional state at strengths generally ranging from .50 - .75. Internal
consistency reliabilities for the 11 lower order scales ranged from .70 to .94, across all
temporal phrasing conditions. The PA and NA scales correlate moderately to strongly
with measures of both trait and state affect, with appropriate temporal phrasing given.
Little research has been conducted using the PANAS in OSA populations, with no
comparative norms available. See Appendix F for this form.
General Cognitive Measures
A series of well-established neuropsychological measures was assembled. The decision
to include each depended on a number of criteria: (1) performance of sleep apnea
populations on the measure in prior research, (2) breadth of domains, and (3) depth of
domains (i.e. multiple measures for domains, measures that tap multiple aspects of a
domain). Additionally, the advice that Dorrian, Rogers, and Dinges (2005) published
concerning neurocognitive battery assemblage that is sensitive to sleep deprivation was
considered. Of their recommendations, most relevant for the present study were that
measures included (1) reflect fundamental features of neurocognitive functions (e.g.,
attention over time), (2) are straightforward and are only minimally affected by aptitude,
(3) have relatively short durations, to avoid extraneous variables (e.g., decreased interest),
(4) consist of a high signal load, to increase opportunity for behavioral sampling within
the limited assessment time, (5) demonstrate good reliability and validity, and (6) have
readily interpretable results (e.g., functional or related to sleep cycle physiology).
However, only those measures discussed in detail below were the focus of the present

50

dissertation. Please note the summary of additional measures and justification for their
inclusion at the end of this section.
North American Adult Reading Test (NAART; Blair & Spreen, 1989)
The NAART is a measure used to estimate premorbid verbal intelligence. Participants are
given a sheet containing 61 words of varying pronunciation difficulty. Total words
pronounced correctly can be entered into a predictive equation for Wechsler Adult
Intelligence Scale - Revised Full Scale, Verbal, and Performance IQ scores (SEE's = 7.63,
6.56, 10.67, respectively; Blair & Spreen, 1989). The NAART is one of the most reliable
measures in clinical use, with a test-retest reliability coefficient of .92, and an interrater
reliability coefficient of .99 (Blair & Spreen, 1989; Raguet, Campell, Berry, Schmitt, &
Smith, 1996). The authors also found moderate to high correlations (.40 - .80) between
the NAART and other measures of general intellectual performance. Additionally, it has
been found to be robust against changes following neurological insults, disease, and
decline related to old age, making it a good measure of premorbid IQ (Anstey, Luszcz,
Giles, & Andrews, 2001). Thus, it is not surprising that the NAART scores in OSA
research are average unless the researchers were seeking out impaired subpopulations
(e.g., Naismith, Winter, Hickie, & Cistulli, 2005). See Appendix G for this form.
California Verbal Learning Test - Second Edition (CVLT-2 Delis, Kaplan,
Kramer, & Ober, 2000)
The CVLT-2 is a measure of learning and memory for verbal stimuli. A 16 word list is
read aloud five times, with the individual attempting to recall all the words after each
presentation. This target list is made up of four animals, four vegetables, four items of
furniture, and four modes of traveling. Next, a distractor list is read aloud with the same
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recall task following. This list is composed of four animals, four vegetables, four parts of
a house, and four instruments; it therefore shares two semantic categories (though made
up of different words) with the target list. Immediately after the recall attempt of the
distractor list is complete, the individual is prompted to recall the target list without a
presentation. After this short-delay free recall, the individual is again asked to recall
target words, but prompted with the four target list's semantic categories. After a 20
minute delay, this free and cued recall process is repeated. Following the long delay
recall, the individual is read a list of 48 words and asked to positively identify those
words that were on the target list. The recognition list is composed of the 16 target words,
the 16 distractor list words, eight novel distractors that fit into a target list semantic
category, and eight novel distractors that do not fit into target list or distractor list
semantic categories. Finally, after another 10 minute delay, individuals are presented with
16 forced-choice items, where a target word is paired with a distractor word unrelated to
any semantic categories used in the test.
Strauss, Sherman, and Spreen (2006) suggest that the CVLT-2 is overall a strong
neuropsychological measure in their psychometric review, which the following
information discusses. For instance, this measure has very high split-half reliability in the
normative sample (r = 0.94) and a clinical sample (r = 0.96). Word category recall across
learning trials were similarly high for the two samples (r = 0.82, 0.83, respectively). Testretest reliability is high (r's = 0.80 to 0.89) for overall measures of achievement (e.g.,
Trials 1-5 Correct, Short Delay Free Recall Correct, Long Delay Free Recall Correct, and
Total Recognition Discrimination). Validity, as measured by correlation coefficients
between the CVLT and the CVLT-2 are generally adequate to high (e.g., r = 0.76 for
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Trials 1-5 Correct); the CVLT normative data were likely too stringent, with the CVLT-2
sample being more representative of the educational population of the U.S. A five-factor
model was found for the CVLT-2, with all 16 of the selected variables used falling into
appropriately representational factors (i.e., general verbal learning, response
discrimination, recall efficiency, organization, and primacy-recency reliance). In clinical
samples, temporal lesion populations have demonstrated learning deficits across Trials 15 and short/long delay recall (Alexander, Stuss, & Fansabedian, 2003). Additionally,
focal frontal lesions have been demonstrated to be significantly related to self-monitoring
(repetitions, intrusions) and organizational strategies of encoding.
Research investigating OSA population performance on the CVLT-2 is limited,
and research conclusions regarding this clinical group's learning and memory
performance is mixed. One study compared 28 OSA patients with 24 healthy controls
using the original California Verbal Learning Test (CVLT; Delis, Kramer, Kaplan, &
Ober, 1987; Salorio, White, Piccirillo, Duntley, & Uhles, 2002). Though an older version,
the two tests differ only in stimulus words/categories and the newer inclusion of a forcedchoice paradigm. Also, the study was methodologically strong (i.e. included women and
men; heterogeneous AHI; PSG diagnosis used; exclusion of medical and learning
disorder comborbidities). The researchers found the OSA group to score significantly
worse on trial 1 recall, trial 5 recall, and trial B recall, but not on delayed recall or
recognition. They interpreted these results to be indicative of encoding deficits rather
than maintenance decrements existing in this population. The researchers also found that
OSA groups used less semantic grouping in free recall and benefited less from semantic
cues than controls. This demonstrated an impaired use of either internally or externally
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sourced executive organization strategies. Finally, they note that though the difference in
performance was statistically significant, OSA performance decrements generally fell
within 1 SD below the control group. This suggests that, from a clinical perspective, the
deficits are subtle. However, the authors also note that even with treatment, the deficits
are persistent, suggesting that OSA's impact on cognition is more significant when
viewed as a contributor to a multi-etiology decline. A meta-analysis found significantly
worse long term verbal memory (including the CVLT and other measures with similar
paradigms) for OSA populations when compared to a normative-reference set (Cohen's d
= 0.52, p = .010), but only a trend for a control-reference set (Cohen's d = 0.27, p = .085;
Beebe, Groesz, Wells, Nichols, & McGee, 2003). A more recent study by Lau, Eskes,
Morrison, Rajda, and Spurr (2010) using the CVLT-2 only found a trend in the OSA
population to demonstrate worse performance across total learning (trials 1-5), (Cohen's d
= 0.45, p = 0.086). See Appendix H for this form.
FAS/Animal Naming verbal fluency tasks (FAS/Animals; Spreen & Benton,
1977; Rosen, 1980)
Verbal fluency was measured using two related tasks. The FAS task is a measure of
phonemic fluency, requiring an individual to generate as many words as possible that
begin with a specific letter, within 60 seconds. Using the instructions first published by
Spreen and Benton (1977) and detailed in Spreen and Strauss (1991), participants are also
instructed that they should not provide proper nouns or multiple words using a stem with
varying suffixes (e.g. eat, eats, eating). A similar measure, that taps semantic fluency, is
the Animal Naming task. The instructions published by Rosen (1980) were used,
requiring the individual to list as many types of animals as they can, within 60 seconds.
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According to Strauss, Sherman, and Spreen (2006), the FAS task has good
internal consistency between letters (Cronbach's alpha = .83) and test-retest reliability (r
= .74, p < .01). Furthermore, the Animal Naming task did not differ significantly in testretest reliability, and correlated with FAS scores significantly (r = .52, p < .01). Age and
education account for small to moderate amounts of variation in both measures, and thus
appropriate norms should be used when comparing between individuals (see Tombaugh,
Kozak, & Rees, 1999). Verbal fluency has been found to be sensitive to injury to
temporal and frontal lobes, as well as the caudate nucleus (for review of articles see,
Tombaugh, Kozak, & Rees, 1999). Additionally, phonemic fluency deficits are related to
cognitive decrements in nondemented individuals, whereas semantic fluency appears to
be more related to a dementia process (e.g. Alzheimer's) (Steenhuis & Ostbye, 1995).
Verbal fluency deficits are not clearly evident in meta-analysis, aside from severely
affected OSA populations (e.g., Bédard, Montplaisir, Richer, Rouleau, & Malo, 1991;
Fulda & Schulz, 2001). However, there is evidence that suggests phonemic fluency
decrements with intact semantic fluency within the OSA research, which may have
confounded meta-analyses that use a unified fluency construct (Salorio et al., 2002).
Despite the potential insensitivity of this measure within an OSA referral sample, it was
included as a measure of interest due to its analogous status compared to a cognitiveaffective processing measure described below. See Appendix I for these forms.
Other Measures
Participants were given other well researched and validated measures of cognitive
performance in traditionally investigated domains of neurocognitive functioning.
However, these were not the focus of the present dissertation. Instead, the data will be
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used for other research projects associated with the primary investigator, his supervisor,
and the lab. The data will also be used in the previously discussed cognitive screen
decision. The full battery was be approved by both University and Hospital ethics boards.
Other battery measures include: Stroop Color-Word Test (Stroop; Golden, 1978), Trail
Making Test A & B (TMT A& B; Reiten, 1955), Symbol Digit Modalities Test-Written
(SDMT-W; Smith, 1982), Digit Span Forward & Backward (DSF & DSB; Wechsler,
1981), Digit Vigilance Test (DVT; Lewis, 1995), and the Grooved Pegboard (GPT;
Matthews & Klove, 1964).
Neurocognitive Measures of Emotional Processing
As previously discussed in the literature review, there has been extensive research
conducted regarding traditional neurocognitive domain deficits associated with
obstructive sleep apnea. Far less research has been conducted on the emotional
processing deficits associated with poor sleep, even less so with regards to a specific,
though common, sleep disorder such as obstructive sleep apnea.
The extant neuropsychological literature on emotional processing as a domain of
neurocognitive functioning is limited with regards to published tests and measures. Often,
the researchers use a self-constructed measure, including a general description of its
characteristics, but limited protocol and psychometric information (for an example of
some current emotional processing measures see Suchy, 2011). Further complicating the
evaluation of this construct (though not unique to emotion) is the presumed broad impact
affective-processing has across all traditional cognitive domains. These characteristics
unfortunately result in problems with wide-spread measurement of emotional processing

56

in research (for replication studies) and clinical settings (assisting in diagnosis and
functional intervention).
With this in mind, a counterpart measurement approach was used to supplement
the more traditional neurocognitive measures described above. Thus, tasks were selected
or constructed with the goal of contrasting the traditional domains (e.g., memory for
neutral verbal stimuli versus memory for affect-based stimuli). In this way, the
researchers hope to distinguish between potential performance differences unique to
either non-emotional or emotional stimuli and processing. The previously described
considerations recommended by Dorrian and colleagues (2005) were again consulted
during the construction of measures. Again, only those measures discussed in detail
below will be the focus of the present dissertation, but there is a summary of additional
measures and justification for their inclusion in the battery at the end of this section.
Cognitive-Affective Verbal Learning Test (CAVLT)
Instructions and construction of this measure were based upon the CVLT-2, which was
described previously. The protocol for this task is exactly the same as the CVLT-2, with
only the stimuli words changing and removal of the forced-choice aspect of the task
(which was not conducted during CVLT-2 testing). Sixteen positively valenced emotion
words, sixteen negatively valenced emotion words, and sixteen neutral words were
selected from the Affective Norms for English Words (ANEW) database (Bradley &
Lang, 1999). Of the sixteen neutral words, half were concrete, the other half abstract.
Mean distances from neutral were averaged for the positive and negative valence groups
and a t-test was conducted to ensure no significant difference. ANOVAs were conducted
across the positive, negative, and neutral groups to ensure that average word length and
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word frequency did not differ. An ANOVA with contrasts was also conducted to ensure
the average valence of each group was significantly different from each other group. Four
words from the positively valenced group, negatively valenced group, abstract-neutral
group, and concrete-neutral group were selected to form a target list. Each neutral group
had a semantic organizational rule. Another four words from each group were selected
for the distractor list. The remaining 16 words were mixed with target and distractor
words to form the 48-word recognition task, meaning eight novel words that fit into
either of the emotion semantic categories and eight novel distractors that do not. Order of
all words in each list was randomized. ANOVAs were conducted across the target list,
distractor list, and supplemental recognition list to ensure no significant difference
between word length and word frequency. Finally, t-tests were conducted to ensure no
significant differences existed in word length or frequency between CAVLT lists and
their corresponding CVLT-2 lists. See Appendix J for this form.
Emotion Word Fluency Test (EWFT; Abeare, Chauvin, Kaploun, Chu,
Dumitrescu, & Pascual-Leone, 2009)
Instructions and construction of this measure were based upon the FAS phonemic fluency
task, which was described previously. Examinees are asked to list as many emotion
words as they can within one minute. Number of emotion words, perseverations, and
rule-breaks (i.e. non-emotion words), are calculated. Emotion versus non-emotion word
determination is done by clinical judgment and consensus judgment for words that
scorers determine to not clearly be addressed by the following rules. Scoring criteria is
inclusive, with any word unambiguously referring to an emotional state (e.g. happy,
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smiling) being counted as a correct response. Words that refer to cognitive states (e.g.
confusion) or somatic states (e.g. tired) are not counted.
Abeare and colleagues (2009) reported that EWFT inter-rater reliability is strong
(Pearson's r = .91), and intra-class correlation coeffcient for agreement was similarly
strong (rICC = 0.806). The measure demonstrates good test-retest reliability across multiple
intervals (r = .74 for five hours, r = .676 for one week). Reliability values for this
measure are comparable to those values found with other measures of verbal fluency.
This measure is in the process of being examined with clinical samples, but has not been
used with OSA populations. See Appendix K for this form.
Other Measures
Participants were also given other newly constructed measures hypothesized to measure
affective-cognitive processing. However, these were not the focus of the present
dissertation. Instead, that data will be used for other research projects associated with the
primary investigator, his supervisor, and the lab. The full battery was approved by both
University and Hospital ethics boards. Other measures will include the Emotion Stroop
Test (EST; emotion-stimuli matched to the Stroop Color-Word Test; Gardizi & Abeare,
not yet published), Emotion-Digit Coding Test (EDCT; emotion-stimuli matched to the
Symbol-Digit Modalities Test), and the Emotion Vigilance Test (EVT; emotion-stimuli
matched to the Digit Vigilance Test).
Physiological Measures
As part of the sleep disorder referral process, the participants underwent
polysomnography (also known as PSG), a hospital lab-based, polymetric measurement of
the biophysiological characteristics of an individual's sleep session. The polysomnogram
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data was collected and analyzed by hospital staff, then provided to the research team.
Both pre-diagnosis/pre-treatment and post-diagnosis/CPAP polysomnograms were
collected, depending on the patient's progress through the referral and treatment
procedure. The polysomnogram data from the study immediately prior to, or subsequent
to, the neuropsychological evaluation was used, in order to match the data as close
temporally to the cognitive/mood data as possible. The polysomnogram is widely used in
sleep research and sleep disorder diagnosis. This data was accessed from participants'
health records after consent was gained. A subset of polysomnogram indicators was
selected for investigation, per the American Academy of Sleep Medicine scoring manual
(AASM, 2007). All of the below physiological indicators have been found to be aberrant
in a variety of OSA samples, as well as associated with cognitive performance variance
to varying degrees (reviewed by Aloia, Arnedt, Davis, Riggs, & Byrd, 2004). See
Appendix L for an example of a polysomnogram report.
Percentage of time spent in each sleep stage (%N1, %N2, %N3, %REM)
Time spent in, non-REM stage 1, 2, 3 (N1, N2, N3), and REM sleep, divided over total
sleep time.
Sleep efficiency
Total time asleep divided by time in bed.
Sleep apneas/hypneas
Number of apneas (>= 10 second cessation of air-flow) and hypneas (>= 10 second
reduction of air-flow of >= 50%).
AHI
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The sleep apnea and hypnea counts are used to create an Apnea/hypnea Index (AHI), an
indicator of apnea severity.
REM-AHI
This is an index of AHI frequency during REM stage sleep.
Oxygen Saturation
Arterial O2 saturation (%) is measured throughout sleep. Less than 85% O2 saturation is
considered of clinical significance

Procedure
Recruitment
Patients who had already undergone a recent OHIP-covered polysomnogram, along with
patients who were scheduled for an upcoming one, were contacted via telephone or in
person at the Hospital's clinic. Each individual was provided with information about the
purpose, benefits, and risks of participating in the study, and then scheduled for
assessment if they voiced interest in volunteering. A script was used for most of the
interaction (Appendix M). Additionally, brochures describing the study and providing
contact information were provided to the physician collaborators, to be given out to those
patients they deemed potentially eligible for the study (Appendix N). Both the graduate
principal investigator (PI) and trained undergraduate research assistants (RA) conducted
recruitment.
Evaluation
Each participant underwent a single evaluation session taking place at Windsor Regional
Hospital, lasting roughly two hours. Each session began with the researcher once again
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covering the consent form with the participant, explaining the purpose, content, and
benefits associated with the study. Additionally, the participant was informed of their
right to discontinue testing at any time. After signing, the participant filled out the
demographic questionnaire (for reassurance that the participant did not meet exclusionary
criteria). Afterward, the participant filled out the PSQI, ESS, CESD, and PANAS, in that
order. Next the researcher administered the battery of neuropsychological measures in the
following order (measures that are the focus of this dissertation project are underlined;
brackets indicate two sections of the battery that were counter-balanced to control for
potential practice effects from parallel measures): 1) NAART, {{2) CVLT-2, 3) TMT
A&B, 4) SDMT -W, 5) DVT, 6) DigSpn, 7) FAS/Animals/EWFT 8) Stroop,}} {{9)
CAVLT, 10) EDCT, 11) EVT, 12) GPT 13) EST}}.
At the conclusion of testing, the researcher asked the participant whether he or she
had any questions or concerns with the evaluation. If the participant made any statements
regarding suicidal ideation, or scored above a 15 on the CES-D, referral information for
psychological counseling was provided on the spot (see Appendix O for both versions).
The researcher explained that the participant would be contacted with cutoff score
feedback in the near future if the participant opted into the cognitive-screen feedback at
the onset of the testing. When necessary (e.g., offered to those not opting-in to the
cognitive screen protocol or those with a positive result on the cognitive screen), referral
information for these services was also provided, as previously discussed. Refer to Figure
2 for details on recruitment, evaluation, and selection for analysis.
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Figure 2. Flow-chart detailing the recruitment process.

Measures, Scoring, Data Storage
Participants were assigned a participant number upon arrival at the evaluation; this
number was only linked to their name and phone number on a password protected keylist, stored on a password protected folder, in order to keep track of those who had
completed the study and those that required follow-up contact. At no point were any
participant names placed on any measure.
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The measures were scored and placed within the locked research lab's storage.
The hard copies will be kept for a minimum of one year after dissertation defense. Raw
scores and demographically matched normative data were entered into an electronic
database. This database and password protected key-list will be kept for a minimum of
seven years after dissertation defense or five years after study publication.
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CHAPTER 4
ANALYSIS OF RESULTS
Statistical Analyses
Analyses of the data were conducted using IBM SPSS Statistics Version 22.
There were four overarching objectives for the analyses; (1) to determine whether results
from past investigations into the interrelationships between sleep physiological
indicators, subjective sleep measures, cognitive performance, and mood could be
replicated; (2) to document the psychometric properties of two novel measures of
cognitive-affective processing; (3) to investigate how the sleep and mood measures relate
to the novel cognitive-affective measures; (4) to investigate whether the novel cognitiveaffective measures help explain the relationship between sleep disturbance and mood.
SPSS software analyses were used to investigate the first three objectives (i.e.,
correlation, ANOVA and repeated measures ANOVA, and regression, respectively).
However, for the fourth objective, a macro developed by Preacher and Hayes (2008) was
also incorporated, as an alternative to hierarchical regression to analyze the path
coefficients in the multiple mediator model. The macros uses a bootstrapping
methodology to produce confidence intervals for the specific indirect, and total, effects of
an independent variable on a dependent variable via multiple potential mediators. The
authors outline multiple advantages to this method. First, the analysis is exploratory in
both its operationalization of a theoretical model (i.e., van der Helm & Walker, 2009), as
well as the novel measures created, while hierarchical regression is difficult to use
without clear theoretically based, a priori, variable-block-entry order. The Preacher and
Hayes (2008) method is specifically useful in this situation, as the bootstrapping
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approach controls for error and maximizes power. Second, the method is argued to be
superior to the common method of using a SOBEL test after individual mediation
analyses. The SOBEL method is too liberal with small samples, and thus interpretation
would be limited within the present study. Third, the macro is capable of handling groups
of mediators as well as covariates, allowing for a more efficient number of analyses and
minimization of a compounding familywise error rate. In the following analyses, 1000
iterations and a 95% confidence interval were selected, per recommendation of the
authors.
Given the number of hypotheses and planned analyses, consideration was given to
concern of familywise error (i.e., type 1 error due to multiple comparisons). With regard
to correlations, all construct interrelationships had specified a priori directionality within
the hypotheses. Furthermore, this type of approach (i.e., multiple correlation matrices) is
a logical first step toward identifying a priori hypotheses that do not warrant follow up
analyses. With regard to the multiple means comparisons, MANCOVA is conducted first,
prior to subgroup comparisons. Finally, the model testing via regression is exploratory
(though based on extant research and framed with a priori hypotheses), therefore there
were no additional measures taken to decease the probability of type 1 error for these
analyses.

Assumptions
Before data collection, a power analysis was conducted using G*Power, a free
software program that allows for a priori sample size estimation for specific statistical
tests (Erdfelder, Faul, & Buchner, 2007). Almost all the cognitive and affective-cognitive
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measures included in this study tap some form of working memory, mental flexibility,
inhibition, or associated executive processes. Extant sleep research does not have reliably
obtained cognitive-affective effect sizes, thus, a collection of review studies that reported
effect sizes for cognitive domains such as complex attention, mental flexibility, working
memory, executive functioning, and frontal processing in OSA samples compared to
healthy controls were collected, and these effect sizes (d's = .70, .75, .79) were then
averaged, resulting in d = .747, or f2 = .140 (Beebe & Gozal, 2002; Fulda & Schulz,
2001; Naegele, Thouvard, Pépin, Lévy, Bonnet, Perret, Pellat, & Feuerstein, 1995). User
settings for hierarchical regression were as follows (since planned F statistic tests would
require the largest sample), a power value of 0.8, an alpha value of 0.05, a total possible
maximum of 7 predictors (age, gender, education, polysomnogram, subjective sleep,
cognitive measure, cognitive-affective measure), and a numerator df of 1 (representing
the experimental variable of interest in each analysis). Of note, the liberal predictor value
was selected in an effort to protect against concerns of an underpowered sample in the
case of the model requiring more predictors and covariates than hypothesized. This
results in an estimated required total sample size of 59.
To investigate normality of data, Shapiro-Wilk tests, skewness and kurtosis cutoffs (-2/2 and -3/3, respectively), Q-Q plots, and boxplots were investigated. All of the
analyzed variables demonstrated a normal distribution, with a few exceptions. Splitting
the sample by OSA cut-offs resulted in non-normal Shapiro Wilk results for the PSQI,
CESD, and PNA measures within the non-OSA group and the PSQI for the severe OSA
group. However, visual inspection of the plots strongly suggested equivalent normality
compared to the other groups. Additionally, the Shapiro-Wilk test is statistically
67

conservative with small groups (i.e., subgroups of the present sample). Finally, all
planned analyses are considered robust against violations of normality. Given these
factors, no transformations were conducted. Multiple extreme outlier scores were
identified (>3*inter-quartile range), including two CESD data points and one Sleep
Efficiency % data point, were removed from analyses. Homogeneity of variance was
confirmed for all variables via use of Levene's test. Variance sphericity was safely
assumed for all relevant measures, with the exception of the CVLT learning trials (1-5);
thus, for this analysis, epsilon tests output was interpreted. Twelve (12) cases contained at
least one missing value, spanning 4 variables, which represented 2.31% of the overall
data. Thus, no statistical procedures to further evaluate or address the missing values was
deemed necessary.
For multivariate regression analyses, a 5:1 (n:predictors) ratio is considered a
minimum standard (Tabachnick & Fidell, 2001). As covariates could be accounted for via
the regression macro selected, and not entered into a control-variable block, the
maximum expected number of predictors (4) resulted in a 15:1 ratio, surpassing this
standard. Standardized residual plot inspection indicated appropriate linearity between
variables of interest, as well as an appropriate homoscedastic distribution. The data
passed a Durbin cut-off (>1), a multicollinearity check (Tolerance < 0.9), Cook's value
cut-off (>1), and a Leverage Value determined by using a sample-specific cut-off ([2 x
number of predictors]/N = 0.13). Lastly, a Mahalanobis’ distance cut-off using df = 4, p =
.01, with a chi-squared table cut-off of 13.277, identified no multivariate outliers.
Neurocognitive data collected for research contains similar validity concerns as
within clinical contexts. While there were no alterior motives for disengenious
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performance with these participants (in fact, most were highly motivated to engage, as all
were attracted to participation due to subjective cognitive complaints), it was thought
advisable to check two embedded performance validity indicators within the database.
Using empirically-derived digit span (7+; Greiffenstein, Baker, & Gola, 1994), verbal
fluency regression (Sugarman & Axelrod, 2015), and 3-variable CVLT regression (Wolfe
et al., 2010) cut-offs, no sub-optimal performance participants were identified (i.e., above
cut-off on 2+ of the three indnicators).
Demographic and Descriptive Data
The demographic descriptives of the whole sample, as well as the AHI severity
subgroups, are summarized in Table 2. Chi-squared analyses found no significant gender
distribution differences, χ² (3, N = 61) = 6.40, p = 0.09. The same non-significance was
found for reported household income, χ² (24, N = 61) = 13.70, p = 0.95. Over a third of
the sample (n = 22) reported the highest bracket of income ($75,100+), followed by
“prefer not say” (n = 10), $50,100-$75,000 and $40,100-$50,000 (both n's = 7), $20,100$30,000 (n = 5), $30,100-$40,000 (n = 4), $15,100-$20,000 (n = 3), $0-$10,000 (n = 2),
and $10,100-$15,000 (n = 1). No significant differences were identified between groups
for age, education, or estimated IQ, p's > 0.10. No analyses were run for ethnicity due to
the limited number of non-white participants (n = 3).

Table 2
Sample Demographic Descriptives by OSA Clinical Severity Group
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Whole
Sample
(N=61)

Gender

Age
Mean
(SD)

Education
Mean
(SD)

NAART IQ
Mean
(SD)

Ethnicity

29 females
47.5%

52.74
(14.40)

13.86
(3.07)

103.63
(8.04)

58 White
2 Black
1 Asian

No OSA
(n=22)

15 females
68.2%

49.64
(15.18)

15.18
(3.46)

106.46
(6.60)

22 White

Mild
(n=11)

4 females
36.4%

58.64
(13.55)

13.27
(4.20)

106.67
(8.31)

11 White

Moderate
(n=11)

3 females
27.3%

54.00
(12.51)

13.65
(2.76)

106.1
(8.05)

10 White
1 Black

Severe
(n=17)

7 females
41.2%

52.74
(14.40)

13.65
(2.76)

105.38
(7.78)

15 White
1 Black
1 Asian

Note: NAART IQ: North American Adult Reading Test Estimated Premorbid IQ

Correlational Analyses
Demographic Investigation
As only a minority of the variables of interest provided demographically-corrected
normative scores, a bivariate correlation analysis was used to determine potential
covariates for the planned analyses. Participant age was found to significantly correlate
with the following measures, p's < 0.01: CVLT Learning, r = -0.41; CVLT Short Delay
Recall, r = -0.39; Animals Fluency, r = -0.37; CAVLT Learning, r = -0.44; CAVLT
Short Delay Recall, r = -0.53; CAVLT Long Delay Recall, r = -0.55; Sleep Efficiency, r
= -0.27. Gender and Education did not significantly correlate with any self-report,
cognitive, cognitive-affective processing (CAP), or sleep study (PSG) variables. Thus,
the decision was made to use raw scores across all measures and to control for age in all
subsequent analyses, unless otherwise noted.
70

Variables of Interest Investigation
Six partial correlations, controlling for age, were conducted to both investigate a number
of hypotheses as well as assist in guidance for subsequent regression analyses. Results of
each are summarized below. Additional variables were calculated for CAVLT subtests, in
order to quantify response bias with regard to the emotional words versus non-emotional
words, as well as positive-versus-negative valence response bias within emotional word
recall responses. These factors were designed to represent response bias controlling for
the actual learning or memory production performance itself. With regard to the former,
an Emotionality Factor (EF) was calculated by using positive emotion word responses
(PE), negative emotion word responses (NE), and non-emotion word responses (NEF,
i.e., the two remaining word groups), where EF = ((PE+NE)-NEF)/(Total Words))*100.
However, due to the non-emotion word response categories containing a concrete nonemotion word category (i.e., body parts) and an abstract non-emotion word category (i.e.,
units of time), a corrected EF was calculated in order to parse out recall variance
impacted by the abstractness-versus-concreteness of the words. This resulted in
Emotionality Factor = ((Positive Emotion Words+Negative Emotion Words)-(2*Abstract
Non-Emotion Words)/(Positive Emotion Words+Negative Emotion Words+(2*Abstract
Non-Emotion Words)))*100. For the CAVLT Emotionality Factor, values can range
between -100 and 100, with positive values representing a tendency towards emotionalword response, a negative value representing a tendency toward non-emotional word
response.
71

With regards to positive-versus-negative valence response bias, the following was
used to calculate a Valence Factor (VF) = ((Positive Emotion Words-Negative Emotion
Words)/(Positive Emotion Words+Negative Emotion Words))*100. For VF, positive or
negative values (-100 to 100) represent the corresponding valence tendency in responses
given, designed to represent response bias controlling for the actual learning or memory
production performance itself. For purposes of reporting, VF differences are phrased as
“bidirectionally diverged” if the group difference's midpoint is near 0 and “more
negative/positive” if one group's factor score is near 0 and the contrasting group is
significantly higher/lower.
Sleep & Mood
Self-report sleep measures, polysomnogram sleep measures, and self-reported mood
interrelationships were analyzed (see Table 3 for details related to correlation strengths
and significance values). Overall, subjective sleep disturbance measures were more
widely and strongly associated with mood reports compared to objective sleep measures.
Specifically, sleepiness and sleep disturbance were associated with increased depressive
symptoms and negative affect, along with less positive affect. Objective sleep disturbance
measures demonstrated more limited results. Higher sleep efficiency was associated with
less negative affect and less depressive symptoms, and fragmented REM sleep also was
associated with less negative affect.
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Table 3
Partial Correlation Matrix (controlling for age) of Mood, Subjective Sleep Measures,
and Sleep Study Indicators
1

2

3

4

5

6

7

8

9

1.CESD

--

2. PPA

-0.69

--

3. PNA

0.68

-0.39

--

4. ESS

0.39

-0.38

0.30

--

5. PSQI

0.20

-0.13

0.23

0.18

--

6. AHI

0.21

-0.27

0.01

0.01

-0.4

--

7. R-AHI

-0.10

-0.07

-0.25

-0.02

0.04

0.45

--

8. SE%

-0.20

0.08

-0.37

0.15

0.07

-0.25

-0.04

--

9. lowO2%

0.19

-0.15

0.06

-0.03

0.12

0.41

-0.08

-0.07

--

10. REM% -0.04
0.11
p <0.05, p <0.01, p <0.001

0.20

0.14

0.02

-0.27

0.23

0.04

-0.28

Note: CESD: Center for Epidemiological Study – Depression Scale, PPA: PANAS
Positive Affect Scale, PNA: PANAS Negative Affect Scale, ESS: Epworth Sleepiness
Scale, PSQI: Pittsburgh Sleep Quality Index (high scores = high sleep disturbance), AHI:
Apnea-Hypnea Index, R-AHI: REM Sleep Apnea-Hypnea Index, SE%: Sleep Efficiency,
Low O2%: Proportion of sleep time spent in hypoxia, REM%: proportion of sleep spent
in REM.

Sleep and Cognition
Self-report sleep measures, polysomnogram sleep measures, and cognitive performance
interrelationships were analyzed; see Table 4 for details related to correlation strengths
and significance values. Self-reported sleepiness (ESS) and sleep quality (PSQI) had no
significant correlational findings with the cognitive measures. Sleep apnea severity (AHI)
had small (based on Cohen, 1988) negative correlations with the CVLT's Long Delayed
Recall and Recognition trials (r's = -0.23, -0.25, respectively). There were moderate-tostrong negative correlations between hypoxia (low O2%) and Long Delayed Recall and
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Recognition (r's = -0.42, -0.29 respectively), and hypoxia was moderately correlated with
worse category-fluency for Animals (r = -0.31). In sum, objective measures of sleep
disturbance demonstrated wider and stronger correlations with impaired cognitive
performance measures than subjective sleep disturbance reports.
Table 4
Partial Correlation Matrix (controlling for age) of Subjective Sleep Self-Report
Measures, Sleep Study Indicators, and Standard Cognitive Measure Performance
CVLT
CVLT
CVLT
CVLT
Verbal
Learnin Short Delay Long Delay Recognition Fluency:
g
Recall
Recall
FAS

Verbal
Fluency:
Animals

ESS

-0.01

-0.09

-0.18

-0.14

0.04

0.13

PSQI

-0.11

-0.21

-0.11

-0.11

-0.09

-0.12

AHI

-0.07

-0.05

-0.23

-0.25

-0.01

-0.03

R-AHI

0.11

0.20

0.12

0.12

0.09

0.09

REM%

-0.09

-0.14

0.01

0.01

-0.11

-0.16

SE%

0.04

0.04

0.07

0.07

0.12

0.06

Low O2%
-0.02
-0.10
-0.42
-0.29
-0.15
-0.31
p <0.05, p <0.01
Note: ESS: Epworth Sleepiness Scale, PSQI: Pittsburgh Sleep Quality Index (high scores
= high sleep disturbance), AHI: Apnea-Hypnea Index, R-AHI: REM Sleep ApneaHypnea Index, SE%: Sleep Efficiency, Low O2%: Proportion of sleep time spent in
hypoxia, REM%: proportion of sleep spent in REM, CVLT: California Verbal Learning
Test-2
Sleep and Cognitive-Affective Processing
Self-report sleep measures, sleep study (polysomnogram) measures, and cognitiveaffective processing (CAP) performance interrelationships were analyzed; see Table 5 for
details related to correlation strengths and significance values. Self-reported sleep
disturbance (PSQI) correlated moderately with increased negatively biased (VF) CAVLT
Long Delayed Recall (r = -0.32) and to a lesser degree with a bias away from emotional
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words in the CAVLT Recognition trial (Emotionality Factor, r = -0.24). Self-reported
sleepiness (ESS) demonstrated no significant correlations with cognitive-affective
processing measures.
For sleep study measures, sleep fragmentation severity (AHI) negatively
correlated with CAVLT Short and Long Delay Recall (r's = -0.23, -0.28, respectively).
Furthermore, AHI was correlated with a bias toward recall for negative words in Short
Delay Recall (Positive Emotion Words, r = -0.30) and in Long Delay Recall (Positive
Emotion Words, r = -0.29; Valence Factor, r = -0.26). Sleep fragmentation in REM (RAHI) was not associated with reduced word recall, but was associated with a bias toward
negative valence (VF) within the CAVLT Learning (r = -0.23), Short Delay Recall (r =
-0.32), and Long Delay Recall (r = -0.28) trials. Percentage of REM sleep (REM%)
correlated with lower CAVLT Short Delay Recall (r = -0.23), and a bias away from
negative emotion word production in that subtest (SDR NE, r = -0.24). Time asleep spent
in a hypoxic state (Low O2%) impacted long delay recall (CA-LDR) qualitatively, in a
pattern similar to the AHI findings increased amount of negative emotion words (NE, r =
-0.23) and negative valence for those recalled (VF, r = -0.28). Hypoxia was also
correlated with reduced CAVLT Recognition (r = -0.24). Higher sleep efficiency (SE%;
i.e., sleep time regardless of fragmentation) was associated with more emotionality of
those words recalled after short and long delay (Emotionality Factor, r's = 0.38, 0.22,
respectively), as well as increased initiation and fluency for emotion words (EWFT, r =
0.27).
Overall, the analysis reveals a pattern whereby objective sleep study measures
(and to a lesser extent, subjective measures) of sleep disturbance were associated with 1)
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lower short and long delayed recall, recognition, but not initial learning performance, and
2) recall responses (and to a lesser extent learning) biased away from positive words and
emotion-related words.

Table 5
76

Partial Correlation Matrix (controlling for age) of Subjective Sleep Self-Report
Measures, Sleep Study Indicators, and Cognitive-Affective Processing Performance
Measures
ESS

PSQI

AHI

SE%

lowO2%

0.07

-0.01

0.02

-0.08

0.05

0.27

0.08

-0.08

0.01

0.01

0.01

-0.15

-0.01

0.02

(+) Words

-0.17

0.05

-0.17

-0.12

0.01

0.09

-0.10

(-) Words

-0.12

0.09

0.04

0.05

-0.16

-0.09

0.07

Valence Factor

0.05

0.07

-0.18

-0.23

0.12

0.20

-0.22

Emotionality Factor

0.07

-0.03

-0.01

-0.01

0.01

0.25

0.17

-0.08

-0.07

-0.23

0.01

-0.23

-0.05

-0.19

(+) Words

-0.20

-0.10

-0.30

-0.19

-0.17

0.18

-0.06

(-) Words

0.05

0.18

0.06

0.29

-0.24

0.15

-0.12

Valence Factor

-0.16

-0.2

-0.20

-0.32

-0.09

-0.12

0.04

Emotionality Factor

0.10

0.08

-0.06

0.10

-0.09

0.38

0.19

-0.17

0.13

-0.28

0.07

-0.02

0.08

-0.17

(+) Words

-0.17

0.16

-0.29

-0.06

0.04

0.22

-0.23

(-) Words

-0.02

0.22

0.08

-0.19

-0.16

0.09

-.080

Valence Factor

-0.22

-0.32

-0.26

-0.28

0.09

-0.02

-0.28

Emotionality Factor

0.14

0.14

0.11

0.28

-0.16

0.22

0.01

Recognition

-0.11

0.03

-0.18

-0.06

-0.12

-0.20

-0.24

(+) Words

0.01

-0.02

-0.13

-0.15

0.08

-0.07

-0.11

(-) Words

-0.21

0.01

0.16

0.17

-0.26

-0.08

0.19

Valence Factor

0.19

-0.01

-0.20

-0.25

0.32

-0.06

-0.22

EWFT

R-AHI REM%

CAVLT
Learning

Short Delay Recall

Long Delay Recall

Emotionality Factor 0.07 -0.24 -0.20 -0.16
0.06
-0.15
0.21
p <0.05, p <0.01, p <0.001
Note: ESS: Epworth Sleepiness Scale, PSQI: Pittsburgh Sleep Quality Index (high scores
= high sleep disturbance), AHI: Apnea-Hypnea Index, R-AHI: REM Sleep ApneaHypnea Index, SE%: Sleep Efficiency, Low O2%: Proportion of sleep time spent in
hypoxia, REM%: proportion of sleep spent in REM, EWFT: Emotion Word Fluency
Test, CAVLT: Cognitive-Affective Verbal Learning Test, (+) Words: Positive Emotion
Words, (-) Words: Negative Emotion Words
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Mood and Cognition
Self-report mood measures and cognitive performance were analyzed; see Table 6 for
details related to correlation strengths and significance values. Overall, depressive
symptom report was associated with small-to-moderate range decrements in delayed
recall and verbal fluency measures. Neither positive nor negative affect report scores
were correlated with cognitive performance.
Table 6
Mood and Cognitive Performance Partial Correlation Matrix (controlling for age)
CVLT
Learning

CVLT
SDR

CVLT
CVLT
Verbal
Verbal
LDR Recognition Fluency: FAS Fluency: Anm

CESD

-0.14

-0.16

-0.39

0.07

-0.23

-0.23

PPA

0.01

0.02

0.14

0.01

-0.03

0.01

PNA
-0.03
-0.08
-0.15
-0.03
-0.11
-0.12
p <0.05, p <0.001
Note: CESD: Center for Epidemiological Study – Depression Scale, PPA: PANAS
Positive Affect Scale, PNA: PANAS Negative Affect Scale, CVLT: California Verbal
Learning Test-2.
Mood and Cognitive-Affective Processing
Self-report mood measures and cognitive-affective performance were analyzed; see Table
7 for details related to correlation strengths and significance values. Depressive symptom
report (CESD) correlated with CAVLT Learning for Negative Emotion Words (r = 0.26),
lower Short Delay Recall for Positive Words (r = -0.34) and Valence Factor (r = -0.25),
lower overall Long Delay Recall (r = -0.20), and a negative bias for the Recognition
Valence Factor (r = -0.23). Positive Affect scores were conceptually similar, correlating
with lower CAVLT Learning for Negative Emotion Words (r = -0.21), higher Short
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Delay Recall for Positive Words (r = 0.38), and a positive bias for the Short Delay Recall
Valence Factor (r = 0.34) and Recognition Valence Factor (r = 0.24) trial. Contrary to the
pattern, higher Positive Affect had a small correlation with negatively biased Learning
trial Valence Factor (r = -0.25). Negative Affect had no significant correlations with
cognitive-affective processing measures.
Overall, the depression scale (CESD) demonstrated a correlational pattern
consistent with more negative Valence Factors/Negative Emotion Word production
across Learning, Short Delay Recall, and Long Delay Recall trials of the CAVLT. The
PANAS Positive and Negative Affect scales demonstrated less consistent and less strong
pattern of correlations with the CAVLT subtests and qualitative factors. None of the
mood variables correlated with Emotion Word Fluency Test scores.
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Table 7
Partial Correlation Matrix (controlling for age) for Self-Reported Mood Scores and
Cognitive-Affective Processing Performance
CESD

PPA

PNA

-0.18

-0.09

0.11

-0.14

-0.09

-0.07

(+) Words

-0.03

-0.13

0.08

(-) Words

0.26

-0.21

-0.07

Valence Factor

0.09

-0.25

0.11

Emotionality Factor

0.20

-0.03

0.10

-0.14

0.06

-0.01

(+) Words

-0.34

0.38

-0.10

(-) Words

-0.34

0.37

-0.01

Valence Factor

-0.25

0.24

0.07

Emotionality Factor

-0.09

0.10

-0.06

-0.20

0.05

-0.18

(+) Words

-0.15

0.11

-0.03

(-) Words

-0.11

-0.04

-0.13

Valence Factor

-0.04

0.16

0.14

Emotionality Factor

-0.01

-0.03

0.03

Recognition

-0.02

0.06

0.06

(+) Words

0.14

-0.06

0.10

(-) Words

-0.10

0.27

-0.11

Valence Factor

-0.23

-0.25

0.20

EWFT
CAVLT
Learning

Short Delay Recall

Long Delay Recall

Emotionality Factor 0.14
0.08
0.05
p <0.05, p <0.01
Note: ESS: Epworth Sleepiness Scale, PSQI: Pittsburgh Sleep Quality Index (high scores
= high sleep disturbance), AHI: Apnea-Hypnea Index, R-AHI: REM Sleep ApneaHypnea Index, SE%: Sleep Efficiency, Low O2%: Proportion of sleep time spent in
hypoxia, REM%: proportion of sleep spent in REM, EWFT: Emotion Word Fluency
Test, CAVLT: Cognitive-Affective Verbal Learning Test, (+) Words: Positive Emotion
Words, (-) Words: Negative Emotion Words
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Cognition and Cognitive-Affective Processing Performance
Standard cognitive performance and cognitive-affective processing performance
intercorrelations were analyzed, see Table 8 for details related to correlation strengths
and significance values. All standard cognitive measures and subtests demonstrated
significant positive correlations with the counterpart cognitive-affective processing
measures and subtests. Correlations for the Learning measures were generally in the
strong range, and correlations for the Short/Long Delay Recall measures were in the
moderate-to-strong range. The standard measure of semantic fluency (Animals)
correlated strongly with the cognitive-affective processing fluency task (EWFT),
compared to the phonemic fluency measure (FAS), which was significant but statistically
less strong (Fisher's z = 2.76, p < 0.01). The small-to-moderate range positive correlations
found between the CVLT and the standard verbal fluency measures were slightly less
strong (i.e., small range exclusively), and less broad, for the CAVLT and the EWFT. The
NAART intelligence estimate did not significantly correlate with the CAVLT or EWFT,
p's > 0.10.
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Table 8
Cognitive and Cognitive-Affective Processing Performance Partial Correlation Matrix
(controlling for age)
1

2

3

4

5

6

7

8

9

10

CVLT
1. Learning

.

2. SDR

0.87

.

3. LDR

0.72

0.75

.

4. Recognition

0.39

0.42

0.43

.

5. Learning

0.63

0.53

0.42

0.26

.

6. SDR

0.64

0.61

0.49

0.33

0.76

.

7. LDR

0.57

0.51

0.48

0.35

0.72

0.75

.

8. Recognition

0.46

0.47

0.26

0.37

0.54

0.49

0.57

9. FAS

0.18

0.20

0.25 -0.03

0.23

0.22

0.15

10. Animals

0.34

0.35

0.46

0.26

0.27

0.20

CAVLT

.

Fluency
0.32

.
0.25

0.25

11. EWFT
0.20
0.22 0.34 0.10 0.24
0.11
0.29 0.08 0.12
p <0.05, p <0.01, p <0.001
Note: CAVLT: Cognitive-Affective Verbal Learning Test, CVLT: California Verbal
Learning Test-2, SDR: Short Delay Recall, LDR: Long Delay Recall, EWFT: Emotion
Word Fluency Test
Mean Comparisons for Sleep Apnea Severity Subgroups
A one-way MANCOVA using OSA severity group (AHI) as the IV, and cognitive
(CVLT: Learning, SDR, LDR, Recognition; FAS, Animals), cognitive-affective
processing (CAVLT: Learning, SDR, LDR, Recognition, VF for each previous subscore;
EWFT), and mood dependent variables (CESD, PNA, PPA) as DV's, with age as a
covariate, was significant, Wilk's lambda = 0.52, F(45, 107.73) = 1.52, p = 0.04. Though
a conservative approach would use the MANCOVA contrasts to determine differences
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.
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for specific measures, the small amount of missing values combined with list-wise
deletion significantly reduced the available n for each contrast, which was judged to be
too restrictive on power for such an exploratorially driven study. Thus, the previously
listed dependent variables were entered into an ANCOVA, controlling for age, in order to
compare OSA severity group profiles. The following tables (10-13) contain unadjusted
means and standard deviations, as these are more easily interpretable. Tukey's contrasts
were used to investigate pattern of subgroup differences, and those p-values were
reported where applicable. Additionally, below each table, the pattern of contrast
differences will be specified where applicable. Limitations on the interpretations that
follow this course of analysis are appropriately addressed in the discussion.
Polysomnogram Indicator Comparisons
Apnea-hypnea Index (AHI) scores significantly differed between groups (see Table 9 for
details), in the expected direction given that this indicator is the clinical classifying
criteria, F(3, 61) = 167.24, p < 0.001, ES = 0.90, with contrasts indicating all groups
significantly differing amongst each other, p’s < 0.001. AHI severity during REM sleep
(R-AHI) significantly differed between groups, F(3, 57) = 6.29, p = 0.001, ES = 0.27. A
Post-hoc contrast indicated that AHI severity during REM sleep was significantly lower
for the No OSA groups compared to the Moderate and Severe OSA groups, p's < 0.01.
Sleep Efficiency (SE%) also differed significantly, F(3, 60) = 3.58, p = 0.03, ES =0.10,
with higher efficiency in the No OSA group compared to the Severe group, p = 0.05.
Percentage of sleep time spent in REM (REM%) significantly differed amongst groups,
F(3, 61) = 3.68, p = 0.02, ES = 0.17. Specifically, it was significantly lower for the No
OSA and Severe groups compared to the Moderate group, an unexpected finding without
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obvious explanation, p's < 0.05 . Finally, hypoxia during sleep (Low O2%) differed
amongst the severity groups, F(3, 60) = 7.38, p < 0.001, ES = 0.29. Clinically low oxygen
blood saturation time was significantly higher for the Severe OSA group compared to the
other groups, which did not differ amongst themselves, p's < 0.01. Overall, a general
pattern of significant polysomnogram abnormality was demonstrated across indicators for
the Severe OSA group compared to the others, with Moderate OSA less frequently
distinguished as significantly more abnormal than the lower-severity groups, and the
Mild group not differing from the No OSA group across any, aside from AHI (a finding
expected as AHI was used to create clinical groups).
Table 9
ANCOVA (controlling for age) Comparison of Polysomnogram Sleep Quality Indicators
by AHI Diagnostic Category
AHI*
Mean
(SD)

R-AHI^
Mean
(SD)

SE%#
Mean
(SD)

REM%& Low O2%+
Mean
Mean
(SD)
(SD)

No OSA
(n=22)

2.45
(1.38)

8.91
(11.20)

85.20
(12.07)

14.58
(8.30)

0.39
(1.20)

Mild
(n=11)

10.03
(3.24)

23.36
(14.13)

81.28
(8.27)

15.52
(3.66)

5.15
(13.69)

Moderate
(n=11)

23.48
(3.75)

37.18
(19.35)

84.46
(7.74)

21.44
(3.56)

2.78
(3.14)

Severe
66.76
37.74
76.10
11.21
18.50
(n=17)
(16.93)
(34.34)
(19.04)
(11.01)
(14.21)
*: No < Mild < Moderate < Severe;
^: No < Moderate & Severe;
+: No, Mild, & Moderate < Severe
#: No > Severe;
&: No & Severe < Moderate
Note: AHI: Apnea-Hypnea Index, R-AHI: REM Sleep Apnea-Hypnea Index, SE%: Sleep
Efficiency, Low O2%: Proportion of sleep time spent in hypoxia, REM%: proportion of
sleep spent in REM
Self-Reported Mood and Sleep Quality Score Comparisons
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No significant group differences emerged upon comparison of self-reported mood or
sleep quality measures, p's > 0.10 (see Table 10 for details).

Table 10
ANCOVA (controlling for age) Comparison of Self-Reported Mood and Sleep Quality
Scores by AHI Diagnostic Category
CESD

PNA

PPA

ESS

PSQI

No OSA
(n=22)

10.28
(6.91)

16.55
(7.76)

30.42
(8.51)

9.14
(4.74)

8.16
(5.69)

Mild
(n=11)

13.77
(8.83)

16.36
(5.95)

30.73
(8.06)

8.09
(3.83)

8.91
(4.25)

Moderate
(n=11)

13.36
(9.50)

15.73
(2.80)

32.82
(9.63)

9.45
(4.50)

8.64
(4.13)

Severe
16.00
15.59
26.88
9.12
9.09
(n=17)
(13.14)
(4.71)
(8.18)
(4.50)
(5.37)
Note: CESD: Center for Epidemiological Study – Depression Scale, PNA: PANAS
Negative Affect Scale, PPA: PANAS Positive Affect Scale, ESS: Epworth Sleepiness
Scale, PSQI: Pittsburgh Sleep Quality Index (higher scores = more reported sleep
disturbance).

Cognitive Performance (Raw Scores) Comparisons
No significant group performance differences emerged upon analysis for any of the
standard cognitive test measures (p's > 0.10; see Table 11). No significant differences
were found when repeated measure ANCOVAs were used to evaluate whether significant
patterns of performance differences existed (p's >0.10) within the CVLT learning trials
(i.e., Trials 1, 2, 3, 4, 5) or across time-increments within the verbal fluency tasks (i.e.,
total output at 15 seconds, 30s, 45s, 60s; output during increments 1-15 seconds, 16-30s,
31-45s, 46-60s).
Table 11
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ANCOVA (controlling for age) Comparison of Cognitive Raw Score by OSA Diagnostic
Severity Category
No OSA
n=22
Mean
(SD)

Mild
n=11
Mean
(SD)

Moderate
n=11
Mean
(SD)

Severe
n=17
Mean
(SD)

Learning

49.05
(12.70)

47.00
(13.73)

45.91
(8.83)

45.53
(10.42)

Short Delay Recall

10.29
(3.57)

10.18
(5.33)

9.18
(2.79)

9.35
(3.39)

Long Delay Recall

10.19
(2.99)

10.36
(5.26)

9.00
(2.65)

8.29
(4.04)

Recognition

14.33
(1.80)

14.45
(2.02)

14.50
(1.35)

14.00
(1.66)

35.73
(9.36)

40.00
(11.23)

36.36
(17.97)

38.69
(7.61)

19.09
(4.06)

18.56
(3.60)

CVLT

Verbal Fluency
FAS
Animals

17.91
18.27
(4.00)
(5.33)
Note: CVLT: California Verbal Learning Test-2

Cognitive-Affective Performance (Raw Scores) Comparisons
For the CAVLT, total number of words recalled across learning trials was significantly
different across OSA severity groups, F(3, 60) = 2.98, p = 0.04, ES = 0.14. Specifically,
the number of words recalled was higher for the No OSA group compared to the three
diagnostic groups, p's < 0.05, which did not differ amongst themselves (see Table 12).
No significant performance differences were found for total recall after short delay, but
positive-emotion word recall was different, F(3, 59) = 3.25, p = 0.03, ES = 0.15 with the
No OSA group demonstrating greater Short Delay Recall for Positive Words than the
Moderate and Severe groups, p's < 0.05. Similarly, the Valence Factor for Short Delay
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Recall (i.e., controlling for overall amount of recall) was significantly different, F(3, 59)
= 3.35, p = 0.03, ES = 0.16, with more positive affective bias for the No OSA and Mild
groups compared to the more negative bias for the Moderate and Severe groups, p's <
0.05.
Long Delay Recall on the CAVLT differed significantly across OSA severity
groups, F(3, 59) = 2.97, p = 0.04, ES = 0.14. Specifically, the No OSA group recalled
significantly more words after a long delay than the Moderate and Severe groups, p's <
0.05. For the Long Delay Recall subtest, significant group differences were found for
Positive Emotion Words, F(3, 59) = 3.02, p = 0.04, ES = 0.14, and the valence factor,
F(3, 59) = 3.62, p = 0.02, ES = 0.17. The No OSA group recalled more Positive Emotion
Words than the Severe group, p = 0.004, and the Valence Factor was significantly lower
(more negatively biased, controlling for amount of recall) for the Severe group compared
to all other groups, p's < 0.05. No recognition subtest differences were found (p's > 0.10).
No significant differences were noted across any of the submeasures for the Emotionality
Factor, which was designed to measure bias toward recall of emotional words versus nonemotional words (p's > 0.10). Similar to the standard verbal fluency tests, no EWFT
performances differed significantly. Repeated measure ANCOVAs did not reveal
significant differences between AHI severity groups in CAVLT learning trial
performance, nor EWFT quartile-sum and quartile-production performances (p's > 0.10).

Table 12
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ANCOVA (controlling for age) Comparison of Cognitive-Affective Raw Scores by OSA
Diagnostic Category
No OSA
n=22
Mean
(SD)

Mild
n=11
Mean
(SD)

Moderate
n=11
Mean
(SD)

Severe
n=17
Mean
(SD)

52.27
(10.49)

43.30
(13.01)

40.91
(8.80)

45.35
(10.50)

(+) Words

12.14
(3.80)

9.40
(2.76)

9.64
(3.85)

9.88
(3.87)

(-) Words

11.95
(3.19)

10.60
(2.50)

10.55
(3.59)

10.41
(3.08)

Valence Factor

-0.40
(16.01)

-7.18
(8.36)

-6.14
(31.01)

-9.94
(19.66)

Emotionality Factor

13.48
(31.83)

39.60
(12.52)

36.77
(11.09)

41.23
(10.00)

10.86
(3.18)

8.10
(4.04)

7.91
(2.21)

8.18
(3.01)

(+) Words^

2.38
(1.16)

1.70
(1.16)

1.36
(1.03)

1.35
(0.93)

(-) Words

2.10
(0.89)

1.30
(1.16)

1.82
(0.75)

1.82
(1.02)

Valence Factor#

4.53
(27.81)

24.33
(47.97)

-27.27
(49.84)

-24.18
(44.40)

Emotionality Factor

11.06
(47.11)

12.19
(64.56)

26.88
(64.26)

28.02
(76.38

10.52
(3.43)

8.00
(4.52)

7.82
(2.56)

7.41
(3.03)

(+) Words@

2.19
(1.33)

1.50
(1.27)

1.55
(0.93)

1.00
(1.06)

(-) Words

1.90
(1.18)

1.30
(1.25)

1.55
(1.04)

1.59
(1.00)

Valence Factor&

5.44
(29.52)

6.00
(24.59)

1.52
(49.70)

-35.69
(57.10)

Emotionality Factor

-7.03
(42.42)

-11.25
(50.67)

18.18
(58.64)

13.08
(73.09)

Recognition

14.67
(1.71)

14.60
(1.78)

13.90
(1.29)

13.60
(1.77)

(+) Words

3.33
(1.02)

3.50
(1.08)

3.40
(0.70)

3.20
(0.68)

(-) Words

3.43
(0.75)

3.50
(0.85)

3.20
(0.63)

3.33
(0.72)

CAVLT
Learning*

Short Delay Recall

Long Delay Recall^
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Valence Factor

-3.24
(16.91)

-1.90
(19.72)

2.76
(15.08)

-1.90
(14.07)

Emotionality Factor

-45.47
(16.17)

-24.00
(28.56)

-31.68
(22.26)

-33.22
(33.47)

10.00
(2.93)

11.27
(3.47)

9.36
(3.96)

10.44
(3.03)

EWFT

*: No > Mild, Moderate, & Severe
^: No > Moderate & Severe
@: No > Severe
#: No & Mild > Moderate & Severe
&: No, Mild, & Moderate > Severe
Note: CAVLT: Cognitive-Affective Verbal Learning Test, EWFT: Emotion Word
Fluency Test, (+) Words: Positive Emotion Words, (-) Words: Negative Emotion Words
Mean Comparisons for Subjective Sleep Report Clinical Groups
Both subjective sleep self-report measures (ESS and PSQI) significantly and strongly
correlated with depressive symptom report (CESD), and demonstrated more sporadic and
weaker correlations with cognitive and cognitive-affective performance, suggesting there
may be important subjective sleep quality group differences. Clinical cut-offs supported
within the literature were used to create “good” versus “bad” reported sleep quality
(PSQI > 5 and 7; Buysse et al., 2008) and sleepiness (ESS > 7 and 9; Rosenthal & Dolan,
2008) groups. These four variables (i.e., two sets of bivariate cut-offs for each of the two
subjective sleep self-report measures) were used as independent variables in a four-way
MANCOVA, with the same cognitive, cognitive-affective processing, and mood
variables used previously as dependent variables, with age as a covariate. The analysis
was non-significant, Wilk's lambda = 0.20, F(54, 87.25) = 1.16, p = 0.26. However, Roy's
Largest Root, a liberal estimate of lower bound significance, was significant, p = 0.03.
Given the liberal significance indicator, exploratory ANCOVA's were used to explore
whether there were any underlying contrast findings that might partially direct study
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interpretations. Only the use of the ESS cut off of over 7 showed significant differences
for performance measures, though they were all in one measure, the CAVLT. Those
judged to be excessively sleepy at the described cutoff recalled fewer words over the
course of the Learning Trials, F(1, 57) = 4.42, p = 0.04, ES = 0.07, after Short Delay,
F(1, 56) = 4.43, p = 0.04, ES = 0.07, and after Long Delay, F(1, 56) = 8.13, p = 0.004, ES
= 0.14. With regard to the CESD, more depressive symptoms were reported in the
excessively sleepy group using both a cut off score of over 7, F(1, 56) = 10.68, p = 0.002,
ES = 0.16, and over 9, F(1, 56) = 86.64, p = 0.013, ES = 0.11.
Regression Pathway Analysis
The planned Preacher and Hayes (2008) regression pathway analysis was designed to
investigate whether a proportion of the variance between polysomnogram factors and
mood could be explained through the degree of valence bias in cognitive-affective
processing performance content (see Figure 3). Note, Figure 3's unidirectional arrows are
meant to represent the a priori model based upon van der Helm and Walker (2009). While
these regression analyses on cross-sectional data cannot address the causal elements, the
results will be reported as being at least consistent or inconsistent with said model. The
authors suggest placing all potential pathway variables into the analysis, and if significant
or near-significant findings result, post-hoc removal of non-significant pathway variables
can be conducted in an exploratory fashion. To test this a priori hypothesis, the AHI was
entered as the predictor variable for CESD score, with inclusion of the four CAVLT
Valence Factors (affective-valence bias indicators) as potential mediation pathway
variables, controlling for age. The resulting model was non-significant, with the
underlying problem being no significant relationship between AHI and CESD (p > 0.10).
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Based upon the regression findings, REM, AHI, and Sleep Efficiency % were considered
as alternate predictor variables, with consideration of both PANAS affect subscales (PPA
and PNA) as a dependent variable of mood. Each combination of these alternative
predictor and dependent variables resulted in the same non-significant model obstacle,
i.e., the relationship between the polysomnogram indicator and the mood variable (p's >
0.10). Alternative exploratory analyses were generated to explore alternative relationship
patterns, and are discussed below.

PSG Indicators
AHI
R-AHI
SE%

Mood Self-Report
CESD
PNA
PPA

CAVLT Valence Factors
Learning VF
Short Delay VF
Long Delay VF
Recongition VF

Figure 3. Proposed Mediation of Relationship between Sleep Study Indicators and Mood
Measures via Cognitive-Affective Processing Valence Bias
Note: Controlling for Age. Original measures proposed for the model are bolded
Exploratory
The proposed model was not supported by the data analyses conducted. However, despite
the documented weakness in relation between AHI severity and depressive symptoms
(CESD), the sleep study and mood constructs did demonstrate other correlations.
Furthermore, the CAVLT Valence Factors demonstrated significant correlations with the
sleep study and mood constructs, as well as significant differences within the ANOVA
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analyses. Taken together, this suggested that further exploratory analyses were warranted,
in order to explore alternative relationships between sleep study indicators (PSG), mood
(CESD, PNA, PPA), and cognitive-affective processing bias in emotional-valence
processing (i.e., Valence Factors)
Alternative Pathway Analysis – Subjective Sleep
As self-reported depression significantly and strongly correlated with self-reported
subjective sleep measures, the potential for a model adjustment to substitute subjective
for objective sleep disturbance was explored. While the relationship between the selected
predictor (ESS or PSQI) and the dependent variable (CESD or PPA) was significant, p's
< 0.01, as seen in the previous correlation analyses, the predictor → mediators and
mediators → dependent variable pathway coefficients were non-significant, p's > 0.10.
Thus, while this pathway analysis redemonstrated a significant relationship between the
self-reported sleep measures and the self-reported mood measures, there were not
findings suggestive of a mediation pathway through any Valence Factors (i.e.,
negative/positive bias in processing of emotional information) in the CAVLT subscores.
Regression: Predicting CAP-emotion/VF with Mood and Polysomnogram
Null findings for the a priori mediation pathway model, using AHI, CESD, and CAVLT
VFs, were unexpected for reasons based in theoretical expectations but also due to the
significant correlation and mean-comparison results (specifically, with regard to the
CAVLT VF variables) of the present study. The latter suggest that the affective bias in
recall performances are significantly associated with both physiological sleep
disturbance, as well as self-reported mood. The unexpected null findings relating
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polysomnogram and mood variables will be commented on in the discussion. For the
purpose of exploring alternative conceptualizations of these relationships, stepwise
hierarchical regression was used as it allowed for interpretation of the best set of
predictors, an important factor given that our theoretical a priori hypothesis was nonsignificant.
The regression structure consisted of two blocks: 1) forced entry for Age, and 2)
stepwise entry for CESD (reported depressed mood), PPA (positive affect), AHI, R-AHI,
and lowO2%. This analysis was run for each CAVLT affective bias indicator (VFs).
Significant models were found for short delay VF, F(3, 53) = 3.82, p = 0.02, adj R2 =
0.19, and long delay VF, F(3,53) = 3.58, p = 0.02, adj R2 = 0.18. See Tables 13 and 14
for regression details. Amount of AHI during REM was significantly predictive of more
negative bias in short and long delay recall. Self-reported depressive symptom score was
uniquely predictive of more negative bias in short delay recall, but not for long delay. In
contrast, hypoxia during sleep accounted for prediction of more negative bias in long
delay recall but was not significant for the short delay model. No significant models were
found for CAVLT total learning trial or Recognition trial affective bias indicators (VF's).

Table 13
Regression Statistics: Significant Sleep Study Indicators and Self-reported Mood Scores
that Predict CAVLT Short Delay Recall Valence Factor
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Model # Component
1
2

3

B

SE

Constant

-13.04

24.79

Age

0.19

0.46

Constant

-5.97

23.86

Age

0.34

0.44

R-AHI

-0.58

0.24

Constant

18.97

25.62

Age

0.23

0.43

R-AHI

-0.66

CESD

-1.29

Standardized B

t

p-value

-0.53

0.60

0.41

0.68

-0.25

0.80

0.10

0.77

0.45

-0.33

-2.43

0.02

0.74

0.46

0.07

0.54

0.59

0.23

-0.37

-2.83

0.01

0.58

-0.29

-2.21

0.03

0.06

p <0.05
Note: R-AHI: REM Apnea-Hypnea Index, CESD: Center for Epidemiological Study
Depression Scale
Table 14
Regression Statistics: Significant Sleep Study Indicators and Self-reported Mood Scores
that Predict CAVLT Long Delay Recall Valence Factor
Model #
1
2

3

Component

B

SE

Constant

-22.43

25.67

Age

0.32

0.47

Constant

-26.13

24.76

Age

0.52

0.46

Low O2%

-0.97

0.43

Constant

-19.61

24.09

Age

0.64

0.45

Low O2%

-0.93

R-AHI

-0.52

Standardized B

t

p-value

-0.87

0.39

0.67

0.51

-1.06

0.30

0.15

1.12

0.27

-0.31

-2.27

0.03

-0.81

0.42

0.19

1.43

0.16

0.41

-0.29

-2.24

0.03

0.24

-0.28

-2.17

0.04

0.09

p <0.05
Note: R-AHI: REM Apnea-Hypnea Index, Low O2%: proportion of time spent in
hypoxic state

Alternate ANCOVA Investigations
94

Another statistical approach to investigate potential interaction effects of disturbed
polysomnogram and depressed mood was conducted through two different sets of
analyses. The first was to add CES-D as a covariate to the four previously conducted
ANCOVAs (using AHI severity group as the independent variable and CAVLT VFs as
dependent variables). Self-reported depression scores on the CESD were not a significant
covariate for any of those analyses (p's > 0.10). Another approach was conducted via the
creation of a bivariate CESD variable (non-depressed versus probable depression) to
incorporate into the 4x2 ANCOVA (AHI severity x CESD status). No main or interaction
effects were found for depression status (p's > 0.10).

Alternate Clinical-vs.-Nonclinical Subgroup Comparisons:
An exploratory effort using MANCOVA was conducted in order to investigate whether
CAVLT VFs differed significantly amongst other potential clinical subgroups. A
MANCOVA (controlling for age) was conducted using clinical cut-off splits for the
following independent variables: REM-AHI, SE%, lowO2, PSQI, ESS. All four CAVLT
VFs were entered as dependent variables. No significant main or interaction effects were
found, p's > 0.10, and the decision was made not to investigate post-hoc contrasts due to
concerns about avoiding a “fishing-expedition” approach.
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CHAPTER 5
DISCUSSION, CONCLUSIONS, AND RECOMMENDATIONS
The present study was designed to further investigate the interrelationships between sleep
processes, neurocognition, and mood. Extant research outlines the breadth and severity of
impact that disturbed sleep causes to the effectiveness of processing information and the
experience of depressive symptoms. More recent research has examined the relationship
between disturbed sleep and negative affective biases. This dysfunctional process has
theoretical support as a mechanism underlying the cause and/or maintenance of
psychiatric conditions that involve negative mood (e.g., depressive and anxiety
disorders). We constructed a battery designed to measure these constructs and evaluated
61 patients referred for polysomnogram for diagnostic differential of obstructive sleep
apnea, a condition associated with both sleep physiology disruption and chronic
nighttime hypoxia. Notable inclusions in the battery were two novel cognitive-affective
processing measures, which were counterparts of standard neurocognitive measures of
memory and verbal fluency.
The results will be summarized briefly as they apply to specific hypotheses
(matching the organization of numbered and lettered hypotheses found in Chapter 2),
organized under the previously outlined four overarching study objectives. Discussion
will then focus on: 1) the theoretical implications and clinical utility of the findings; 2)
how the results of this study reflect on the state of current research within the cognitiveaffective processing field, specifically related to the improvements that the present
measures offer upon previous paradigms, and 3) limitations and directions for additional
research will be outlined.
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The study offered mixed support for replicating the interrelationships documented
in the research between sleep physiological indicators, subjective sleep measures,
cognitive performance, and mood: (1a) correlations were significant between objective
indicators of sleep quality (i.e., polysomnogram), self-reported sleep quality, mood, and
standard measures of neuropsychological performance; (1b & 1c) using objective sleep
pathology clinical cutoffs, significant differences between severity groups were not
detected on two standard cognitive measures (i.e., CVLT-2 and FAS/Animals fluency),
and three measures of mood (i.e., CESD, PPA, PNA) were not detected.
Results documented and provided support for the validity of the two novel
measures of cognitive-affective processing; (2a) convergent and divergent validity were
demonstrated, as well as support for aspects of the measures being sensitive to sleepbreathing disorder pathology in our sample.
The interrelationship between sleep, mood, and the novel cognitive-affective
measures were supported; (3a) the cognitive-affective processing measures were
significantly related to objective indicators of sleep quality (i.e., polysomnogram), selfreported sleep quality and mood; (3b) the more severe OSA severity groups performed
significantly worse than less severe OSA groups on the CAVLT, though not the EWFT;
(3c) the more severe OSA severity groups demonstrated a negative bias in learning and
recall on the CAVLT, independent of overall production.
Finally, the study provided mixed support for the proposed model; (4 a) a lack of
relationship between objective measures of sleep disturbance and mood meant that
negative bias in the CAVLT could not be explored as a mediating pathway between the
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two. However, further exploratory analyses suggest a more complex relationship between
the constructs exists.

The Relationship of Sleep with Cognition and Mood
The first broad hypothesis was the replicative expectation of a significant
interrelationship between the constructs of interest. Overall, this hypothesis was
supported, with significant correlations existing amongst sleep study indicators, selfreported subjective sleep measures, self-reported mood measures, standard cognitive
performance, and cognitive-affective processing performance. As expected, objective
indicators of sleep disturbance were significantly correlated with both fluency and
memory performance decrements. Of note, amount of sleep time spent in hypoxia
appeared to be a stronger and broader indicator of cognitive performance than number of
disturbed-breathing related arousals. This finding is important given the fact that all a
priori hypotheses relied on AHI as the independent variable subgroup construct.
Depressive symptom report also correlated with cognitive performance measures, though
to a less broad and strong degree. The relationship between objective sleep indicators and
negative mood existed, but was narrower and weaker than expected. While subjective
sleep report demonstrated significant relationship with negative mood indicators, it did
not relate to cognitive performance. Previous research findings suggest that cognitive
processing deficits found within different sleep deprivation samples (clinical and
experimental) are not due to lack of motivation or effort (Harrison & Horne, 2000;
Wilkinson, 1961). Furthermore, two embedded performance validity indicators within
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this study's battery identified no sub-optimal performances. Thus, despite the lack of
performance validity measures in the study's battery, the cognitive findings are thought to
represent true neurocognitive variation, rather than amotivation or lack of engagement.
Examination of these relationships through creation of clinically meaningful OSA
groups (based on AHI severity) showed group differences that were much less consistent
with replicative expectations. Lack of subjective sleep report differences across AHI
severity groups suggested the constructs to be significantly independent of each other.
Unexpectedly, no cognitive performance differences were found across OSA severity
groups, for memory or semantic/phonemic word-fluency. The only OSA severity group
differences related to mood were limited to trend significance, with the severe group
endorsing more depressive symptoms and less positive affect than the other groups.
When clinical and non-clinical groups were created via subjective sleep report measures,
no significant standard cognitive performance differences were noted, though use of the
ESS at two supported clinical cut-offs identified significantly more depressive symptom
report.
With regard to the null findings for cognitive differences across OSA severity
groups, there are a number of potential explanations, one being that the decrements in
neurocognitive functioning are predominantly in those with severe OSA (e.g., as seen in
Engleman, Kingshott, Martin, & Douglas, 2000). This study’s sample had fairly even
distribution between severity groups, which would be suitable for evaluating a severitydependent pattern of deficit expression. However, if neuropsychological sequelae tend to
emerge primarily only within severe OSA populations, our study’s sample was too
skewed (i.e., 75%) toward “non-clinical” distribution. Thus, the relationship between
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neuropsychopathology and sleep pathology in OSA may not be linear, but resemble a
rapid accumulation of impairments after a severe-AHI range is present. Compounding
this issue, the a priori sample size was determined through amalgamation of dichotomous
effect size estimates (i.e., OSA versus HC) from recent meta-analyses, which may have
been subject to publication bias – i.e., including studies that found significant differences
due to a maximization approach of using a more severe clinical group and comparing
them to healthy controls.
Another possible explanation arises from the findings of Beebe and colleagues
(2003), who identified resiliency in verbal functions and vulnerability in workingattention like tasks within OSA studies. It is possible that the memory and fluency tasks
selected for this study were not as well suited to pick up neurocognitive sequelae as
initially hypothesized. Resiliency in verbal functions potentially minimized
initiation/divergence variability within the fluency tasks and recall variability within the
verbal-memory task. In the context of the significant polysomnogram indicator
relationships with cognitive performance (not the case with the subjective sleep
variables), the findings support the argument that subjective measures of sleep quality
measure a construct that correlates less with neurophysiological sequelae than objective
measures of sleep quality (e.g., Buysee et al., 2008's null relationship findings between
subjective and objective sleep indicators).
The even distribution of our sample into the four diangnostic OSA severity
categories (versus a dichotomous No versus Severe group split) may also explain the null
findings across OSA severity group for depressive symptoms; again, due to the potential
non-linear relationship. This explanation is reinforced given the trend significance
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identified for the Severe group being identified as the potential sole source of variability.
As previously cited, while depressive symptoms are associated with AHI, the magnitude
of the effect size is quite small for lower AHI levels (i.e., ~0.3) and only with the more
severe groups do reliably large effect sizes emerge (i.e., d = ~2-3.0; Engleman,
Kingshott, Martin, & Douglas, 2000). The lack of findings is not completely
unprecedented (e.g., Andrews & Oei, 2004), and lends some additional weight to the
hypothesis that the relationship between chronic sleep fragmentation and depression is
mediated through secondary conditions acquired through long-term untreated sleepdisordered breathing conditions (e.g., white matter hyperintensities; Aloia, Arnedt, Davis,
Riggs, & Byrd, 2004). The findings that the subjective sleep measure related to daytime
sleepiness (i.e., the ESS) identified clinical groups reporting significantly more
depression is consistent with the hypothesis of previous research that excessive daytime
sleepiness contributes to quality of life decrements, thus increasing the odds of depressed
mood (Sforza, de Saint Hilaire, Pelissolo, Rochat, & Ibanez, 2002). However, it should
be noted that unlike research proposing those causal chain, this study is not longitudinal,
and thus cannot provide for causal inferences.
On a final explanative note, beyond the potential for a non-clinical skewing
within the OSA severity, the sample's mood, cognitive, and health-comorbidity rates
were all skewed toward non-clinical severity. This “high functioning” group may be
linked to the non-severe OSA skewing, or be related to a sampling bias toward stronger
cognitive reserve (e.g., skewness toward high economic status and average education).
Cognitive-Affective Processing Findings
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Given the meticulous effort to match the cognitive-affective processing (CAP)
measures on both instruction paradigms and stimuli content, the strong basis for expected
acceptable cognitive-affective processing psychometrics was well-founded. The
affective-memory measure (CAVLT) had strong internal correlations between subscores,
and moderate-to-strong correlations with the standard memory measure (CVLT). The
affective-word fluency measure (EWFT), which could be considered a variant of a
semantic-category fluency task, correlated more strongly with the animal-category task
than the phonemic fluency task. Correlations between the CAVLT and fluency measures
were less broad and in the weak-range, demonstrating acceptable divergent validity.
These findings suggest that the cognitive-affective processing measures are tapping
constructs closely related to, but significantly different from, those processes validated in
the CVLT and FAS/Animal fluency tasks.
In contrast with the relatively limited previously discussed findings, cognitiveaffective processing performance demonstrated notable statistically significant
correlations (see Figure 4) and group differences suggesting the overlapping construct
was more sensitive to IV’s. There was a wide variety of success amongst the novel and
exploratory hypotheses. With regard to sleep, analyses found that objective sleep
disturbance indicators significantly correlated with affective-memory, both in terms of
number of words recalled and the number of negative words. However, affective-word
fluency was more narrowly related, only correlating with sleep efficiency. Subjective
sleep disturbance was significantly less related to cognitive-affective processing
measures, being negatively related to only one of the four affective-memory valence
factors (Long Delay Recall VF). Despite that finding, when a measure of excessive
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sleepiness (ESS) was used to create clinical and non-clinical groups, the subjectively
sleepy group underperformed on total word production across the total learning trials,
short delay recall, and long delay recall.

Figure 4. Graphical Representation of Significant Correlation Findings between Five
Construct Domains. Note: for purposes of clarity, correlations are not show between
variables within domains, as well as correlations between Standard Cognitive and
Cognitive-Affective Processing domains.
When AHI severity groups were compared, the non-OSA group outperformed all
clinical groups on the affective-memory task's learning trials; however, after a short
delay, there were no differences for total word output. Instead, the valence of the recalled
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words differed, with a general pattern of less negative valence within the non-OSA group
(and to a lesser degree, the mild OSA group). After long-delay, the non-OSA group
recalled more words than the clinical groups, and after controlling for that output
difference, had less negative delayed recall. Interestingly, there were no group differences
for recognition memory in terms of number of words and word valence. Importantly,
there were no concreteness-bias differences found for submeasures of affective-memory
that demonstrated a negative valence bias. This suggests that the valence finding is not
only independent of amount of information recalled, but also independent of any bias
related to processing differences due to concreteness versus abstractness of the stimuli, an
important factor considering emotional words are semantically abstract.
One pattern of note is the negative correlation between REM-related
polysomnogram pathology (i.e., high REM AHI and low REM%) and valence factors
(i.e., more negatively biased processing). Alternatively, AHI (i.e., sleep fragmentation in
part caused by apnea/hypnea events) and hypoxic blood saturation related more to the
actual amount of words produced on recall trials. This pattern suggests the possibility of
parallel impacts to memory processes, mediated by different physiological processes
disturbed by OSA pathology. Specifically, disrupted sleep architecture (e.g., suppressed
REM) may be more related to affective biases in memory, whereas breathing-related
pathology (e.g., hypoxia) may be more related to learning and recall ability in general.
The OSA clinical group differences are consistent with this impression, though not
exclusive to it (i.e., the study did not conduct more refined REM or hypoxia based meancomparisons to explore this possible interpretation).
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Taken overall, the more limited learning and recognition findings, in the context
of significant recall production and affective valence bias in the short/long delay free
recall trials, suggest a subcortical-frontal retrieval dysfunction mediating CAVLT
performance. That this retrieval dysfunction could also be affectively-biased, is of
particular note. The absence of CVLT findings further confirms that the cognitiveaffective processing measure is tapping a different construct (or subdomain) than learning
and memory for neutral verbal information. The ESS differences for CAVLT production,
given the lack of any standard cognitive measure findings but significant relationship to
negative mood, lends credence to this cognitive-affective processing measure evaluating
neurocognitive processes impacted by both physiological and psychological pathology,
though specific relationships are beyond comment at this point.
With regard to mood, depressive symptoms demonstrated a small correlation with
reduced overall word recall after long delay, but were primarily associated with affectivememory in terms of negative words produced and negative bias during recall and
recognition tasks. Negative mood indicators were not associated with affective-word
fluency. Given the significant correlational findings for the standard long delay recall and
verbal fluency measures, this suggests non-overlapping variability being tapped by the
CAVLT and CVLT with regard to potential impacts of depression on performance.
After the promising findings regarding the cognitive-affective processing
measures relating to both sleep and mood measures, it was surprising to not confirm the
proposed mediation model as posited. Unexpectedly, AHI was not found to significantly
predict degree of depression, thus no pathway could be established via CAVLT valence
bias. Upon expansion of the model to include promising polysomnogram indicators
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predicting mood measures, one relationship was found (i.e., sleep efficiency predicting
lower negative affect), but in this case the CAVLT valence factors did not have
significant path effects between either predictor or dependent variable. Using either
subjective sleep report as a predictor of any of the three mood indicators resulted in a
similar problem, i.e., the presence of a significant relationship between IV and DV but no
pathway via any of the CAVLT valence factors. While regression analyses themselves
cannot confirm a causal model, the failure of the mediation model suggests there is a lack
of conceptual fit with our a priori framework.
We hypothesized that sleep disturbance and mood may both be related to
cognitive-affective processes, but perhaps produce independent impact on cognitiveaffective processing within our sample. Regressions were successful in demonstrating
that REM AHI and hypoxia, along with depressive symptoms, were uniquely predictive
of negative affective bias at delayed recall. Additional exploratory hypotheses were not
supported, including analysis of whether depression as a covariate impacted OSA group
differences in cognitive-affective processing scores, as well as including a dichotomous
depression variable to investigate potential main/interaction effects on CAP scores. This
further suggested that the increased negative bias in affective processing associated with
disturbed sleep physiology was independent of negative mood (i.e., the possibility that
any relationship between polysomnogram and negatively-biased CAP was due to cooccurring depression leading to a bias toward negative information). A final multivariate
analysis did not find enough promising results to warrant further group comparisons
amongst other bivariate polysomnogram and reported-sleep quality variables with regard
to cognitive-affective processing scores, though this does not rule out their potential
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impact, given power limitations for multivariate analyses of that size. Due to the lack of
relationship between objective sleep and depression, an attractive alternative order of
variables could not be explored (i.e., depressed mood mediating the relationship between
sleep pathology and negative bias on the CAVLT). However, the reader is reminded that
multiple alternative longitudinal research studies have identified disturbed sleep
occurring prior to depression , suggesting a causal relationship (e.g,. Paunio et al, 2009;
Peppard, Szklo-Coxe, Hla, & Young, 2006). The same limiations due to potential nonlinear relationships and the non-pathologicaly skewed sample outlined above also apply
to potential contributors to the null-findings within the proposed model.

Relating Findings to Theory and Clinical Use
The model described by van der Helm and Walker (2009) that suggests disturbed
sleep causes cognitive-affective processing dysfunction, which leads to the onset and
maintenance of mood disorders, received mixed support from the findings of this study.
Due to the cross-sectional nature of this study's methodology, true causal features of the
van der Helm and Walker (2009) model cannot be commented on. However, the extent
and pattern of relationships demonstrated in this study is not mutually exclusive with the
overall conceptualization of a causal sleep, cognitive-affecitve processing bias, and
depression model. Valence-biased information processing within the CAVLT related to
sleep physiological indicators and mood measures, as we expected. However, the
unexpected failure to find a significant relationship between sleep physiology and
depression broke down the prospective pathway model for our sample. In an effort to
explore a potential alternative model, subjective sleep quality was substituted in place of
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objective sleep physiological indicators. However, while this model demonstrated the
appropriate predictor to DV relationship, the CAP valence bias pathways broke down.
The mean comparisons between OSA severity groups suggests that detectable
neuropsychopathology may be limited to the severe OSA group, which suggests that
clinical consideration of the model should not be thrown out at this point – rather, a more
complex model may be better suited.
Thus, an alternative approach was explored in order to determine whether the
constructs could be related to each other in a different manner. Hierarchical regression
demonstrated that REM AHI, hypoxia, and depressive symptoms were unique predictors
of the valence bias on delayed recall tasks of the CAVLT. Null findings resulted from
adding the depression symptoms inventory (CESD) to the previous ANCOVA analyses
for CAVLT valence bias in the form of an additional covariate, as well as a dichotomous
IV. This further supported the lack of interaction between AHI and depressed mood in
our sample. However, the initial investigation of correlations amongst the constructs did
find a small correlation between negative affect and non-AHI indicators (i.e., REM-AHI
and sleep efficiency). So, while we failed to confirm a proposed model with our sample
(see Figure 3), these findings allow some crude alternative modeling specific to this
sample (Figure 5). Interpreting these results cautiously, we first must consider the
possibility that the lack of relationship between AHI and depressed mood is an aberration
within the sample, for reasons outlined previously (i.e., severity distribution). An
alternative, though not mutually exclusive, consideration is that the model is actually
nested within a more complex framework of related constructs. Figure 5 is an example
that fits the data collected within our sample. Of note, there is an indirect relationship
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between AHI and Depressed Mood via related constructs, though the direct relationship
hypothesized was not found. In this sense, while the study could not offer strong support
for the proposed model, it instead might be seen as providing methodologically useful
information (i.e., alternative variables to focus on within the mood and sleep physiology
constructs) in future investigations of CAP functioning/mediation in the same or different
patient populations (expanded upon below). Furthermore, as the data collected for this
study was cross-sectional, Figure 5 does not imply unidirectional/causal relationships;
use of longitudinal methodologies in future research would add clarity in that aspect.

Other
PSG

AHI

Negative
CAP bias

R-AHI
↑Negative
Affect;
↓Positive
Affect

Depressed
Mood

Figure 5. Rough Diagram of Alternative to Proposed Model
Note: original model constructs included are bold
From a clinical practice perspective, the findings provide variable confirmation of
the neuropsychological impacts of OSA. However, the findings are significantly limited
in the applicability to individual patients, both due to effect size and variable intraconstruct patterns. While there was correlational evidence connecting disordered sleep
and cognitive decrements, OSA severity groups were not detectably different at a group
level. This finding suggests that while overall functioning and quality of life issues may
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be clinically relevant to the neuropsychological case conceptualization of a patient with
untreated OSA, only a small amount of variance within a patient's neurocognitive
performance on memory or verbal fluency tasks might be attributable to severity of OSA
(though as mentioned previously, within severe OSA groups, these differences may be
larger and more reliable). Of note, a number of cognitive-affective processing
performance submeasures were significantly different across OSA severity categories
(e.g., CAVLT Learning and Long Delay Recall trials). This was in addition to CAP
valence bias existing independent of production (i.e., the Valence Factors for the CAVLT
submeasures). Thus, the neuropsychological test paradigm was supported as a means of
detecting neurocognitive (affective) disturbance secondary to sleep physiology
pathology.
However, from a single-patient perspective, the CAVLT production and valence
score differences had effect sizes that were still far below a level that might be useful for
detecting a recognizable and reliable OSA profile pattern (see Zakzanis, 2001). While
explaining depressive presentation due to untreated OSA was not supported by our
findings, polysomnogram indicators were significantly related to related the PANAS
affect constructs, supporting continued clinical attention to the interaction of sleep quality
and emotional experience. In that context, it may be that the CESD was not capturing the
potential affective or mood changes related to any negative bias in the processing of
emotional information in the world (or on the cognitive-affective processing measures in
the lab/clinic). For instance, a construct such as pessimism could feasibly be a result of
negative bias in processing, which is a psychological construct intricately related to
clinical depression (Abramson, Metalsky, & Alloy, 1989). Alternatively, the study’s
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premise that an OSA population would be ideal to test the CAP-mediated model may be
flawed. Picking a mood or neurological population to run through polysomnograph and
neuropsychological evaluation would have been more ideal, though would have
significantly higher costs associated with dozens of non-clinically indicated sleep studies.
The pattern of cognitive and cognitive-affective processing performance across
severity groups is notable for an apparent cliff or threshold for the OSA severity. Rather
than a dose-effect pattern (i.e., progressive deficits across mild, moderate, and severe
groups), our data suggests that a tipping-point is reached with regard to neurocognitive
functioning for the severe OSA group. Two possible explanations for the abrupt
detectability of neurocognitive changes are 1) the pattern reflects a required “minimum”
level of sleep-disordered breathing pathology being met, after which neurocognitive
functions begin to change and/or, 2) the pattern reflects a breaking point for the brain,
which has been compensating for the progressive pathological load by recruiting
additional neurocognitive (and perhaps neurophysiological) resources. Neuroimaging
research into the apparent normal cognitive performance within mild traumatic brain
injury and aging populations provides support for the latter explanation (e.g., Park &
Reuter-Lorenz, 2009; Maruishi, Miyatani, Nakao & Muranaka, 2007).
Finally, the findings provide intiail support for a measure (the CAVLT) that has
promising clinical utility from a neuropsychological perspective. For instance, with
regard to mood disorders and posttraumatic stress disorder, the ability to quantify one
potential underlying etiology or exacerbating facotr (negative CAP), might help with
differential diagnosis and assessment of prodromal information processing changes.
Treatment-response prediction would also be served, if additional research does indeed
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identify subgroups of sleep disordered patients who are suffering negative CAP and thus
potentially at risk for depression. These individuals might be referred to sleep
interventions prior to antidepressant therapies. Finally, within neuriological and
rehabilitation settings, evaluation of communication style deficits would be vauable
within the sub-acute rehabilitation setting and for family/vocational recommendations
during disposition planning.

Relating Findings to Research Utility
If research on the intersect between cognition and affect (i.e., cognitive-affective
processing, or, the processing of emotionally-valenced information) is to be integrated
more successfully into the clinical domain, the measures produced should be crafted with
consideration of research methodology. Specifically, the research must build upon past
approaches, fill in missing elements in present literature, and advance novel
methodologies. This dissertation provided advancements in each of these areas, though
the limitations subsequently discussed leave room for a number of future research
directions. One important research consideration was made clear from the variety of
polysomnogram indicators involved in identifying significant cognitive/depressive
differences. Neuropsychological research with OSA samples should avoid dependency on
only one indicator of sleep disturbance severity, due to the multiple parallel pathological
and disruptive influences sleep-disordered breathing creates (e.g., hypoxia, sleep
architecture disturbance, reduced total sleep time).
Memory measures for words with affective-valence or emotional qualities exist in
the research, but are typically created solely for use within the research group's study or
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studies (i.e., as a means of operationalizing affective bias in information processing), and
not intended for clinical use. In effect, this kind of research demonstrates the impact of
various independent variables or manipulations on memory processes for affectivelyvalenced stimuli, but does not go the extra step of suggesting an optimal methodology to
use in measuring affective-memory construct going forward. Only two existing studies
assembled affective word memory tests with the goal of wider use in research and clinic
(i.e., Affective Auditory Verbal List test, AAVL; Snyder & Harrison, 1997; Emotion
Verbal Learning Test, EVLT; Strauss & Allen, 2013). Both measures offer excellent
advancement in affective-memory research, but we argue the CAVLT construction is
better suited for a number of reasons.
The AAVL was designed with a list-learning paradigm paralleling Rey's Auditory
Verbal Learning Test (RAVLT; Rey, 1964). Specifically, the protocol is nearly the same
as the CVLT-2 or CAVLT, but uses 15 words that do not relate semantically into
categories. Two lists were developed, using high familiarity words of high or low
pleasantness ratings. The researchers estimated the RAVL words to represent an equally
familiar, but neutral set of words. The EVLT design mirrors that of the CVLT-2 more
closely, utilizing emotional categories. The CAVLT offers advantages compared to both
of these alternative measures from a methodological standpoint, thereby allowing for
future research to better explore the mechanisms of affective-memory. For instance, the
AAVL forms are categorically positive or negative, requiring both to be administered to
evaluate cognitive-affective processing functioning across the full valence spectrum. The
CAVLT incorporates the full valence spectrum into the word-list, allowing for internal
comparisons. Additionally, the AAVL is methodologically analogous to a list-learning

113

paradigm that does not allow for as many memory subprocesses to be evaluated and
compared. Specifically, the categorical approach that the CAVLT use, taken from the
CVLT-2, allows for evaluation of cued recall and category-comparisons. While the
EVLT also uses this category approach, it sacrifices co-evaluation of neutral stimuli in
exchange for more specific emotion categories (i.e., happy/sad/anger/anxiety vs.
positive/negative in the CAVLT). The CAVLT neutral word categories allow for
comparison of emotion versus non-emotion word recall. The splitting of the non-emotion
word categories into abstract and concrete categories allows for control of any linguistic
processing factors that may be underlying difference in the emotion word memory (i.e,.
concreteness of the words). Finally, while the EVLT construction did ensure that word
length, frequency, and emotional intensity were equivalent amongst the categories, it
does not ensure equivalence between CVLT-2 words and the chosen emotion words. The
CAVLT's word selection allows interpretation of performance differences to be more
attributed to the cognitive-affective processing differences, rather than methodological
differences, a strength in future cognitive-affective processing research conducted with
populations where CVLT-2 data has been widely collected.
The EWFT has narrow use in the literature thus far (e.g., Abeare et al., 2009;
Freund & Abeare, unpublished dissertation; Abeare et al., unpublished manuscript). The
counterpart measures (FAS, Animals) are widely used in research, for both their ease of
administration and sensitivity to neurocognitive dysfunction (for review, see Tombaugh,
Kozak, & Rees, 1999). As there are no direct alternatives to the EWFT in the research,
the argument we make for future use of the EWFT in research is based upon proposed
incremental validity beyond standard verbal fluency measures. The only significant
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results related to any of these measures in the present study were correlative, higher sleep
efficiency was positively related to emotional word production and hypoxia was related
to lower animal word fluency. No significant findings resulted from the phonemic
fluency measure. The relative lack of findings limits the production of new arguments for
inclusion of the EWFT in future research, above and beyond inclusion of cognitiveaffective processing measures within batteries in general, and argument outlined in the
introduction of this manuscript. However, we can support the notion that the EWFT may
be tapping overlapping neurocognitive systems that any semantic/category fluency
measure captures. Whether the inclusion of an affective process within the paradigm is
differentially impacted (compared to neutral category fluency) is not yet clear.
One promising finding was the valence factor differences found within the
CAVLT when deeper analysis of production was analyzed. In order to conduct a similar
level of analysis, Abeare and colleagues are currently producing a scoring system that
would allow for analysis of various affective-linguistic characteristics of the words
produced during an EWFT trial. Based on that finding, as well as research indicating that
poor sleep leads to less inhibition of negative information (e.g., Anderson & Platten,
2011), we expect to find an overall negative bias in the affective-valence of the words
produced by those with more severe OSA, despite no quantitative production differences.
Applications of that scoring system to the content of this study's data (and future
research) should allow for capturing more subtle differences in affective-word fluency
that might be significantly related to constructs of clinical and research interest.
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Limitations and Future Direction of Research
A number of factors should be discussed in the context of limiting the
interpretations and conclusions of the present study to appropriate bounds. The sample's
demographics were determined through the clinical referral process, and therefore
mirrored the OSA patient population's heterogenous nature with regard to age. While age
was controlled for during analyses, in the context of a sample size that just met powerestimates requirements, the age-distribution could reflect other age-related factors that
might influence neuropsychological factors that were not controlled for (e.g., chronic
medical conditions, pain, vulnerability to circadian changes). Additionally, the
homogenous ethnicity of our sample (i.e., 58 of 61 participants were white) does not
reflect the epidemiological incidence rate of OSA. In fact, Blacks and Hispanics in North
America have a higher risk for OSA than whites, though this is thought to reflect
socioeconomic status and access to healthcare, the latter being related to higher incidents
of obesity and other comorbid medical conditions related to OSA risk (Punjabi, 2008;
Ralls & Grigg-Damberger, 2012). The ethnic makeup of our sample suggests a sampling
bias within the referrals to the sleep clinic, or, more likely, within those agreeing to
participate in the study.
Related to the sample's demographics, was the fact that normative transformations
could not be made with the novel measures at this point in their development. Under ideal
circumstances, both raw and normative score comparisons would be explored due to the
novel nature of many of the hypotheses, thus reducing type II error. As noted above,
while valence analysis was possible for the CAVLT, the necessary scoring system was
not yet available for the EWFT (though is nearing completed development in this author's
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associated lab). This limited the interpretations related to affective-word fluency within
the sample to a shallower level (i.e., raw production). Finally, the limited and weak
correlations between physiological sleep disturbance and depressive symptomatology in
this sample was a barrier to fully exploring the model hypothesized (per van der Helm &
Walker, 2009). While the use of sleep disorder patients was advantageous for certain
constructs (e.g., naturalistic sleep disturbance, easy access to polysomnogram data), the
narrow and suppressed depression severity likely limited our ability to fully investigate
variance mediated by CAP valence bias. Finally, while analyses were based on a priori
directional hypotheses, and we did use multivariate variance analysis prior to
comparisons, the exploratory analyses must be interpreted cautiously . Our findings must
therefore be taken as suggestive of potential patterns and rather than absolutes. In
contrast, our negative findings for a few of the replicative hypotheses (e.g.,
polysomnogram and depression) are more notable and the impressions related to them
deserve stronger consideration, given the liberal significance approach selected.
The results of this study, as well as continued work within the associated lab,
allow for a number of concrete proposals for future research to be presented, falling into
two broad categories. First, regarding cognitive-affective processing measures and
psychometrics, normative data is currently being collected for the CAVLT and
EWFT(along with the other non-discussed CAP measures included in the battery). A
CAP battery is currently being administered to student volunteers at the University (by
this authors associated lab), and will be a first step toward allowing normative
comparisons. Additionally, ongoing development of the EWFT linguistic-affective
scoring protocol will allow for the norms to include valence factors and other affective-
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process indicators that might be of use in model development/evaluation and clinical
practice. Secondly, from a model and theoretical standpoint, additional research should
improve upon this study's methodology to better explore a cognitive-affective processing
mediated model for the sleep-mood disorder relationship. This might include using
known psychiatric groups (e.g., depression, anxiety, PTSD) and acquired brain injury
groups (e.g., TBI, right-hemisphere stroke, neurodegenerative disorders), which would
provide a much deeper and broader set of affective dysregulation. These populations also
are likely to have comorbid sleep disturbance, which would facilitate investigation into
the discussed model. Alternatively, a more severe sleep disorder sample might result in a
similar depth of mood disorder symptomatology to allow exploration of the model.
Further integration of physiological measures, and inclusion of functional
imaging/mapping, would allow for exploration of how our cognitive-affective processing
measures differ at a neural network level from other standard counterparts. This would
provide information that could guide future hypotheses about types of conditions and
injuries that might have clinical/functional decrements associated with as-of-yet
unquantified biases in their processing of affective stimuli. This author's associated lab
recently acquired simultaneous EEG - near infrared spectroscopy, which will be
incorporated in future studies, to facilitate pursuit in these directions. For example, using
this functional imaging technology with healthy groups during norm collection could
provide neuroanatomical convergent validity data, if CAP-related areas of the brain are
recruited during CAVLT versus CVLT performance. Follow-up investigation of
compensatory hypotheses as applied to concussion, sleep-deprivation, and normal aging
populations would similarly lednt themselves to the concurrent imaging research
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methodology. Finally, exploring what ecological and/or psychosocial functioning
constructs are associated with the cognitive-affective processing measures would
reinforce the importance of exploring the proposed model and provide guidance in further
hypothesis generation.

Conclusions
In this study, novel measures of cognitive-affective processing (memory and word
fluency) were constructed and administered to patients with obstructive sleep apnea,
along with standard neurocognitive measures of memory and word fluency, self-reported
sleep quality, and self-reported mood. The polysomnogram (sleep physiology) data of
each patient was obtained, and all constructs analyzed, in hopes of validating the new
cognitive-affective processing (CAP) measures and evaluating the applicability of a
CAP-mediated relationship between sleep and depression. Mixed findings suggested that
cognitive-affective processing was related to both sleep physiology and depression, but
unexpected null findings between sleep and mood impeded the evaluation of a pathway
model. Exploratory analyses suggest there may be a more complex model relating the
three constructs of interest, incorporating multiple sleep physiological indicators (e.g.,
REM sleep pathology, hypoxia, disturbed sleep architecture) and emotional constructs
beyond just depression (i.e., positive and negative affect).
Of additional interest, cognitive-affective processing differences between OSA
severity groups were broader and more significant than those detected for standard
neurocognitive measures, suggesting potential better sensitivity toward dysfunction
secondary to sleep-disordered breathing. Dysfunction across constructs was
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predominately found in the severe OSA group, suggesting that a threshold-model (rather
than dose-dependent model) of OSA pathology might best explain neuropsychological
pathological expression. This hypothesis suggests that mild and moderate OSA
populations might be eligible targets for neuro-compensation research already being
conducted in mild TBI and ageing populations.
Additionally, this study provides initial support for a neuropsychological measure
of how humans process emotionally-laden information. The measure has significant
potential for use in research, specifically in exploring whether biases in processing
certain valenced emotional information contributes to the onset or maintenance of mood
and personality disorders. Clinical application will follow advances in the research.
Incorporation of the new measures into practice will ideally allow neuropsychologists to
improve differentials, treatment-response prediction, and functional coping
recommendations. The goals of future research will be to generate normative data and
expand the psychometrics of the CAP measures produced by this author and his
supervisor. In addition, the biased cognitive-affective processing model of negative mood
will be evaluated within psychiatric and neurological samples. Integration of functional
imaging in both research directions will further elucidate the mechanisms underpinning
normal and dysfunctional cognitive-affective processing.
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Appendix A: Additional Sleep Physiology Information
Sleep
Sleep Stages and Characteristics
Sleep in mammalian species has been generally categorized into two separate types rapid eye movement (REM) sleep, and non-rapid eye movement (NREM) sleep, which
has predominently been further subdivided in primates into four, progressively deeper,
stages (Rechtschaffen & Kales, 1968). Research in human sleep patterns has identified a
90 minute alternating, ultraradian cycle between NREM and REM sleep. The length of
this cycle generally does not change throughout a normal sleep session, however, the
ratio of NREM to REM sleep shifts from predominantly stage 3 and 4 NREM sleep early
in the sleep session to stage 2 NREM and REM sleep in the latter half of the sleep
session. Thus far, the purpose or principal behind this sleep-type organization is not well
understood (Walker, 2009).
More recently, NREM sleep stages have undergone a terminology transition; the
American Academy of Sleep Medicine (2007) concluded that there no significant
physiological or clinical differentiation existed for NREM stage 3 and stage 4 sleep, thus
they were combined into a final NREM sleep stage termed N3. The original NREM stage
1 and stage 2 sleep terms were altered to N1 and N2, respectively. In this review, the new
terminology will be used, unless otherwise noted.
Electroencephalographic & Associated Physiological Characteristics
Progression through sleep stages usually is tracked using electroencephalographic (EEG)
activity and patterns, with progression through NREM sleep being associated with a
slowing of brain wave frequency. The most recent scoring manual of the AASM (2007)
provides classification guidelines in part based upon EEG phenomena, as well as certain
physiological activity. During alert wakefulness, desynchronized beta waves (12-30 Hz)
with a high mixture of frequencies dominate EEG readings. In stage N1, the brain
transitions from alpha waves (8-12 Hz; associated with relaxed wakefulness with closed
eyes) to theta waves (4-7 Hz). This stage is characterized as a state of
drowsiness/somnolence and is associated with hypnic jerks (also known as positive
myoclonus), and some loss in conscious environmental awareness and muscle tone. If
aroused during this stage, most individuals will report having been fully awake. Stage N2
(see Figure 2*inset sleep graph of spindles & k-complexes) is characterized by EEG
waves in the 11-16 Hz range (12-14 Hz is most common). Sleep spindles, brief bursts of
activity, occur during this stage, and are thought to represent the brain inhibiting
processing and response to external stimuli in order to maintain a tranquil state (DangVu, McKinney, Buxton, Solet, & Ellenbogen, 2010). K-complexes are also present,
which are thought to represent a brief evaluation of how dangerous external stimuli are
before an inhibition of cortical arousal (Cash, Halgren, Dehghani, Rossetti, Thesen,
Wang, et al., 2009). Roughly 50 percent of a normal sleep session is spent in N2 sleep
(NIH, 2007). Reports of dreaming during N1 and N2 sleep is rare (AASM, 2007).
The AASM (2007) characterizes stage N3 (formerly stages 3 and 4) as the deepest
stage of sleep, and is often referred to as slow-wave sleep (SWS) due to the occurrence of
low frequency brain waves (0-4 Hz), with a minimum of 20% activity being delta waves
(.5-2 Hz). Delta waves begin emerging at the onset of N3, eventually dominating the
EEG. During delta wave sleep, global inhibition of neurons occurs via the release of
gamma-aminobutyric acid (GABA), which will be discussed further in the neurobiology
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section (Hobson & Pace-Schott, 2002). The global slowing represents a mass cortical
synchronization (Steriade & Amzica, 1998), which is thought to represent an
organizational processing related to daytime cognition and will be discussed later. N3
sleep is often when parasomnias (e.g., night terrors, somniloquy, sleepwalking, nocturnal
enuresis) occur. Though dreaming was previously thought not to occur during any stage
of NREM sleep, recent research has suggested that more disconnected, and less vivid and
memorable dreams can occur during this stage (McNamara, McLaren, & Durso, 2007).
A shift in frequency occurs during REM sleep, with a reemergence of theta waves
(4-7 Hz) along with the occurrence of high frequency gamma waves (30-80 Hz) that
demonstrate synchronic activity (Llinas & Ribary, 1993). Another defining phenomena of
REM sleep is the presence of bursts of rapid eye movement in rhythm with phasic
endogenous waveforms. The waveforms primarily occur in the pons, lateral geniculate
nuclei of the thalamus, and the occipital cortex, and thus are sometimes referred to as
PGO waves (Callaway, Lydic, Baghdoyan, & Hobson, 1987). A typical sleep session will
have REM sleep make up 20-25% (90-120 minutes) of sleep time, over the course of 4-5
progressively longer REM periods. A period of light sleep or brief arousal often occurs
following a period of REM. Vivid and easily recalled dreams occur during this stage of
sleep. During periods of REM sleep an increase in the variability of breathing rate, heart
rate, and temperature occurs, along with increased blood flow and engorgement in the
genitals (AASM, 2007). Descending muscle atonia also occurs, which has been
hypothesized to be a protective process designed to prevent acting out dream sequences
(Mahowald & Schenck, 2009). Thus, failure of this process is thought to be the cause of
REM behavior disorder (Schenck & Mahowald, 2002).
Neurochemical Characteristics
Wakefulness is associated with ascending, efferent projections from the reticular
activating system, located in the brainstem. These ascending projections arrive in the
hypothalamus, thalamus, and basal forebrain, which eventually continue to the cortex.
The neurotransmitters associated with the reticular formation include the catecholemines,
histamine, acetycholine, asparate, and glutamate. Behavioral consequences like increased
arousal after use of amphetamines and somnolence after use of anti-histamines primarily
impact this system.
As an individual progresses through the different stages of sleep, dramatic
changes occur to the neurochemical makeup of the brain. Saper, Chou, and Scammell
(2001) offered a review that concluded the sleep-wake cycle is regulated by a
reciprocally inhibitory sleep/wake switch made up of the ventrolateral preoptic nucleus
(activated during sleep; GABA-ergic and galanergic) and the posterior lateral
hypothalamus (activated during arousal and wakefulness maintenance; consists of orexin
and hypocretin neurons). During NREM sleep GABAergic neurons in the cortex,
thalamus, hypothalamus, and brain are at their highest activation. An increase of
intracerebroventricular adenosine levels has also been associated with increased NREM
sleep time (Rosenthal, 1998). Different studies of NREM sleep have found a decrease in
the activity of subcortical cholinergic systems found in the forebrain and brainstem
(Hobson, McCarley, & Wyzinski, 1975; Lydi & Baghdoyan, 1988). Additionally,
compared to wakeful activation levels, the noradrenergic locus coeruleus neurons and
serotonergic Raphe neurons have decreased firing rates (Aston-Jones & Bloom, 1981;
Shima, Nakahama, & Yamamoto, 1986).
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The acetycholinergic neurons in the pontine tegmentum (specifically, the
medullary reticular and lateral pontine areas) have been termed "REM on cells," and
innervate hypothalamus, hippocampus, and thalamus. Rising levels of physostigmine (a
catabolic enzyme inhibitor) during NREM precipitate the initiation of REM sleep.
Additionally, research has demonstrated that introducing carbochal (a muscarinic agonist)
to REM on cells causes REM sleep to occur (Rosenthal, 1998). During REM sleep, both
of the previously mentioned aminergic centers are significantly inhibited and the
cholinergic systems become as (or more) activated as wakeful levels. This results in a
neurochemical environment dominated by acetylcholine with little, if any, amingergic
modulation (Kametani & Kawamura, 1990; Marrosu, Portas, Mascia, Casu, Fa,
Giagheddu, et al., 1995). The Raphe and locus coeruleus contain serotonergic and
noradrenergic cells that have been labeled "REM off cells," which are completely or
largely inactive during REM sleep, with higher degrees of activation during NREM and
wakeful periods (Rosenthal, 1998). The finding that serotonin and norepinepherine levels
impact REM sleep is supported by research demonstrating that anti-depressants that
increase these two neurotransmitters decrease the percentage of REM sleep individuals
experience, and that this decrease is proportional to the effectiveness of the drug (Benca,
Obermeyer, Thisted, & Gillin, 1991; Vogel, Thurmund, Gibbons, Sloan, Boyd, &
Walker, 1975).
Functional Anatomical Characteristics
NREM and REM sleep have been found to have distinctly different functional anatomy
patterns, across a variety of neuroimaging techniques. Generally speaking, reduced
activity in the prefrontal and temporal lobes, basal ganglia, thalamus, and brainstem
occurs during NREM (specifically, stage N3). In contrast, REM sleep is associated with
elevated activity in the mediobasal prefrontal lobes, occipital cortex, thalamic nuclei, and
pontine tegmentum. Additionally, affect-related areas like the anterior cigulate cortex,
amygdala, and hippocampus are activated. Conversely, the posterior cigulate, parietal
cortex, and dorsolateral prefrontal cortex are the least activated during REM sleep
(Nofzinger, 2005).
Sleep-Wake Cycle
Three separate yet networked neuroanatomical systems regulate the sleep-wake cycle in
humans (Borbely & Achermann, 1999; Pace-Schott & Hobson, 2002). A homeostatic
regulation system is responsible for intensity, length, and quantity of sleep. The cyclical
vacillation between REM and NREM sleep within each sleep period is controlled by an
ultradian system. Finally, a circadian system manages the timing of sleep and wake
periods within the overall day-night cycle. Preoptic neural circuitry has been associated
with the homeostatic functions, mesencephalic and pontine rostral brainstem areas with
the REM/NREM regulation, and anterio-hypothalamic elements with circadian functions.
With the REM/NREM relationship discussed in detail previously, the present section will
focus on the remaining two drives, how the two drives interact to consolidate sleep, and
finally, the current conceptualization of how the switch between sleep and wake occurs.
Homeostatic Regulation
There exists no exact understanding of the physiological processes responsible for the
sleep drive that humans (and all mammals) experience, it is currently conceptualized as a
homeostatic pressure that accrues during wakefulness and dissipates during sleep periods.
This propensity for sleep can be thought of as how much an individual is in need of sleep
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to regain homeostatic balance. The power of delta EEG waves (mentioned previously)
have been demonstrated as a marker for the degree of homeostatic pressure (Fuller,
Gooley, & Saper, 2012). While no cellular substrate for the process has thus been
identified, adenosine has been identified as a molecular-level somnogen at the cellular
level. During wakeful periods, it is hypothesized to naturally accumulate to levels that
impact sleep/wake related areas of the brain. This nucleoside has an activating effect on
VLPO neurons bordering the basal forebrain and an inhibitory effect on wake-promoting
areas of the basal forebrain (Porkka-Heiskanen, Strecker, Thakkar, Bjorkum, Greene, &
McCarley, 1997). Thus, during wakeful accumulation of adenosine, a drive towards sleep
accrues.
Consistent with this model, research has demonstrated that blood serum levels of
adenosine rise during extended periods of wakefulness, decrease during sleep, that
adenosine agonists promote sleepiness when injected intraventricularly, and that
adenosine antagonists (e.g., the commonly known substance caffeine) increase
wakefulness and decrease sleepiness when introduced near the VLPO (PorkkaHeiskanen, Alanko, Kalinchuk, & Stenberg, 2002). At the same time, the cellular basis
for homeostatic pressure to sleep has not been identified, as recent research pointing out
that accumulation of adenosine in the basal forebrain is not required for sleep propensity
(Blanco-Centurion, Xu, Murillo-Rodriguez, Gerashchenko, Shiromani, Salin-Pascual,
Hof, & Shiromani, 2006).
Circadian Regulation
Reactive homeostatic drives are useful for restoring physiological equilibrium. However,
there exists another regulatory process, termed the circadian timing system, that provides
temporal organization of most biochemical, physiological, and neurobehavioral
processes. The advantage of temporal organization, as opposed to homeostatic reaction, is
its predictive and anticipatory nature (Moore-Ede, Sulzman, & Fuller, 1982). For
example, prior to waking, the circadian timing system (CTS) cues processes that will be
advantageous to the wakeful state (e.g., increased sympathetic autonomic activity, rise in
body temperature, increased circulating cortisol levels).
The CTS is comprised of three components, the central of which is the
suprachismatic nucleus (SCN) of the anterior hypothalamus, which acts as a circadian
pacemaker - coordinating circadian oscillator subcomponents via control over melatonin
secretion by the pineal gland (Rossenwasser & Turek, 2005). The SCN is responsible for
establishing the sleep-wake circadian rhythm. Support for SCN regulation of the 24.2
hour sleep-wake cycle has been demonstrated via continuation of the cycle in the absence
of temporal environmental cues, but only when the nucleus is intact (Mistlberger, 2005).
The SCN is entrained (i.e. synchronized) via physiological and environmental signals,
these include the retinohypothalamic tract (responsive to light-dark cycles),
geniculohypothalamic tract (secondary light-dark cycle entrainment, with a moderating
effect rather than direct influence), mesencephalic raphe nuclei (seratonergic modulation
of photic inputs and mediation of behavioral activity-states), and other neurochemicalspecific afferent tracts (histaminergic projections from the hypothalamus, cholinergic
projections from basal forebrain and pontine tegmentum, and noradrenergic projections
from the brainstem) (Bina, Rusak, & Semba, 1993; Moga & Moore, 1997; Morin &
Allen, 2006; Morin & Pace, 2002; Stephan & Zucker, 1972; Wada, Inagaki, Itowi, &
Yamatodani, 1991). The subcomponent circadian-oscillators in peripheral tissues are in
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turn entrained by physiological signals from the pacemaker component. Peripheral
circadian oscillators are understood to also contain endogenous, cellular-level pacemaker
"clock cells," independent of the circadian system as a whole (Herzog, 2007). The SCN is
thus thought to entrain the various peripheral cellular oscillators rather than sustain their
rhythmic activity (Okamura, 2004). Finally, the third component of the CTS are the
efferent projections that serve to regulate otherwise non-rhythmic physiological and
behavioral systems (e.g., body temperature, autonomic/endocrine systems, feeding,
sleep/wake state, locomotor activity). Most SCN efferent projections reach regions of the
thalamus, basal forebrain, preoptic area, and hypothalamus (Morin & Allen, 2006).
Current understanding of the circadian system posits that it promotes both wakefulness
and sleep - at opposite phases (Mistlberger, 2005).
Sleep-Wake "Switch"
Saper, Chou, and Scammell (2001) reviewed recent literature on sleep regulation and
identified a substantial amount of evidence that a reciprocal inhibition model of sleep and
arousal systems exists. GABAergic and galaninergic neurons of the ventrolateral preoptic
nucleus (VLPO) are active and necessary for normal sleep. In contrast, hypocretin/orexin
(exchangeable names) neurons within the posterior lateral hypothalamus (PLHT) are
necessary for maintaining normal wakefulness. These two systems are thought to exist in
a sustained state of balanced reciprocal inhibition (a bistable feedback loop) when not
influenced from external pressures. Once either of the systems is excited, it inhibits the
other, thereby resulting in further excitation due to decreased inhibitory afferents from its
partner.
This neuroanatomical equivalent of a "flip-flop" circuit has the advantage of
resulting in two potential firing patterns and an avoidance of an intermediary state. The
result is a behaviorally stable wakeful or sleep state, with switches occurring rapidly and
therefore transition periods being brief. Additionally, the self-reinforcing characteristic
means the wakeful/sleep states are relatively resistant to switching due to normal
projection fluctuations occurring over the day and night. Instead, the switch can only be
"flipped" by the large, accumulating, physiological pressure from homeostatic and
circadian inputs. Dysfunction of either system decreases the balance of the switch,
lowering the threshold for one behavioral state to be initiated and raising the needed
pressure to "flip" the switch to the other. To summarize the effects of both the individual
wakeful/sleep systems, and their reciprocal relationship, let us consider a lesion to the
VLPO. This would result in decreased sleep-encouraging projections, more wakefulness,
and therefore increased homeostatic pressure for sleep on the flip-flop circuit. This results
in the circuit nearing its switch-point more often, and more episodes of falling asleep,
however, due to the self-reinforcing characteristic of the switch having been weakened,
this sleep-state is interrupted more often. The overall result being shortened periods of
wakefulness and sleep, switching more frequently.
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Appendix B: Demographics
DATE: ____________________
TIME:________________________
Please provide the following information. You are not obligated to answer questions that
you do not feel comfortable answering.
1) Gender:
__Female
__Male
__Other:__________________________________
2) Age: ______
3) Country of birth: _____________________________________________________
Length of residence in Canada: _______________
4) Ethnicity:
__ Caucasian/White __ African-Canadian/Black __ Asian/Southeast Asian
__Hispanic
__ First Nation/Indigenous __ Arabic
__ Other:
5) First language: _______________
Other languages spoken:
If English is 2nd language, at what age did you begin speaking it?
6) Highest grade completed in high school: _____
If you attended school after high school was it a (check all that apply):
__Technical or Vocational School?
__ College or University?
How many years of education did you complete after high school? _______
7) History of military service?
__ No
__ Yes; please specify length of service, and if you were deployed in combat:
__________________________________________________________________
8) What is your current occupation, if you are retired, what was your primary occupation
before you retired?
_______________________________________________________________________
_______________________________________________________________________
__
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9) Approximately what was the total combined income of all members of this family in
2011?
___ 0 - $10,000
__ $10,001 - $15,000
__ $15,001 - $20,000
__ $20,001 - $30,000
__ $30,001 - $40,000
__ $40,001 - $50,000
__ $50,001 - $75,000
__ $75,001 or more
10) List of current medications (if you cannot remember the name, please describe what
the medication looks like and what reason it is being taken):
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
____
11) Have you ever been assessed, diagnosed, and/or treated for a psychological disorder
(e.g., Attention-deficit hyperactivity disorder, Depression, Anxiety, Bipolar Disorder,
Schizophrenia, etc.)?
__ No
__ Yes; please specify disorder/s, and whether you currently use or in the past
used medication to treat the symptoms:
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
12) Do you smoke tobacco products currently?
__ Yes; specify type and amount per week: ____________________
__ No
If you smoked in the past, how much, for what period of time, and when did you
quit?
___________________________
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13) Do you drink alcoholic beverages currently?
__ Yes; specify type and amount per week: ___________________
__ No
If you drank in the past, how much, for what period of time, and when did you
quit?
__________________________________________________________________

14) Do you use any other recreational drugs (e.g. cocaine, marijuana, heroin, etc.)
currently?
__ Yes; specify type and amount per week: _________________
__ No
If you used the past, how much, for what period of time, and when did you quit?
__________________________________________________________________

15) Have you ever suffered a hard hit to the head (sometimes called a concussion)?
__ No
__ Yes; How many instances (estimate if you need)?________
Did you lose consciousness?
__ No
__ Yes, for how long? _______

16) Have you ever suffered from seizures or any other neurological conditions (e.g.,
cerebral-vascular accidents, strokes, traumatic brain injuries, etc.)?
__ No
__ Yes; please specify condition and the time period it occurred:
__________________________________________________________________
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17) Do any of your blood relatives suffer from psychological disorders (e.g., Depression,
Bipolar Disorder, Schizophrenia, etc.)?
__ No
__ Yes; please specify relation and disorder:
__________________________________________________________________
18) Do any of your blood relatives suffer from neurological disorders (e.g., Alzheimer's
disease, Parkinson's disease, other dementias, etc.)?
__ No
__ Yes; please specify relation and disorder:
__________________________________________________________________
19) Do you suffer from any sort of chronic pain?
__ No
__ Yes; please specify source of pain and whether it is controlled with
medication:
__________________________________________________________________
__________________________________________________________________
Are you in pain today?
__ No
__ Yes; please draw an X on the line below indicating the severity of pain
in at this moment

you are

|---------------------------------------------------------------------------------------------------------|
No Pain

Worst Pain

Imaginable
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20) Are you diagnosed with any sleep-related disorder?
__ No
__ Yes; please specify type of disorder and when you were diagnosed:
__________________________________________________________________
21) Approximately what month & year did you undergo a sleep study, also called a
polysomnogram study?
(This would have entailed you coming into a sleep lab, being hooked up to many wires,
and monitored throughout the night)
Year: ____

Month: ____ Day (if you can recall): ____

22) How many hours of sleep did you get last night? ______ Hours
Was your sleep last night restful?
__ Yes
__ No; why?
_______________________________________________________
23) How many times do you take a nap each week? _____ times per week
How many minutes do your naps usually last? _____ minutes
24) Do you have a Continuous Positive Airway Pressure (CPAP) device?
__ Yes
__ No; why not? (e.g., doctor never prescribed one; too expensive; it got lost; it
broke, etc.)_________________________________________________________
25) Has your physician ever recommended you use a Continuous Positive Air Pressure
(CPAP) device?
__ No
__ Yes;
Please specify how long ago the CPAP was suggested/prescribed
________
How often do you use your CPAP?
__ every night (7 nights per week)
__ most (5-6 nights per week)
__ every other night (3-4 nights per week)
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__ infrequently (1-2 nights per week)
__ rarely to never (0-1 nights per week)
If you are currently using a CPAP, how many nights have you used it in
the past week?
____ nights (1-7)
If you do not use your CPAP every night, what stops you? Mark those
descriptors that if improved, would result in you using your CPAP significantly more
often.
__ too uncomfortable
__ too embarrassing

__ too loud
__ I forget to put it on before

sleeping
__ I do not understand how to use it, I was not given enough
instruction
__ I do not understand how to use it, I have forgotten the
instructions I was given
26) How tall are you? __________
How much do you weigh? __________
27) List any cardio-vascular or metabolic disorders or diseases (e.g., diabetes, congestive
heart disease, arthrosclerosis, history of heart attack, history of stroke)
_______________________________________________________________________
_______________________________________________________________________
__
28) List any respiratory disorders, diseases, or problems you have (e.g., asthma, Chronic
Obstructive Pulmonary Disorder - COPD, chronic bronchitis, emphysema, etc.)
_______________________________________________________________________
_______________________________________________________________________
29) Do you exercise regularly?
__ No
__ Yes
How many days per week? __________ (1-7)
On days you do exercise, how long does your workout last on average? ________
What types of exercise do you use (check all that apply)?
__ Brisk walking

__ Jogging/Running

__ Swimming

__ Bicycling

__ Other cardio (e.g., jumping jacks, lunges, aerobics, stairclimbing, etc.)
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__ Weight-lifting

__ Other:_____________

30) Please place a check mark next to any of the below medical conditions that you have
been diagnosed with:
__

Myocardial infarction
(heart attack)

__

Congestive heart failure

__

Peripheral vascular disease
(also known as peripheral arterial disease, peripheral artery occlusive disease)

__

Cerebrovascular disease

__

Dementia

__

Chronic pulmonary disease

__

Connective tissue disease

__

Peptic ulcer disease

__

Mild liver disease (without portal hypertension, inlcudes chronic hepatitis)

__

Diabetes without end-organ damage (excludes diet-controlled alone)

__

Hemiplegia (one-sided paralysis of limbs/trunk of body)

__

Moderate or severe renal disease

__ Diabetes with end-organ damage (retinopathy, neuropathy, nephropathy, or brittle
diabetes)
__

Tumor without metastasis (found within last 5 years)

__

Leukemia (acute or chronic)

__

Lymphoma

__

Moderate or severe liver disease

__

Metastatic solid tumor

__

AIDS (not just HIV positive)
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Appendix C: Pittsburgh Sleep-Quality Index (PSQI)
INSTRUCTIONS:
The following questions relate to your usual sleep habits during the past month only.
Your answers should indicate the most accurate reply for the majority of days and nights
in the past month. Please answer all questions.
1. During the past month, what time have you usually gone to bed at night?
BED TIME ___________
2. During the past month, how long (in minutes) has it usually taken you to fall asleep
each night?
NUMBER OF MINUTES ___________
3. During the past month, what time have you usually gotten up in the morning?
GETTING UP TIME ___________
4. During the past month, how many hours of actual sleep did you get at night? (This may
be
different than the number of hours you spent in bed.)
HOURS OF SLEEP PER NIGHT ___________
For each of the remaining questions, check the one best response. Please answer all
questions.
5. During the past month, how often have you had trouble sleeping because you . . .
a) Cannot get to sleep within 30 minutes
Not during the
Less than
Once or twice
Three or more
past month_____
once a week_____
a week_____
times a week_____
b) Wake up in the middle of the night or early morning
Not during the
Less than
Once or twice
past month_____
once a week_____
a week_____

Three or more
times a week_____

c) Have to get up to use the bathroom
Not during the
Less than
past month_____
once a week_____

Once or twice
a week_____

Three or more
times a week_____

d) Cannot breathe comfortably
Not during the
Less than
past month_____
once a week_____

Once or twice
a week_____

Three or more
times a week_____

e) Cough or snore loudly
Not during the
Less than
past month_____
once a week_____

Once or twice
a week_____

Three or more
times a week_____

f) Feel too cold
Not during the

Once or twice

Three or more

Less than
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past month_____

once a week_____

a week_____

times a week_____

g) Feel too hot
Not during the
past month_____

Less than
once a week_____

Once or twice
a week_____

Three or more
times a week_____

h) Had bad dreams
Not during the
past month_____

Less than
once a week_____

Once or twice
a week_____

Three or more
times a week_____

i) Have pain
Not during the
past month_____

Less than
once a week_____

Once or twice
a week_____

Three or more
times a week_____

j) Other reason(s), please describe__________________________________________
How often during the past month have you had trouble sleeping because of this?
Not during the
past month_____

Less than
once a week_____

Once or twice
a week_____

Three or more
times a week_____

6.
During the past month, how would you rate your sleep quality overall?
Very good _____Fairly good _____Fairly bad ___Very bad ___________
7.
During the past month, how often have you taken medicine to help you sleep (prescribed
or
"over the counter")?
Not during the
Less than
Once or twice
Three or more
past month_____
once a week_____
a week_____
times a week_____
8.
During the past month, how often have you had trouble staying awake while driving,
eating
meals, or engaging in social activity?
Not during the
Less than
Once or twice
Three or more
past month_____
once a week_____
a week_____
times a week_____
9.
During the past month, how much of a problem has it been for you to keep up enough
enthusiasm to get things done?
No problem at all __________
Only a very slight problem __________
Somewhat of a problem __________
A very big problem __________
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10. Do you have a bed partner or room mate?
No bed partner or room mate __________
Partner/room mate in other room __________
Partner in same room, but not same bed __________
Partner in same bed __________
If you have a room mate or bed partner, ask him/her how often in the past month you
have had . . .
a) Loud snoring
Not during the
past month_____

Less than
once a week_____

Once or twice
a week_____

Three or more
times a week_____

b) Long pauses between breaths while asleep
Not during the
Less than
Once or twice
past month_____
once a week_____
a week_____

Three or more
times a week_____

c) Legs twitching or jerking while you sleep
Not during the
Less than
Once or twice
past month_____
once a week_____
a week_____

Three or more
times a week_____

d) Episodes of disorientation or confusion during sleep
Not during the
Less than
Once or twice
past month_____
once a week_____
a week_____

Three or more
times a week_____

e) Other restlessness while you sleep; please
describe__________________________________
Not during the
Less than
Once or twice
past month_____
once a week_____
a week_____

Three or more
times a week_____
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Appendix D: Epworth Sleepiness Scale (ESS)
How likely are you to doze off or fall asleep in the following situations, in contrast to
feeling just tired? This refers to your usual way of life in recent times. Even if you have
not done some of these things recently, try to work out how they would have affected
you. Use the following scale to choose the most appropriate number for each situation.
0 = would never doze
1 = slight chance of dozing
2 = moderate chance of dozing
3 = high chance of dozing
Situation

Chance of Dozing

Sitting and reading
Watching TV
Sitting, inactive, in a public place (e.g., a theater or a meeting)
As a passenger in a car for an hour without a break
Lying down to rest in the afternoon when circumstances permit
Sitting and talking with someone
Sitting quietly after a lunch without alcohol
In a car, while stopped for a few minutes in traffic
Total
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Appendix E: Center for Epidemiological Studies Depression Scale (CES-D)
Below is a list of the ways you might have felt or behaved. Please tell me how often you
have felt this way during the past week.
Rarely or
none of
the time
(less
than 1
day )
1. I was bothered by things that usually don’t
bother me.
2. I did not feel like eating; my appetite
was poor.
3. I felt that I could not shake off the blues
even with help from my family or friends.
4. I felt I was just as good as other people.
5. I had trouble keeping my mind on what I
was doing.
6. I felt depressed.
7. I felt that everything I did was an effort.
8. I felt hopeful about the future.
9. I thought my life had been a failure.
10. I felt fearful.
11. My sleep was restless.
12. I was happy.
13. I talked less than usual.
14. I felt lonely.
15. People were unfriendly.
16. I enjoyed life.
17. I had crying spells.
18. I felt sad.
19. I felt that people dislike me.
20. I could not get “going.”
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Some or a
little of the
time (1-2
days)

Occasionally
or a
moderate
amount of
time (3-4
days)

Most or
all of the
time (5-7
days)

Appendix F: Positive and Negative Affect Schedule - Expanded (PANAS-X)
This scale consists of a number of words and phrases that describe different feelings and
emotions. Read each item and then mark the appropriate answer in the space next to that
word. Indicate to what extent you have felt this way during the past few weeks. Use the
following scale to record your answers:
1
very slightly
extremely
or not at all

2
a little

3
moderately

4
quite a bit

5

1. ______ cheerful

23. ______ timid

46. ______ angry at self

2. ______ disgusted

24. ______ alone

47. ______ enthusiastic

3. ______ attentive

25. ______ alert

48. ______ downhearted

4. ______ bashful

26. ______ upset

49. ______ sheepish

5. ______ sluggish

27. ______ angry

50. ______ distressed

6. ______ daring

28. ______ bold

51. ______

7. ______ surprised

29. ______ blue

blameworthy

8. ______ strong

30. ______ shy

52. ______ determined

9. ______ scornful

31. ______ active

53. ______ frightened

10. ______ relaxed

32. ______ guilty

54. ______ astonished

11. ______ irritable

33. ______ joyful

55. ______ interested

12. ______ delighted

34. ______ nervous

56. ______ loathing

13. ______ inspired

35. ______ lonely

57. ______ confident

14. ______ fearless

36. ______ sleepy

58. ______ energetic

15. ______ disgusted

37. ______ excited

59. ______

with self

38. ______ hostile

concentrating

16. ______ sad

39. ______ proud

60. ______ dissatisfied

17. ______ calm

40. ______ jittery

with self

18. ______ afraid

41. ______ lively

19. ______ tired

42. ______ ashamed

20. ______ amazed

43. ______ at ease

21. ______ shaky

44. ______ scared

22. ______ happy

45. ______ drowsy
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Appendix G: North American Adult Reading Test (NAART)
Please read the following words aloud:

DEBT

RARELY

ASSIGNATE

DEBRIS

GIST

TOPIARY

AISLE

CORPS

CAVEAT

REIGN

HORS D'OUERVE

SUPERFLOUS

DEPOT

SIEVE

LEVIATHAN

SIMILE

HIATUS

PRELATE

LINGERIE

GAUCHE

QUADRUPED

RECIPE

ZEALOT

SIDEREAL

GOUGE

PARADIGM

ABSTEMIOUS

HEIR

FACADE

BEATIFY

SUBTLE

CELLIST

GAOLED

CATACOMB

INDICT

DEMESNE

BOUQUET

DETENTE

SYNCOPE

GAUGE

IMPUGN

ENNUI

COLONEL

CAPON

DRACHIM

SUBPOENA

RADIX

CIDEVANT

PLACEBO

AEON

EPERGNE

PROCREATE

EPITOME

VIVACE

PSALM

EQUIVICAL

TALIPES

BANAL

REIFY

SYNECDOCHE

INDICES
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Appendix H: California Verbal Learning Test - Second Edition (CVLT-2)
The details of this measure have been redacted from the appendix to comply with
copyright law. Committee members were provided an example copy for review purposes.
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Appendix I: FAS & Animal Fluency
In a moment, I will give you a letter. List as many words that you can think of that begin
with that letter, you will have 1 minute. Do not give me proper nouns (e.g., Boston,
Betty), or simply change the ending of a word repeatedly (e.g., eat, eats, eating, eaten).
Now tell me as many animals as you can in 1 minute.
F

A

S

15

30

45
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Animals

Appendix J: Cognitive-Affective Verbal Learning Test (CAVLT)
Instructions: I am going to read a list of words to you. Listen carefully, because after I
am done, I would like you to repeat back as many words as you can remember. Do not
worry about the order of the words, just try to repeat back as many as you can remember.
Are you ready? Trial 1
I will now read that same list of words again. Repeat back as many of the words as you
can remember, in any order. Do not leave out words simply because you repeated them in
the last trial.
Are you ready? Trials 2-5
1st Trial

2nd Trial

column
triumphant
context
theory
aroused
sad
method
engine
happy
utensil
lonely
misery
reserved
tool
afraid
proud
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3rd Trial

4th Trial

5th Trial

Now I am going to read a second list of words to you. When I am done, I would like you
to repeat back as many words as you can remember from this second list as you can. Do
not give words from the first list, just this second list.
Are you ready? Distracter Trial
Now I would like you to repeat back the words from the first list, the one I read to you
multiple times. Do not repeat back words from the second list, just the first list. Short
Delay Free Recall
Now tell me words from the first list that were (+/-/nonemotion) words. Short Delay
Cued Recalls
Distracter
SDFR
SDC+
SDCLDNE
despise
pleasure
journal
confident
noisy
terrific
helpless
hatred
industry
elbow
depression
detail
statue
umbrella
kindness
serious
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After 20 minutes. Remember earlier I read two lists of words to you? The first list I read
to you multiple times, tell me all the words you remember from that first list, the one I
read to you multiple times. Long Delay Free Recall
Now tell me words from the first list that were (+/-/nonemotion) words. Long Delay
Cued Recalls
LDFR
LDFR
LDC+
LDCLDCNE

I am going to read you a long list of word. It will contain all the words from the first list,
the one we repeated multiple times, as well as many other words. For each word say
"Yes" if the word was on the first list, or "No" if it was not on the first list. Recognition
List
terrified
time
sad
aroused
elbow
kindness
journal
clock
method
afraid
grief
umbrella
context
success

locker
triumphant
reserved
lucky
misery
romantic
column
happy
delight
unhappy
rejected
proud
statue
industry

helpless
utensil
hatred
month
terrific
concentrate
lonely
serious
depression
history
swamp
noisy
theory
despise
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detail
engine
odd
confident
tool
pleasure

Recognition
Correct

Total
Breakdown
Neg
Emotions

Pos
Emotions

False Positive
False Negative
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NonEm
Conc

NonEm
Abs

Appendix K: Emotion Word Fluency Test (EWFT)
For this next task, I would like you to give me as many different EMOTION words as
you can in 1 minute.
Emotions

15”

30”

45”

60”

Emotions:

Total Correct

Perseverations

174

Non-Emotion Words

Appendix L: Sample Polysomnogram Report
Split Night Polysomnography Report
History: Upon review of the available data, the patient reports symptoms including:
snoring and daytime sleepiness. The Epworth Sleepiness score is 19 / 24.
Technical Summary: Attended in-laboratory recording montage included: EEG, EOG,
EMG, EKG, nasal thermistor flow, nasal pressure, pharyngeal snoring, respiratory effort
(2 channels), anterior tibialis EMG, SaO2 and body position. Continuous Positive Airway
Pressure (CPAP) was initiated after the patient demonstrated clinically significant
obstructive sleep apnea. This study was performed in accordance with the AASM scoring
manual.
Pre-CPAP
Baseline
Duration
Sleep Time
Sleep
Efficiency
Sleep
Latency
Obstructive
Apnea
Mixed
Apnea
Central
Apnea
Hypopnea

184.0
min

Total RDI

93.2

WASO

51.0 min

114.0
min
62.0%

NREM RDI

95.8

Stage N1

49.1 %

Stage R
RDI
Supine RDI

66.0

Stage N2

42.1 %

91.11

Stage N3

0.00 %

Non-supine
RDI
Medicare
AHI
Min
%SaO2
Baseline
%SaO2

107.4

Stage R

8.8 %

88.9

Stage R
Latency

132.0 min

10.5 min
3
0
16
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All Night
Total
Recording
Time
Total Sleep
Time
Sleep
Efficiency

412.0
min
238.0
min
63.8%

69 %

PLM index

0.0

92 %

PLM
arousal
index

0.0

Snoring: Frequent and loud during the diagnostic portion of the study.
PAP was titrated from 5 to 11 cm of water pressure. At a CPAP pressure of 10 cm of
water, supine-REM sleep was observed with very rare respiratory events. Lower
pressures were associated with respiratory events.
EKG Findings: Single-lead demonstrated isolated premature atrial and ventricular
complexes.
EEG Findings: Three channel EEG demonstrated no seizure activity.
Further Interpretive Notes: The patient reported that sleep was better than usual, awoke
feeling rested and would be willing to wear CPAP at home.
Diagnosis: Obstructive Sleep Apnea 327.23
Discussion: Treatment for severe obstructive sleep apnea is often warranted even in the
absence of clinical symptoms. Recommended options include positive airway pressure,
custom-made oral appliances, or upper airway surgery. Regardless of treatment approach
for the obstructive sleep apnea, maximization of nasal airway patency, weight loss if
appropriate, and avoidance of sedatives and alcohol in proximity to bedtime are strongly
encouraged.
• This study shows the effectiveness of CPAP in treating sleep-disordered breathing.
Consider a trial of CPAP at 10 cm of water pressure during sleep with clinical follow-up
to assess treatment response.
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Appendix M: Phone Script
Telephone Recruitment Script
Hello Mr./Ms. _______, my name is _______ and I am a researcher associated with the
University of Windsor and the Windsor Regional Hospital. Do you have a moment to
talk, or is there a better time I could reach you?
We obtained your number from the Windsor Regional Hospital and Dr.'s Anil Dhar &
Winston Rajkumar, of the Windsor Pulmonology & Sleep Clinic. The reason we are
contacting you is that you may be eligible to participate in a research project investigating
certain characteristics related to obstructive sleep apnea, sleep quality, thinking, and
mood. Could I tell you a little more about the project and its potential benefits for the
field and yourself?
Other research has found that when sleep is poor, individuals sometimes experience more
problems than usual with certain types of thinking, such as sustaining attention and
processing information quickly. Additionally, sleep has sometimes been found to be
related to mood. You may in fact have had firsthand experience with these phenomena,
for example, having a night where you slept very little, and the next day feeling grumpy
and/or finding it hard to think straight. As you likely know, sleep apnea disrupts sleep
often throughout the night.
Regardless of when you were diagnosed with sleep apnea and how frequently you follow
your treatment regimen, we would really appreciate your involvement in the study. Could
I tell you about what participating would entail?
If you agree to participate, we would arrange a date and time that work for you to come
to the hospital to meet with a researcher. Once there, you would fill out a series of
questionnaires asking about your sleep quality, daytime sleepiness, and mood lately. The
hospital has data on how well you slept during your sleep evaluation, which we will look
at with your permission. Finally, the researcher would lead you through a series of
cognitive tasks, designed to measure how well you perform in different domains of
thinking, such as memory, attention, and language. Your name will not be attached to
ANY of the data we collect. The whole session should not last longer than 2 or 2.5 hours.
Could I tell you about what potential benefits participating has?
First off, there is free parking; second, we will provide you a free Tim Horton's gift card
for 1 small item as thanks for participating (there is even a Tim's in the hospital, if you
would like). But also, by participating, you would be helping researchers learn more
about possible cognitive complications associated with a sleep problem that you have
experienced. This could guide screening and treatment options for healthcare providers
and apnea sufferers in the future. Additionally, there is a personal benefit that we can
offer you, if you wish. Individuals who suspect that their thinking abilities have changed
(such as recently noticing a lot of trouble with memory) due to age, a disorder or disease,
an injury to the head, etc., often go to a clinical psychologist to have testing done and
help handle any changes to their thinking. If you participate, you can request us to take a
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look at your scores, and we will offer an opinion on whether you might benefit from at
least discussing your cognitive health with your primary care physician. We will also
give you some clinical psychologist referral information you can discuss with him or her.
All of that is only done if you ask us to. To be clear, our assessment would not be like
that conducted in a patient-clinician relationship, but merely a screening system that
MAY indicate you could benefit from talking with your physician about your cognitive
health.
Do you have any questions or concerns about participating that I could answer for you?
Could I arrange a time and date for an appointment right now?
We appreciate your involvement, and look forward to meeting you. If you would like, we
can call the day before to remind you of the appointment, would you like that?
Thank you.
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Appendix N: Brochure
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Appendix O: Referral Information
Referral Information
You have expressed interest in further information related to cognitive health, the
following information should assist you with the suggested process.
Suggested Referral Process:
The best first step is to contact your primary care physician, or another physician who
you see regularly.
Inform him or her that you recently participated in a study related to cognition, and are
interested in discussing the possible benefits of undergoing neuropsychological
evaluation to evaluate your current cognitive health.
Discuss with your doctor whether he or she also feels a referral might be useful for you
and your healthcare team.
Your doctor will likely have his or her own preferred referral sources for cognitive health
screening and/or neuropsychological evaluation services. However, below are some
popular programs through the Windsor Regional Hospital that may be appropriate to
contact as a referral source, depending on your eligibilities:
--------------------------------The Geriatric Assessment - Consultation Program (GAP)
Service Director: Rose Grant-Rennie,
Phone: (519) 257-5112
Fax: (519) 257-5242
The Community Psychogeriatric Outreach Program
Service Director: Bill Marcotte
Phone: (519) 257-5105
Fax: (519) 257-5197
The Acquired Brain Injury Program (ABI)
Service Director: John Norton
Phone: Program Secretary - (519) 257-5458
Manager: Chris Edwards - (519) 254-5577 Extension, 75230
Fax: (519) 257-5242
--------------------------------Alternatively, there are private neuropsychologist service providers who can be contacted
by your doctor or yourself:
Hobbs & Associates
Phone: (519) 948-1212
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Referral Information
You have expressed interest in further information related to psychological health, the
following information should assist you with the suggested process.
Suggested Referral Process:
The best first step is to contact your primary care physician, or another physician who
you see regularly.
However, if an emergency arises related to your mood (e.g., suicidal
thoughts),
please immediately call 911 or 999 or go immediately to
your nearest Emergency
Department.
Inform him or her that you recently participated in a study related to cognition, and are
interested in discussing the possible benefits of receiving psychological services.
Discuss with your doctor whether he or she also feels a referral might be useful for you
and your healthcare team.
Your doctor will likely have his or her own preferred referral sources for psychological
services. However, below are some popular programs through the Windsor Regional
Hospital that may be appropriate to contact as a referral source, depending on your
eligibilities:
--------------------------------The Specialized Inpatient Mental Health Care Program
Service Director: Judy Smith
Phone: (519) 254-5577 Extension 75186
Fax: (519) 257-5197
Geriatric Mental Health Outreach Team
Service Director: Bill Marcotte
Phone: (519) 257-5105
Fax: (519) 257-5197
--------------------------------Alternatively, there are private psychology service providers who can be contacted by
your doctor or yourself:
Sandwich Community Health Centre
Phone: (519) 258-6002
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